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ABSTRACT 
IL-13 is a key cytokine orchestrating the development of protective immune responses against 
Nippostrongylus brasiliensis (N. brasiliensis) infection. The contribution of CD28 costimulation 
during primary responses to helminth infections is well established. Mice lacking CD28 
expression failed to clear N. brasiliensis infection and exhibited impaired Th2 cytokine responses. 
The necessity of CD28 costimulation during recall of protective memory responses to pathogens 
has remained largely controversial. Hence, in this study, we investigated the role of CD28 during 
recall of memory responses to N. brasiliensis infection using a novel mouse model that allows for 
cd28 gene deletion by oral administration of estrogen receptor analogue tamoxifen. As expected, 
CD28
-/-
 mice failed to clear primary N. brasiliensis infection due to impaired cellular and humoral 
immune responses. Interestingly, deletion of cd28 gene by oral administration of tamoxifen in 
CD28
-/lox
Cre
+/-
 mice prior to secondary infection resulted in abrogated worm expulsion, reduced 
recruitment of CXCR5
+
 TFH cells, reduced expansion of central and effector memory CD4
+
 T 
cells and follicular B cells. Likewise, CD28
-/-
 mice failed to expel N. brasiliensis worms during 
secondary infection and displayed reduced numbers of CXCR5
+
 TFH cells. Together, these data 
demonstrate a crucial role for CD28 costimulation in recall of protective Th2 immune responses 
and expansion of CXCR5
+
 TFH cells during N. brasiliensis secondary infection.  
 
Protective immunity to S. mansoni infection is dependent on the development of sufficient CD4
+
 
T cell driven Th2 immune response and granuloma formation. Mice deficient in IL-4, IL-4/IL-13, 
IL-4/IL-10, IL-4Rα and signal transducer and activator of transcription-6 (STAT-6) were found to 
be highly susceptible to S. mansoni infection due to impaired Th2 polarisation, reduced 
granuloma formation, reduced fibrosis and increased tissue inflammation. Studies from our 
laboratory using cell-specific IL-4Rα deficient mice have been crucial in elucidating mechanisms 
conferring protection or susceptibility to acute Schistosomiasis. Mice lacking IL-4/IL-13 
responsive macrophages and neutrophils (LysM
cre
IL-4Rα-/lox) quickly succumbed to S. mansoni 
infection compared to littermate control mice despite the presence of Th2 cytokines. Heightened 
susceptibility in LysM
cre
IL-4Rα-/lox mice was associated with augmented liver pathology and 
destruction of gut integrity that ultimately led to endotoxemia and septic shock. IL-4Rα 
expression on pan-T cells and smooth muscle cells is crucial for protection against acute 
schistosomiasis.  
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In this study, we investigated the role of IL-4Rα expression on B cells using mice deficient in IL-
4Rα expression specifically on B cells (mb1creIL-4Rα-/lox) and on CD11c+ DC’s and alveolar 
macrophages by utilising CD11c
cre
IL-4Rα-/lox mice. Mb1creIL-4Rα-/lox mice were highly 
susceptible to S. mansoni infection compared to littermate control mice due to impaired 
production of Th2 cytokines, augmented granuloma formation, exacerbated hepatocellular 
damage and increased gut inflammation. Furthermore, the absence of IL-4/IL-13 responsive B 
cells resulted in abrogated intracellular cytokine secretion indicated by reduced production of both 
Th1 and Th2 cytokines by CD4
+
 T cells and CD19
+
 B cells. More importantly, mice deficient in 
IL-4Rα expression on B cells failed to down-regulate granuloma formation and CD4+ T cells 
responsiveness indicated by uncontrolled Th1, Th2 and Th17 cytokines production during the 
chronic stages of infection. Lastly, we investigated whether IL-4 derived from B cells drives host 
protective immune responses during S. mansoni infection in mice. Since there are no transgenic 
mice that restrict IL-4 expression specifically on B cells, we exploited bone marrow chimeras. 
Infection of chimeras lacking IL-4 derived from B cells showed that IL-4 is not a key cytokine 
initiating host protective immune responses, as demonstrated by unaltered humoral immunity, 
reduced granuloma formation and sufficient cytokine production. Therefore, these data 
demonstrates that the ability of B cells to respond to Th2 stimuli provided by IL-4/IL-13 but not 
their capacity to produce IL-4 is crucial for development of host protective immune responses 
during S. mansoni infection in mice.  
 
CD11c
cre
IL-4Rα-/lox mice succumbed to S. mansoni infection and presented with body weight loss 
at the chronic stages of infection compared to littermate control mice. Death was caused by 
elevated serum levels of pro-inflammatory cytokine TNF-α and colitis-type pathology despite 
controlled liver and gut inflammation. Interfering with IL-4Rα expression on DCs and alveolar 
macrophages resulted in impaired CD4
+
 T cell activation, reduced intracellular cytokine secretion 
of IL-4, IL-5 and IFN-γ by CD4+ T cells and classical activation of DCs and macrophages 
indicated by increased iNOS expression. Together, these data demonstrate that IL-4/IL-13 
responsive DC’s and alveolar macrophages are essential for protection against S. mansoni 
infection and are involved in initiating and amplifying Th1 and Th2 immune responses.
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CHAPTER 1 
 
INTRODUCTION 
1.0 Immune System 
The immune system is a body’s defence mechanism against foreign invading pathogens such as 
viruses, bacteria and parasites [1]. The immune system has evolved the capacity to specifically 
recognise and eliminate pathogens and foreign particles (antigens) whilst exercising tolerance 
towards “self” antigens [1]. The immune system comprises of two parts; namely innate (natural) 
immunity that arises from primary exposure to pathogens and adaptive (acquired) immunity that 
is a more complex, and highly specific system arising from infection [2,3]. 
 
1.1 Innate Immunity 
Innate immunity is considered to be the “first line defence” against invading pathogens [1]. Innate 
immunity consists of cells such as neutrophils, macrophages, dendritic cells (DCs), natural killer 
(NK) cells, basophils, mast cells, platelets and the complement system. Innate cells such as 
macrophages and neutrophils mediate host protection by internalising (phagocytosis) and directly 
killing pathogens, a process that involves recognition of a wide array of conserved structural 
moieties on pathogen surfaces known as pathogen-associated molecular patterns (PAMPs) by 
pattern recognition receptors (PRRs) [4,5,6,7]. Importantly, binding of PAMPS to PRRs is a 
cornerstone to innate immunity, leading to activation of the complement system and uptake and 
processing of antigen by antigen presenting cells (APCs) like dendritic cells, monocytes and 
macrophages [1]. Complement and C-reactive proteins are important serum proteins that bind to 
pathogen membranes, mediating their killing [1,8,9].  
 
Eosinophils are involved in attacking pathogens that are too large for phagocytosis by releasing 
cytotoxic factors like eosinophil peroxidase (ESO) [10]. Furthermore, they limit inflammation by 
releasing enzymes that inhibit the activity of mast cell products [4]. Natural killer cells are 
involved in killing cells that are infected with intracellular pathogens. Studies have shown that 
NK cells initiate the immune response by producing IFN-γ, a pro-inflammatory cytokine [11], 
while NK T cells produce IL-4 in innate immunity [12].  
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1.2 Adaptive immunity 
Adaptive immunity is a highly specific arm of the immune system that is co-ordinated to ensure a 
response that is appropriate in quality and magnitude to the eliciting antigenic stimuli. A key 
feature of adaptive immunity is development of immunological “memory responses” that ensures 
immediate recognition of pathogens during re-infection [1]. It is orchestrated by B and T 
lymphocytes, which express randomly generated antigenic receptors that possess the ability to 
recognise a wide array of antigens. Antigens are presented to lymphocytes by APCs, which 
provide an interface between innate and adaptive immunity [6]. APCs carrying antigen on major 
histocompatibility class I molecule (MHC I) activate cytotoxic CD8
+
 T cells that are involved in 
killing of cell infected with intracellular pathogens [1] Conversely, CD4
+
 T helper (Th) cells 
receive antigenic stimuli via presentation by MHC II molecules on the surface of APCs. CD4
+
 T 
cells mediate immunity against extracellular pathogens, allergens, viruses and bacterial infections. 
 
1.2.1 Cytokines 
Cytokines are small extracellular proteins that act as messenger molecules during host defences 
(immunity) and are involved in tissue repair, cell division and differentiation. Cytokines can be 
produced and secreted by a variety of cells in response to diverse stimuli. A cell possesses the 
capacity to produce a wide array of cytokines from its repertoire. However, the type of cytokine 
the cell makes is dependent on the activating stimuli, its nature, duration, intensity as well as 
presence of other factors like hormones and cellular interactions [13]. Cytokines are pleiotropic in 
a short operational radius and they can act directly on cells producing them (autocrine) or on other 
surrounding cells (paracrine) ([1,14]. The production of cytokines is transient under normal 
circumstances but it can be prolonged during a disease state [15,16]. The function of cytokines 
has been studied by utilising gene knock-out mice. However, a caveat for using this system is that 
absence of a gene during thymic development/ontogeny may result in compensatory mechanisms 
that may not be present in gene sufficient mice [17].  
 
Cytokines are grouped into families based on common structural features. A summary of cytokine 
families is provided in Table 1.1 below. 
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Table 1.1: Summary of cytokine families grouped based on structural similarities of ligands 
and/or receptors. Adapted from [13]. 
___________________________________________________________________________ 
Family  Abbreviation    Name 
___________________________________________________________________________ 
Hematopoietins  IL-2     Interleukin-2 
   IL-4     Interleukin-4 
   IL-5     Interleukin-5 
   IL-6     Interleukin-6 
   IL-10     Interleukin-10 
   IL-12     Interleukin-12 
   GM-CSF    Granulocyte macrophage colony  
        stimulating factor 
   G-CSF     Granulocyte colony stimulating  
        factor 
TNF family  TNFα     Tumor necrosis factor α 
   LTα/β     Lymphotoxin α or β 
IL-1 family  IL-1α     Interleukin-1 α 
   IL-1β     Interleukin-1 β 
α (CXC) family  IL-8     Interleukin-8 
   NAP-2     Neutrophil activating protein 2 
β (CC) family  MCP1/2/3    Monocyte chemoattractant protein 1/2/3 
   MIP 1α/β    Macrophage inflammatory protein 1α/β 
   RANTES    Regulated upon activation normal T cell  
        expressed and secreted 
PDGF family  PDGF A/B    Platelet-derived growth factor A/B 
   CSF     Macrophage colony-stimulating factor 
   SCF     Stem cell factor 
TGFβ family  TGFβ     Transforming growth factor β 
___________________________________________________________________________ 
 
1.2.2 CD4
+
 T cell differentiation 
Differentiation of naive CD4
+
 T cells is dependent on type of APC, co-stimulatory molecules, the 
nature and doses of antigen and more importantly, the cytokine microenvironment that T cell 
experiences during antigen presentation [3,18,19]. Traditionally, CD4
+
 T cells were subdivided 
into Th1 or Th2 subsets based on their cytokine secretion profiles [20,21,22,23]. However, recent 
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studies have extended the number of CD4
+
 T cell subsets to include Th17 [24,25,26], Tregs 
[27,28], Th9 [29] and Th5 [30]. The T cell paradigm is illustrated in Figure 1.1. 
 
 
Figure 1.1: T-helper cell differentiation. 
Naive CD4
+
 T cells differentiate into Th1, Th2, Th5, Th9, Th17 and Tregs upon receiving antigenic stimulation in the 
presence of cytokines. Th1 differentiation is governed by IL-12 (from DCs) and IL-18 while Th2 is prompted by IL-4 
produced by NK, B cells, basophils and γδ cells. Th9 cell differentiation is orchestrated by TGF-β in association with 
IL-4. However, Th2 cells can be reprogrammed into Th9 cells in the presence of TGF-β. IL-23 and IL-6 are important 
for differentiation of Th17 cells during inflammatory responses while IL-33 drives the differentiaton of Th5 cells. 
Regulatory T cells produce an immunosuppressive cytokine IL-10 after stimulation with TGF-β. Red arrows indicate 
cross-regulatory effects. The illustration is adapted from previous publications ([14,25,29]. 
 
Differentiation of Th1 cells is triggered by IL-12 signalling via a STAT-4 dependent pathway and 
induces the production of the hallmark cytokines IFN-γ and TNF-α [31]. STAT-4 signalling up-
regulates the transcription factor T-box expressed in T cells (T-bet) [32,33,34], which in turn 
promotes IFN-γ and IL-12R (IL-12Rβ2) expression, thus creating a positive feedback mechanism 
[35]. Th1 cells mediate protection against intracellular pathogens by mediating antibody 
responses, activating macrophages and delayed-type hypersensitivity. In contrast, Th2 immunity 
driven by IL-4 signalling is crucial for protection against helminth infections [36,37,38,39] and 
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exacerbates allergies and asthma ([40,41,42]. Th2 cell differentiation occurs upon engagement of 
T cell receptor (TCR) and IL-4Rα signalling via STAT-6 pathway that up-regulates the expression 
of the transcription factor GATA-3 [43,44]. Th2 cells secrete IL-4, IL-5, IL-6, IL-10 and IL-13. 
IFN-γ produced by Th1 cells counter-regulate the development of the Th2 immune response while 
IL-4 down-regulates the Th1 immune response [45]. Furthermore, STAT-6 has been shown to 
suppress Th1 development by inhibiting IL-12Rβ2 expression while STAT-4 prevents GATA-3 
expression by Th2 cells [35].  
 
Th17 cells produce IL-17 after receiving antigenic stimulation in the presence of IL-6, TGF-β and 
IL-23 [24,26]. Differentiation of Th17 cells is directed by the orphan nuclear receptor (RORγt) 
[46]. These cells are important for expulsion of extracellular microbes [47], autoimmunity [48] 
and cause asthmatic symptoms [49]. Tregs stimulated by TGF-β signalling are identified by the 
expression of CD25 and the transcription factor forkhead box P3 (FoxP3) [27]. IL-6 can 
negatively regulate the generation of Tregs, cells that are crucial for suppressing immunity 
towards “self” and “non-self” antigens [28]. Recently, TGF-β has been shown to be capable of 
reprogramming Th2 cells into IL-9 producing Th9 cells in the presence of IL-4 [29]. Lastly, IL-33 
signalling via ST2 and Myd88 pathways induces the differentiation of IL-5 secreting Th5 cells 
independently of IL-4 or STAT-6 [30,50].  
 
1.2.2.1 T cell activation 
Differentiation of naive T cells requires three signals; the first provided by the interaction between 
the T cell receptor (TCR) and the antigen presenting MHC molecule, secondly the interaction of 
the costimulatory molecule CD28 with it ligands CD80 and CD86 and lastly, secretion of 
polarising cytokines (Figure 1.2) [51,52]. Studies have demonstrated a crucial role for CD28 
costimulation in CD4
+
 T cell activation [53,54], organisation of secondary lymphoid tissue 
[54,55,56] and production of antigen-specific antibodies during S. mansoni infection [57] and 
Leishmania major infection [58]. Abrogation of CD28 costimulation results in impaired 
recruitment of follicular helper T cells (TFH); essential for development of germinal centers, 
isotype switching and differentiation of plasma cells through secreting their effector molecule IL-
21 [59,60,61,62].  
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Figure 1.2: T cell activation. 
Activation of T cells requires three signals provided by the interaction between the TCR and MHC molecule, CD28 
binding to its ligands CD80/CD86 and secretion of cytokines. T cells receiving only signal 1 becomes unresponsive 
and undergo apoptosis. This figure was adapted from [63,64,65]. 
 
The contribution of CD28 costimulation in protective immunity to primary infection with 
helminths is well established. Infection of CD28
-/-
 with S. mansoni [57] and Nippostrongylus 
brasiliensis [66,67] showed that CD28 is essential for development of protective Th2 immunity. 
However, the contribution of CD28 in recall of memory responses has remained largely 
controversial. Harris and colleagues showed that CD28 is not required for recall of memory T cell 
responses during N. brasiliensis infection [66]. Consistent with this data, infection of CD28
-/-
 
mice with H. polygyrus and B. dermatitidis demonstrated that recall of memory responses occurs 
independently of CD28 costimulation [68,69]. Conversely, development of memory responses 
during T. gondii infection was found to be CD28 dependent [70]. Likewise, clearance of persistent 
viral infection is dependent on CD28 costimulation [71,72]. Hence, more studies are required to 
clarify the role of CD28 during recall of memory responses to helminth infection through using 
appropriate tools and infectious models. 
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1.2.3 B cell differentiation 
B cells originate and begin their development process in the bone marrow (BM). Early events in B 
cell development involve the error-prone process of combinatorial rearrangement of the H chain 
locus and the L chain locus [73,74]. Studies in mice have found that surrogate L chain (SLC) 
proteins are crucial regulatory proteins during early B cells development stages [75]. The SLC 
proteins pair up with the µ H chain to form pre-B cell receptor (pre-BCR) in murine B cells [76]. 
Progenitor B cells (pro-B) that do not express pre-BCR or surface immunoglobulin (Ig) develop 
into pre-B cells (Figure 1.3). B cells complete their maturation and development process outside 
the BM. Pre-B cells exiting the BM acquire surface expression of IgD and CD21 and develop into 
immature B cells that are subdivided into transitional 1 (T1) or T2 based on phenotype and 
ontogeny (Figure 1.3). Interestingly, immature B cells are capable of producing rapid antibody 
responses independently of MHC class II-restricted T-cell help during exposure to T cell-
independent antigens like lipopolysaccharides (LPS) [77].  
 
B cells have been classified into two populations; B-1 c lls that express CD5 and B-2 cells that 
are CD5 negative. B-1 cells are distinguished from B-2 cells by anatomic localisation, self-
renewal and capacity to secrete natural antibodies [78]. B-1 cells are further subdivided into B-1a 
(CD5
+
) and B-1b (CD5
-
) (Figure 1.3) and they have unique functions within the host. B-1a cells 
produce natural antibodies that provide innate protection against bacterial infection in naive hosts, 
while B-1b cells secrete long-term adaptive antibody responses to T cell independent antigens 
during infection [79]. B-2 cells consists of conventional B cells that upon receiving antigenic 
stimuli via the interaction of the BCR and antigen carrying follicular DCs and expression of 
Notch proteins, proliferate and differentiate into either non-circulating cells that populate the 
marginal zone (MZ) or into circulating cells that form the germinal center (GC) [80]. MZ B cells 
differentiate into plasma cells (PCs) that produce low affinity IgM antibodies [81,82] and provide 
defence against blood-borne bacteria [77]. 
 
Mature B cells residing in the lymphoid follicles of the spleen and lymph nodes receive antigenic 
stimulation via the BCR and become activated, leading to formation of the GC, transient 
generation of plasmablasts, and short-lived extrafollicular plasma cells that secrete antigen 
specific antibodies (Figure 1.3). Memory B cells develop within the GC through somatic 
hypermutation (SMH) of the VH genes, class switch recombination (CSR) and affinity maturation 
of the BCR for a specific antigenic epitope [83,84]. Memory B cells respond rapidly and secrete 
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high affinity antibodies during secondary exposure to antigen by differentiating into PCs [85]. 
Development of PCs is tightly regulated by transcription factor Bcl-6 and BLIMP-1 [86]. 
 
 
Figure 1.3: B cell development 
B cells are generated in the bone marrow. B cells develop from a common lymphocyte progenitor (CLP) and develop 
into various B cell subsets upon rearrangement of the immunoglobulin H and L chains, expression and engagement of 
B cell receptor (BCR) and somatic hypermutation. The figure was adapted from [77]. 
 
1.2.3.2 Functions of B cells in immunity 
Traditionally, B cells are known for their ability to produce antigen-specific antibodies that 
facilitate clearance of pathogens and other antigens. However, the scope of B cells in the immune 
response to pathogens has been expanded over the years. B cells play a crucial role in the priming 
and proliferation of CD4
+
 T cells after encounter with antigen [87,88,89]. Chimeric reporter mice 
deficient of B cells had a significantly reduced number of IL-4 producing T cells compared to 
control mice following infection with H. polygyrus, suggesting that B cells are required for 
initiation and expansion of CD4
+
 T cell responses during infection [90]. Consistent with this data, 
mice lacking B cells during lymphocytic choriomenigitis virus (LCMV) had reduced number of 
LCMV-specific IFN-γ producing CD4+ T cells at day 8 and 70 post-infection [91]. Activated B 
cells have been shown to act as excellent antigen-presenting cells (APCs) capable of internalising 
specific antigen through the BCR and presenting antigen to CD4
+
 T cells [92,93]. The ability of B 
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cells to present antigens is spectacularly demonstrated when antigen load is low and there is 
evidence suggesting that antigen-presenting B cells shape the magnitude and quality of the 
primary and memory CD4
+
 T cell responses [89,94,95,96,97]. B cells deficient of co-stimulatory 
molecules CD80 and CD86 failed to prime and promote proliferation of autoreactive CD4
+
 T cells 
during a mouse model of arthritis [98], thus demonstrating that B cells expressing co-stimulatory 
molecules modulate T cell responses [87,99]. B cells play a crucial role during lymphoid tissue 
organogenesis [100], formation of B cell follicles [101] and differentiation of follicular DCs 
[102,103]. Interestingly, B cells shape the quality and quantity of the immune response by 
producing a wide array of cytokines [93,104,105,106,107]. This is discussed in more details 
below. 
 
1.2.3.1 B effector cells 
B cells produce cytokines and chemokines constitutively or in response to antigenic stimulation, 
engagement of toll-like receptor (TLR) ligand and interaction with T cells [93,107]. Cytokines 
produced by B cells can amplify or suppress CD4
+
 T cell responses. In a study by Shah and Qiao, 
resting splenic B cells co-cultured with T cells stimulated with CD3-specific antibody primed the 
expansion of CD4
+
CD25
+
FoxP3
+
 regulatory T cells (Tregs) [108]. The expansion of Tregs was 
mediated by TGF-β produced by splenic B cells [108]. Likewise, TGF-β produced by B cells 
promoted the conversion of CD4
+
CD25
-
 T cells into FoxP3
+
 Tregs in vivo in a model of local 
inhalation tolerance [109].  
 
Harris and colleagues identified two subsets of B effector cells based on their cytokine secretion 
profile; namely B effector 1 (Be1) and Be2 [106]. Be1 cells primed in the presence of Th1 cells, 
antigen and/or TLR ligand produced IFN-γ and IL-12p40 (Figure 1.4) [104,106]. The expansion 
of Be1 cells required signalling via the IFN-γR which activated the transcription factor T-box 
expressed in T cells (T-bet) [104]. In contrast, Be2 cells behaved similarly to Th2 cells by 
producing Th2 cytokines IL-2, IL-4 and IL-13 while simultaneously suppressing the secretion of 
IFN-γ and IL-12 after co-culture in the presence of Th2 cells and antigen (Figure 1.4) [105,106]. 
Importantly, signalling via the IL-4Rα mediates the proliferation of Be2 cells [105]. Effector 
molecules produced by Be1/Be2 cells can prime naive CD4
+
 T cells, pushing them towards either 
Th1 or Th2 phenotype (Figure 1.4). Thus, interaction between effector B cells and Th1 or Th2 
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cells creates a positive feedback loop that ensures maintenance of the immune response during 
infection. 
 
 
Figure 1.4: Effector and regulatory B cells enhance or suppress CD4
+
 T cell responses. 
B cells can influence activation of CD4
+
 T cells by presenting antigen and providing costimulation and producing 
cytokines. B effector 1 cells (Be1) generated in the presence of Th1 cells and antigen produce predominantly Th1 
cytokines like IL-12 and IFN-γ. In turn, cytokines produce by Be1 cells can activating naive T cells, pushing them 
towards a Th1 phenotype. Likewise, Be2 cells develop in the presence of Th2 cells and antigen and produce IL-4, IL-
5 and IL-13. They could also influence the activation of naive T cells through the cytokines they produce. Regulatory 
B cells produce IL-10 and play a crucial role in regulating CD4
+
 T cells responsiveness. The figure was adapted from 
[110]. 
 
Recently, a third subset of effector B cells that produces IL-10 (B10) was phenotypically and 
functionally characterised in mice during inflammatory responses [111]. IL-10 producing 
regulatory B cells were identified by a unique expression of CD1d and CD5 [111]. B10 cells 
stimulated with CD40L [112] and TLR ligand [113] suppress CD4
+
 T cell responses and played a 
crucial role in down-regulating autoimmune pathology [114,115,116]. Furthermore, B10 cells 
have been shown to mediate protection against allergic airway inflammation [117], prevent colitis 
[118,119,120] and collagen-induced arthritis [121,122]. 
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1.3 Interleukin 4/ IL-13 
1.3.1 Interleukin-4 
IL-4 belongs to the same cytokine family as IL-5, IL-13 and granulocyte macrophage-colony 
stimulating factor (GM-CSF) and their genes are located in close proximity on chromosome 11 
[123]. Murine IL-4 is a glycoprotein with a molecular weight of 14-19 kDa depending on a 
cellular source secreting it [124,125]. IL-4 is secreted by various innate cells including basophils 
[126], mast cells [127], γδ T cells [128], conventional T cells [129,130], eosinophils [131] and 
NK1.1
+
 T cells [12]. Although it is widely understood that IL-4 is essential for Th2 cells 
differentiation, some studies utilising IL-4Rα and STAT-6 deficient mice demonstrated that Th2 
differentiation can occur independently of IL-4 signalling [132,133,134,135]).  
 
The biological activities of IL-4 are species-specific; murine IL-4 is inactive on human cells and 
vice versa. IL-4 has a profound effect on B cell activation status by influencing the expression of 
low affinity IgE receptor [136], increasing expression of activation markers MHC II, CD80 and 
CD86 [137], up-regulating IL-4Rα expression [138] and promotes isotype switching to IgE and 
IgG1 while suppressing synthesis of IgM, IgG2a and IgG2b [139,140]. IL-4 is crucial for 
conferring host protection against gastrointestinal nematodes like Trichuris muris (T. muris) 
[141], Heligomosomoides polygyrus (H. polygyrus) [142,143] and Nippostrongylus brasiliensis 
(N. brasiliensis) [144,145]. Mice deficient in IL-4, IL-4Rα and STAT-6 were found to be highly 
susceptible to Schistosoma mansoni (S. mansoni) infection due to uncontrolled liver and intestinal 
inflammation ([146,147,148,149]. 
 
1.3.2 Interleukin-13 
IL-13 is derived from a wide variety of cell types that includes T cells, DCs, basophils, NK cells 
and mast cells [150,151,152]. IL-13 gene is located on chromosome 11 between IL-4 and GM-
CSF genes, and is translated into a 10-14 kDa immunoregulatory protein [153,154]. IL-13 shares 
some but not all biological activities with IL-4 [155]. The importance of IL-13 in driving worm 
expulsion was first demonstrated in studies with N. brasiliensis using IL-4 and IL-13 knock-out 
(KO) mice [145,156,157]. Furthermore, IL-13 has been shown to regulate pulmonary 
inflammation induced by allergens ([158,159,160], asthma [158,159,160,161,162,163] and 
anaphylaxis [146]. IL-13 exerts its effector function on a wide variety of cells such as fibroblasts, 
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B cells, macrophages/monocytes, mast cells, eosinophils, smooth muscle cells and vascular 
endothelium [164]. It is important to mention that IL-13 cannot act on T cells [165]. Similarly to 
IL-4, IL-13 is involved in the proliferation of B cells and up-regulates the expression of low 
affinity IgE receptor and induces isotype switching to IgG4 and IgE in human B cells [166]. IL-13 
enhances the expression of integrins like CD11b and CD11c on monocytes and macrophages 
[165]. 
 
1.3.3 IL-4 and IL-13 receptor complexes 
IL-4 and IL-13 signals through a common receptor subunit, the IL-4 receptor alpha chain (IL-
4Rα) which might explain why they have overlapping function [132,167]. IL-4Rα is widely 
expressed on haematopoietic cells, endothelial, epithelial, muscle, fibroblasts, hepatocytes and 
brain tissue [167]. IL-4 uniquely signals through the heterodimeric type 1 receptor composed of 
IL-4Rα subunit and the common gamma chain (γc) [167,168], which is also a component of the 
receptor for IL-2, IL-7, IL-9, IL-15 and IL-21 [153,169]. However, both IL-4 and IL-13 signals 
through the type II receptor consisting of IL-4Rα and IL-13Rα1 subunits [167,168]. Receptors 
mediating IL-4 and IL-13 signalling are illustrated in Figure 1.5. 
 
IL-13 specifically binds to the IL-13Rα1 with low affinity. However, the IL-13Rα1 and IL-4Rα 
complex binds IL-13 with high affinity and activates down-stream signalling molecules 
[153,170]. Another high affinity receptor for IL-13 is the homodimeric IL-13Rα2 that was 
initially thought to be a decoy receptor with no signalling abilities [171]. However, evidence has 
emerged showing that IL-13Rα2 is capable of inducing TGF-β production or mediating fibrosis in 
a chronic model of Crohn’s disease [172,173]. IL-13 receptors are expressed in non-
haematopoietic and haematopoietic cells except for T cells [153,174]. The activity of IL-4 and IL-
13 can be regulated by binding to high affinity soluble IL-4Rα and IL-13Rα2 that carry no 
signalling abilities [175]. 
 
1.3.3 Mechanism of IL-4 and IL-13 signalling 
Engagement of IL-4Rα triggers the activation of STAT-JAK signalling pathway [167]. Briefly, 
IL-4 binding to IL-4Rα induces the activation of JAK1 and 3 and phosphorylation of a specific 
tyrosine residue in the receptor cytoplasmic region. STAT-6 binds to the phosphorylated receptor 
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through a highly conserved domain and allows for phosphorylation of the C-terminal domain by 
the activated kinases [176,177]. Activated STAT-6 disengages from the receptor and forms 
homodimers through the interaction of the conserved domain with the phosphorylated C-terminal 
domain. The STAT-6 homodimers translocate into the nucleus where they bind to specific DNA 
motifs in the promoter of responsive genes thus enhancing transcription. IL-4 signalling via IL-
4Rα has been shown to trigger the insulin receptor substrate (IRS) signalling pathway [178,179] 
and the phosphoinositide-3-kinase (PI-3-K) pathway [180,181]. IL-13 signalling through the IL-
13Rα2 activates AP-1 and is involved in the production of TGF-β and fibrosis [172].  
 
 
Figure 1.5: IL-4 and IL-13 receptor complexes. 
IL-4 signals through a type 1 receptor composed of IL-4Rα subunit and γc while both IL-4 and IL-13 signals via a 
type II receptor consisting of IL-4Rα and IL-13Rα1 subunits. Binding of IL-4 and IL-13 to the receptors results in the 
phosphorylation of down-stream signalling molecules like signal transducer and activator of transcription 6 (STAT-6) 
and Janus kinase 1 (JAK1). IL-13 binds to the IL-13Rα2 with high affinity and activates AP-1 to induce the signalling 
cascade that results in TGF-β secretion. This figure is adapted from previous publications [14,153,155]. 
 
1.3.5 Cell-specific IL-4Rα gene targeting 
Initially, the role of IL-4Rα signalling in host protection or susceptibility to pathogenic infections 
was studied using gene-deficient mice. However, the advent of Cre/loxP recombination system 
has allowed for cell-specific gene deletion [182,183,184]. Here, a transgenic mouse carrying the 
Cyclization recombinase (Cre) under the control of a cell-specific promoter is intercrossed with a 
transgenic mouse carrying the gene of interest flanked by a pair of loxP binding sites (Figure 1.6). 
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Once the promoter induces the expression of Cre recombinase in a specific cell-type, the enzyme 
carries our gene deletion by homologous recombination of the loxP sites [185]. To target cell-
specific IL-4Rα gene deletion, a transgenic mouse carrying exon 7 to exon 9 of IL-4Rα gene 
flanked by loxP sites was generated. In our laboratory we have generated a transgenic mouse 
strain carrying cell-specific deletion of IL-4Rα on CD4+ T cells [186,187], on macrophages and 
neutrophils [147], on smooth muscle cells [188,189]), on pan-T cells [190], on B cells [191] and 
on CD11c
+
 DCs [192].  
 
Figure 1.6: Generation of B cell-specific IL-4R deficient mice (mb1
cre
IL-4Rα-/lox). 
IL-4Rα gene construct was created by flanking exon 7-9 with two loxP sites (blue and red colour) and Cre 
recombinase gene construct has mb1 promoter down-stream Cre gene. IL-4Rα-/- mice were mated with mb1 mice to 
generate the mb1
cre
IL-4Rα-/- F1 offspring. This offspring was again mated with IL-4Rαlox/lox mice to generate 
mb1
cre
IL-4Rα-/lox mice where Cre mediated deletion of IL-4Rα specifically on B cells. Figure is adapted from [190]. 
 
1.4 Nippostrongylus brasiliensis 
Intestinal nematodes are the most prevalent infection in humans and are thought to infect 
approximately one billion people worldwide, particularly in developing regions of Asia, Africa 
and Latin America [38,193]. They are a major cause of under-nutrition and anaemia, thus have a 
negative impact on socio-economic development in areas of high prevalence [193]. Parasites 
belonging to the family Strongylata can be subdivided into three superfamilies; namely 
Strongyloidea consisting of parasites infective to humans (i.e Necator americanus), 
Trichostronglyloidea comprised of parasites infective to rodents (i.e Nippostrongylus brasiliensis) 
and Metastrongyloidea consisting lung infective worms in mammals. The infection and migration 
patterns of N. brasiliensis is analogous to human hookworms such as N. americanus and 
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Ancylostoma duodenale; thus, it can be used as a murine model to investigate the immune 
response to these parasites [194] 
 
1.4.1 Life cycle of N. brasiliensis 
The life cycle of N. brasiliensis in the host begins when infective third stage (L3) larvae penetrate 
the skin and enter the vasculature. Once in the vasculature, the parasites migrate into the lungs via 
the circulatory system causing massive damage in the lungs within 24-48 h. Larvae enter the 
airways, from which they are coughed up and swallowed into the stomach. L3 moult into L4 
mature adult worms that produce eggs upon reaching the small intestinal lumen three days after 
infection. BALB/c mice expel N. brasiliensis worms within 14 days post-infection [195]. IL-13 
driven Th2 immunity is crucial for conferring protection to N. brasiliensis infection 
[144,145,194]. Secondary infection with N. brasiliensis induces a potent memory immune 
response that results in poor worm maturation and inhibits egg production [196]. The life cycle of 
N. brasiliensis is illustrated in Fig 1.7. 
 
 
Figure 1.7: Life cycle of Nippostrongylus brasiliensis. 
Infective third stage N. brasiliensis larvae (L3) infect mice and migrate via the circulatory system to the lungs. They 
enter the airways, get coughed up and swallowed in to the stomach. L3 moults into L4 in the small intestine and 
begins laying eggs. Immuno-competent mice expel the worms by day 14 post-infection. This figure was adapted from 
[194] 
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1.4.2 Immune response to N. brasiliensis infection 
Protective immunity to N. brasiliensis infection is mediated by the development of a dominant 
Th2 immune response characterised by increased production of Th2 cytokines IL-13 and IL-4 
[144,145,197], goblet cell hyperplasia [156,198] eosinophilia [36] and elevated levels of antigen-
specific serum IgG1 and IgE [38,145]. Mice deficient of IL-4 were found to expel N. brasiliensis 
worms similarly to immuno-competent wild-type mice, demonstrating that protection occurs 
independently of IL-4 signalling [199,200]. In contrast, mice deficient of IL-13, IL-4/IL-13, IL-
4Rα and STAT-6 failed to resolve N. brasiliensis infection, indicating the importance of IL-13 in 
driving protection [144,145,155,201]. Moreover, in a study from our laboratory, mice lacking IL-
4Rα expression specifically on smooth muscle cells failed to expel N. brasiliensis worms due to 
impaired Th2 cytokine responses and reduced goblet cells hyperplasia [189]. Mice lacking 
alternatively activated macrophages (LysM
cre
IL-4Rα-/lox) successfully expelled N. brasiliensis 
adult worms and developed sufficient Th2 responses and goblet cell hyperplasia [147].  
 
1.5 Schistosoma mansoni 
Schistosomiasis, also known as bilharzia, is a chronic parasitic disease caused by digenetic 
trematode flatworms (flukes) belonging to the Schistosoma genus. The disease infects 
approximately 200 million people and is endemic in 74 developing countries where it is a measure 
cause for morbidity and mortality [202,203,204]. The disease is estimated to cause 280 000 deaths 
per annum in sub-Saharan Africa alone [203], hence its inclusion amongst the top ten infectious 
diseases of concern by the World Health Organisation (WHO) [202].  
 
Although schistosomiasis can easily be treated with an inexpensive chemotherapeutic drug, 
praziquantel [205]; the spreading of the disease to new areas is a major concern. Furthermore, 
treatment of infected individuals does not prevent re-infection, a common occurrence in areas 
where the disease is endemic. Thus, given the morbidity associated with Schistosomiasis, it is 
wise to develop a long lasting solution that would protect the hosts from continued infections. 
This issue has been made more pressing by the emergence of HIV/AIDS, a disease that is highly 
prevalent in sub-Saharan Africa. There is already evidence suggesting that schistosome infection 
alters the aetiology and transmission of HIV/AIDS [206,207,208,209,210], tuberculosis 
[207,211,212] and malaria [213,214,215]. Hence, more work is required to understand the 
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immunobiology of Schistosomiasis in order to facilitate rational design and development of 
effective vaccine.  
1.5.1 Life cycle 
The life cycle of S. mansoni begins when infective cercariae penetrate the skin of the human host, 
transform into schistosomula by losing their tail and then entering the lymphatic vessels and 
capillaries en route to the lungs. After a few days, the schistosomula migrate into the portal 
venous system where they mature into adult worms and unite. The worm pairs migrate into the 
mesenteric venules that drain the intestines of the mammalian host where they lay hundreds of 
eggs per worm pair per day [216]. Egg production commences 4 to 6 weeks post-infection and 
last the entire life of the worm pair, which may be up to 15 years in a definitive host [216]. The 
eggs deposited in the vein lumen pass through the intestinal tissue, enter the gut and are excreted 
in the faeces. The life cycle is completed when the eggs hatch, releasing miracidia that infect the 
intermediate host, species-specific freshwater snails (Biomphalaria sp. for S. mansoni miracidia). 
After rounds of asexual reproduction within the snail host, infective cercariae are released to 
begin the life cycle yet again. The life cycle of S. mansoni is summarised in Figure 1.8. 
 
 
Figure 1.8: Life cycle of Schistosoma mansoni. 
The life cycle of S. mansoni progresses from a definitive mammalian host to an intermediate host, the freshwater 
snails. The cycle commences when infective cercariae burrow into the skin of the mammalian host, transform into 
schistosomula, and mature into egg laying adult worm pairs in the mesenteric venules. After mating, female worm 
produce eggs that traverse the intestinal tissue and finally get excreted in the faeces. Eggs hatch in the water releasing 
miracidia that infect species-specific freshwater snails. The life cycle was adapted from CDC 
(www.dpd.cdc.gov/dpdx 
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1.5.2 Immunobiology of schistosomiasis 
The host immune response to S. mansoni infection is orchestrated by CD4
+
 T cells and progresses 
through three main phases characterised by the type of the dominant immune response (Figure 
1.9) [217]. During the first 3-5 weeks of exposure to parasites, a dominant Th1 immune response 
is triggered by the immature parasites. However, once egg production by the parasites begins at 5-
6 weeks post-infection, the Th1 immune response is down-regulated while egg-antigens elicit a 
strong Th2 response which drives the development of granulomatous lesions around tissue-
trapped eggs [217]. The development of a Th2 immune response has been shown to be 
indispensable for host protection during S. mansoni infection [147,218,219]. During the chronic 
stages of infection (10 weeks onward), the Th2 immune response is down-modulated due to the 
emergence of IL-10 producing regulatory T cells and granulomas that form around newly 
deposited eggs are smaller than during the acute infection [220,221,222].  
 
 
Figure 1.9: The immune response to S. mansoni infection. 
The immune response to S. mansoni infection progressed from a dominant Th1 immune response during the early 
phases of the infection (3-5 weeks), to a dominant Th2 immune response induced by egg-antigens (5-8 weeks) and 
finally down-modulation of the Th2 immune response during the chronic stages of infection and emergence of Treg 
population. The figure was adapted from [217]. 
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1.5.3 Acute vs chronic schistosomiasis 
Acute schistosomiasis coincides with egg-laying by adult worms (5-6 weeks post-infection), 
peaking at 8 weeks post-infection and is characterised by a dominant Th2-polarised cellular 
immune response induced by S. mansoni eggs trapped in the host tissues [217]. Studies have 
shown that development of a polarised Th2 immune response driven by IL-4 and IL-13 signalling 
is crucial for granuloma formation, tissue fibrosis and limiting pathological consequences of S. 
mansoni infection [147,148,149,218,219]. However, a study by Hoffmann and colleagues 
revealed that maintaining a fine balance between Th1 and Th2 immune response is crucial for 
surviving acute schistosomiasis in mice [222]. A key feature of acute schistosomiasis in 
susceptible mice is rapid weight loss that coincides with egg-laying and this has been correlated 
with increased production of proinflammatory cytokines like TNF-α, iNOS and IFN-γ [218,222]. 
In humans, patients suffering from severe hepatosplenic schistosomiasis exhibit highly elevated 
levels of IFN-γ, NO and TNF [223]. 
 
In mice, chronic schistosomiasis is characterised by d velopment of a Th2-polarised immune 
response indicated by increased production of profibrotic cytokines IL-4 and IL-13 [224,225,226], 
reduced production of IFN-γ [227] and significant tissue fibrosis [228]. The persistent 
granulomatous response and fibrosis eventually leads to portal hypertension, establishment of 
porto-systemic shunts, intestinal bleeding and ultimately death. In order to circumvent the 
destructive effects of the host’s immune response during the chronic stages of infection, it is 
crucial to control the immune response triggered by the eggs. Immuno-competent mice are 
capable of modulating the deleterious effects of the immune response during the chronic stages of 
S. mansoni infection. In these mice, immuno-modulation is indicated by decreased size of newly 
formed granulomas, reduced fibrosis and controlled T cell responsiveness to egg antigens. The 
mechanisms mediating down-modulation of granulomatous hypersensitivity in schistosomiasis 
have been linked to CD8
+
 suppressor cells [229] and cross-regulatory cytokines produced by 
CD4
+
 T cells [229,230,231]. However, subsequent studies demonstrated a pivotal role played by 
B cells in down-regulating granuloma formation during chronic Schistosomiasis [232,233]. 
Although there is a lot of contradictory data, IL-10 produced by B cells has been proposed as a 
key immuno-modulatory cytokines during chronic Schistosomiasis [231,234]. IL-10 has been 
implicated in limiting pathological events associated with severe chronic disease [220,222,235]. 
In a study by Sadler and colleagues, it was shown that IL-10
-/-
 mice suffer from severe 
inflammation during the chronic stage of infection and fail to down-modulate the cellular immune 
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responses. A recent study by Fairfax and colleagues showed that impairing IL-10R signalling 
results in severe pulmonary disease and loss of B cells in the liver during chronic schistosomiasis 
[221].  
 
In humans, the life-threatening form of chronic schistosomiasis occurs at a frequency of 5-10% in 
untreated populations and is characterised by hepatosplenic disease accompanied by severe 
hepatic and periportal fibrosis, pulmonary hypertension and portosystemic shunting of venous 
blood [217,223,236,237]. Patients with severe disease were found to have Th1-like responses and 
high levels of plasma TNF receptor I (TNFRI) and TNFRII, whereas patients with less severe 
disease developed Th2-like responses and down-regulated plasma levels of TNF receptors [238]. 
The severity of disease has been shown to be dependent on the intensity of infection and most 
importantly, genetic predisposition of the individuals [239,240]. A study conducted by Dessein 
and colleagues in S. mansoni endemic areas in Sudan found that certain families were more likely 
to develop severe hepatic fibrosis and portal hypertension than others and this was linked to a 
codominant major gene known as SM2 [239]. SM2 encodes for IFN-γ receptor 1 (IFN-γR1) and 
data suggests that polymorphisms in IFN-γR1 leads to augmented fibrosis due to the inability of 
IFN-γ to inhibit fibrogenesis because the receptor has lost its function [217,239]. 
 
1.5.4 Mechanism conferring protection against S. mansoni infection 
Earlier studies using gene-deficient mice have been instrumental in elucidating factors 
contributing to host protection or susceptibility during S. mansoni infection in mice. Mice 
deficient of IL-4 (IL-4
-/-
) were found to be extremely susceptible to S. mansoni infection and death 
was shown to be preceded by rapid cachexia coincident with egg-laying by adult worms [218]. 
Furthermore, IL-4/IL-10 double deficient mice were found to be more susceptible to S. mansoni 
infection than IL-4
-/-
 mice due to augmented production of pro-inflammatory cytokines IFN-γ and 
TNF-α, increased hepatocellular damage indicated by elevated levels of aspartate transaminase 
(AST), nitric oxide (NO) production and destruction of gut integrity [222]. On the contrary, IL-
10/IL-12 deficient mice did not suffer from severe weight loss during the acute stage of infection 
but displayed a progressive wasting disease that culminated in death during the chronic stages of 
S. mansoni infection [222]. This study demonstrated that excessive Th1 or Th2 cytokine responses 
trigger distinct, but equally detrimental forms of disease following infection [222]. Hence, 
maintaining a fine balance between Th1 and Th2 immune response is crucial for surviving 
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schistosomiasis in mice. Furthermore, IL-10 has emerged a key immunoregulatory factor 
controlling pathogenesis during S. mansoni infection [222].  
 
IL-4Rα-/- and STAT-6-/- mice are highly susceptible to S. mansoni infection due to impaired 
granuloma formation, diminished Th2 cytokine production, reduced fibrosis and exacerbated 
tissue inflammation [148,149]. The importance of cell-specific IL-4Rα expression in the 
mechanism conferring protection or susceptibility to S. mansoni infection has been investigated in 
our laboratory by utilising cell-specific IL-4Rα-deficient mice generated using the Cre/loxP 
recombination system. Mice deficient in IL-4Rα expression on macrophages and neutrophils 
(LysM
cr
eIL-4Rα-/lox) were found to be highly susceptible to acute Schistosomiasis despite the 
presence of the Th2 immune response [147]. Mortality in LysM
cr
eIL-4Rα-/lox mice was caused by 
uncontrolled liver damage and excessive gut inflammation which ultimately led to endotoxemia 
and septic shock [147]. Mice lacking IL-4Rα expression on pan-T cells (iLckcreIL-4Rα-/lox) [190] 
and smooth muscle cells (SMC
cre
IL-4Rα-/lox) [188] were found to be susceptible to S. mansoni 
infection despite controlling gut inflammation. The contribution of IL-4/IL-13 responsive B cells 
and CD11c
+
 dendritic cells in the mechanism conferring host protection or susceptibility to acute 
schistosomiasis are yet to be determined. 
 
1.6 Objectives of the present study 
1.  To investigate the role of CD28 costimulation during recall of protective immunity 
against N. brasiliensis secondary infection. 
2. To determine the contribution of IL-4/IL-13 responsive B cells in host protection or 
susceptibility during acute and chronic schistosomiasis. 
3. To investigate the role of IL-4/IL-13 responsive CD11c+ dendritic cells during infection 
with S. mansoni.  
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CHAPTER 2 
 
CD28 is required for protection against Nippostrongylus brasiliensis secondary infection and 
recall of memory responses in inducible CD28 deleting mice. 
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ABSTRACT 
IL-13 driven Th2 immunity is indispensable for host protection against infection with the 
gastrointestinal nematode Nippostronglus brasiliensis. Disruption of CD28 mediated 
costimulation impairs development of adequate Th2 immunity, showing an importance for CD28 
during the initiation of an immune response against this pathogen. However, any requirement for 
CD28 during recall immunity to secondary infection with pathogens has remained largely 
controversial. In this study, we used global CD28
-/-
 mice and a novel mouse model that allows for 
inducible deletion of the cd28 gene by oral administration of tamoxifen (CD28
-/lox
Cre
+/-
+TM) to 
address these questions. Following primary infection with N. brasiliensis, CD28
-/-
 mice failed to 
expel adult worms in the small intestine in contrast to wild-type C57BL/6 mice. Impaired 
expulsion was associated with reduced production of Th2 cytokines, particularly IL-13, reduced 
serum levels of antigen specific IgG1 and total IgE and failure to develop CXCR5
+
 TFH cells. 
Interestingly, interference with CD28 expression in CD28
-/lox
Cre
+/-
 mice by oral administration of 
tamoxifen prior to secondary infection with N. brasiliensis resulted in impaired worm expulsion. 
This correlated with reduced production of Th2 cytokines IL-13 and IL-4, diminished serum titres 
of antigen specific IgG1 and total IgE and reduced CXCR5
+
 TFH cell population. Importantly, 
abrogation of CD28 during secondary infection inhibited the recruitment of central and effector 
memory CD4
+
 T cells and follicular B cells to the draining lymph node. Therefore, it can be 
concluded that CD28 is essential for the development of protective memory Th2 immunity against 
N. brasiliensis infection and for expansion of CXCR5
+
 TFH cells and follicular B cells. 
 
Keywords: CD28, tamoxifen, recall, N. brasiliensis, mice. 
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2.1 INTRODUCTION 
Infection of mice with Nippostrongylus brasiliensis triggers a host protective immune response 
characterised by increased production of Th2 cytokines IL-13 and IL-4 [144,145,197], goblet cell 
hyperplasia [198] eosinophilia [36] and elevated levels of serum IgG1 and IgE [38,145]. Infection 
with N. brasiliensis begins when L3 larvae penetrate the skin and migrate, via the circulatory 
system, into the lungs. Larvae enter the airways, from which they are coughed up and swallowed. 
The larvae mature into adult worms that produce eggs upon reaching the small intestinal lumen. 
Immune-competent BALB/c mice clear N. brasiliensis infection after approximately 9 days post-
infection [195]. Secondary infection with N. brasiliensis induces a potent memory immune 
response that results in poor worm maturation and inhibits egg production [196].  
 
CD28 is considered to be the main co-stimulator of T cells, providing a critical signal for 
activation of naive T cells [51,52,241]. Interactions between CD28 and its ligands CD80/CD86 
enhances cytokine production, prevents T cell anergy and protects against apoptosis [53,242]. 
These CD28 dependent interactions are important during the initiation of T cell mediated 
immunity against a number of infections. Mice deficient in CD28 failed to develop adequate Th2 
immune response during infection with S. mansoni [57], L. major [58] and N. brasiliensis [66,67]. 
In contrast, infection of CD28
-/-
 mice with H. polygyrus did not hamper normal development of 
Th2 immune response [243].  
 
The absence of CD28 alters the organisation of secondary lymphoid tissue by affecting 
recruitment of T cells to B cell follicles, impairing germinal centre development [54,55,56], 
isotype switching, B cell maturation and development of memory B cells. This is linked to 
diminished recruitment of CXCR5
+
 TFH cells which localise within the B cell follicles 
[59,60,61,62]. TFH cells produce IL-21, a key cytokine involved in isotype switching and 
differentiation of plasma cells [60]. CD28
-/-
 mice infected with S. mansoni [57] or Leishmania 
major [58] failed to produce antigen specific type 2 antibodies IgG1 and IgE. Taken together this 
demonstrates an important role for CD28 in co-ordinating B cell responses. 
 
Studies suggest that CD28 is not required during recall of memory T cell responses to infection 
with N. brasiliensis [66] and H. polygyrus [69]. Furthermore, infection of CD28
-/-
 mice with fungi 
B. dermatitidis revealed maintenance of memory T cells is CD28 independent [68]. In fact, some 
studies suggested that recall memory responses may be dependent on other co-stimulatory 
molecules such as inducible costimulator (ICOS) or 4-1BB [244,245,246]. Contrastingly, 
development of effector and memory CD4
+
 T cells was reduced in the absence of CD28 during T. 
gondii infection [70]. Recall of memory responses to persistent viral infections is dependent on 
CD28 [71,72]. Therefore, the importance of CD28 during development and recall of memory 
responses remains controversial. There have been attempts to address this issue by blocking CD80 
and CD86 or by transfer of memory T cells into CD80/CD86 deficient mice [247]. However, both 
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approaches deprive CTLA-4 (CD152) of its ligands thus caution must be exercised when 
interpreting these data. Hence, new approaches that don’t suffer from these additional effects are 
required to solve the conundrum surrounding the contribution of CD28 during recall of memory 
responses to infections. 
 
The aim of this study was to evaluate the importance of CD28 in initiating protective Th2 
immunity against both primary and secondary infections with N. brasiliensis. Our findings 
demonstrate that CD28 is required for initiation of protective Th2 immunity against primary 
infection with N. brasiliensis. Furthermore, the absence of CD28 impairs development of memory 
CD4
+
 T cell responses resulting in failure to clear adult N. brasiliensis worms during secondary 
infection. Failure to resolve infection was associated with reduced production of Th2 cytokines 
particularly IL-13 and IL-4, abrogated humoral immunity and failure to expand CXCR5
+
 TFH 
cells.  
 
2.2 Materials and Methods 
Mice. C57BL/6 background CD28
-/-
 and CD28
-/lox
Cre
+/-
 were obtained from Prof. T. Hünig at the 
University of Würzburg, Germany. The mice were bred and maintained in specific pathogen-free 
barrier conditions in individually ventilated cages at the University of Cape Town Animal 
Facility. All experimental mice were age and sex matched and used between 8-12 weeks of age. 
 
Ethics statement. This study was conducted under strict recommendation of the South African 
national guidelines and of the University of Cape Town practice for laboratory animal procedures. 
All mouse experiments were carried out in accordance to protocols approved by the Animals 
Research Ethics Committee of the Health Sciences Faculty, University of Cape Town (Project 
Number: 008/011). Care was taken to minimize suffering of the animals. 
 
N. brasiliensis infection 
Primary Infection. Mice were injected subcutaneously with 500 N. brasiliensis L3 larvae. Mice 
were killed nine days post-infection and adults worms were enumerated using a previously 
described method [144]. 
Secondary Infection. Mice were initially injected with 500 N. brasiliensis L3 larvae, orally 
treated with 10 mg/ml Ivermectin in drinking water at seven days post-infection and shelved for 
21 days prior to a secondary subcutaneous infection with 500 N. brasiliensis L3 larvae. Mice were 
killed 5 days post secondary infection by halothane inhalation and exsanguination.  
 
Histology. Tissue sample were fixed in buffered 4% (v/v) formaldehyde, embedded in paraffin 
wax and cut into 5µm sections. The sections were stained with periodic acid-Schiff reagent (PAS) 
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in order to visualize mucus producing goblet cells. The sections were analysed under a light 
microscope.  
 
Determination of antibody titres. N. brasiliensis antigen-specific serum antibody isotypes and 
total IgE titres from infected mice were determined as previously described [248]. Briefly, blood 
was collected in serum separator tubes (BD Bioscience, San Diego, CA) and centrifuged at 8 
000×g for 10 min at 4ºC to separate serum. The flat-bottom 96-well plates were coated with 10 
µg/ml somatic N. brasiliensis antigen (NAg), blocked with 2% (w/v) milk powder for 2 h at 37ºC 
and samples were loaded and incubated overnight at 4ºC. Alkaline phosphatase labelled secondary 
antibody was added and incubated for 2 h at 37ºC. The plates were developed by addition of 4-
nitrophenyl substrate (Sigma). The absorbance was read at 405nm using VersaMax microplate 
spectrophotometer (Molecular Devices, Germany).  
 
Ex vivo restimulation of cells and cytokines detection. Single cell suspensions were prepared by 
pressing the draining lymph nodes through 70 µM cell-strainers. Cells were resuspended in 
complete IMDM (Gibco) supplemented with 10% FCS (Gibco) and penicillin and streptomycin 
(100 U/ml and 100 µg/ml, Gibco). The cells were cultured at 2 × 10
6
 cells/ml in 48-well plates 
coated with α-CD3 (20 µg/ml) or NAg (20 µg/ml) plus sub-optimal concentration of α-CD3 (2 
µg/ml) and incubated at 37ºC in a humidified atmosphere containing 5% CO2. Supernatants were 
collected after 72 h and cytokines were measured by ELISA. Quantities of IL-4, IL-10 and IL-13 
were measured by sandwich ELISA as previously described [248].  
 
Inducible deletion in conditional knock-out mice. CD28
-/lox
Cre
+/-
 mice were given 2.5 mg 
Tamoxifen (Sigma, Deisenhofen, Germany) in vegetable oil for four consecutive days by forced 
feeding.  
 
Flow cytometry. The following antibodies comprising the B cells antibody panel were used: 
B220-V500, CD19-PerCP Cy5.5, CD23-PE, CD21-APC, CD24-PE Cy7, CD80-V450, MHCII-
FITC and IgM-Biotin (BD Bioscience, Erembodegem, Belgium). T cells panel consisted of the 
following antibodies: CD4-PerCP, CD3-AlexaFluor 700, CD62L-V500, CD44-FITC, CD28-PE, 
CXCR5-V450 and CD278-Biotin (BD Bioscience, Erembodegem, Belgium). Cells were acquired 
on a FACS Fortessa machine (BD Immunocytometry system, San Jose, CA, USA) and data was 
analyzed using Flowjo software (Treestar, Ashland, OR, USA).  
 
Statistics: Statistical analysis was conducted using GraphPad Prism 4 software 
(http://www.prism-software.com). Data were calculated as mean ± SD. Statistical significant was 
determined using the unpaired Student’s t test or 2-way ANOVA with Bonferroni’s post test, 
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defining differences to C57BL/6 or CD28
-/lox
Cre
+/-
 given oil as significant (*,p≤0.05; **,p≤0.01; 
***,p≤0.001) 
 
2.3 RESULTS 
CD28 costimulatory signalling is required for protective immunity against N. brasiliensis 
infection. 
In order to investigate whether CD28 is required for development of protective immunity against 
N. brasiliensis infection, CD28
-/-
 mice were infected with 500 L3 N. brasiliensis worms and killed 
9 days post-infection (Fig 2.1A). CD28
-/-
 mice had significantly higher intestinal adult worm 
burdens compared to wild-type C57BL/6 mice (Fig 2.1.B). CD28 deficiency did not affect TH2 
associated goblet cells hyperplasia (Fig 2.1C), a possible mechanism mediating protective 
immunity against parasitic nematode infections [189]. Protective immunity to N. brasiliensis 
infection is dependent on the production of Th2 cytokines, particularly IL-13 [145]. Analysis of 
cytokine production after re-stimulation of total mesenteric lymph node (MLN) cells with 
Nippostrongylus antigen (Nag) in the presence of sub-optimal concentration of α-CD3 showed 
significantly reduced production of IL-13 and IL-10 (Fig 2.1D) in infected CD28
-/-
 mice when 
compared to infected C57BL/6 mice. Furthermore, restimulation of MLN cells with α-CD3 only, 
resulted in diminished production of the key cytokines IL-13 and IL-4 in CD28
-/-
 mice compared 
with C57BL/6 mice (Fig 2.1E). However, production of IFN-γ was not affected by the deficiency 
of CD28 costimulatory signalling on MLN cells (Fig 2.1E). CD28
-/-
 mice up-regulated the 
expression of IL-6 after restimulation with either NAg plus sub-optimal concentration of α-CD3 
or CD3 alone compared to wild-type control mice. Finally, production of N. brasiliensis specific 
IgG1 was not altered whereas total IgE was markedly reduced in mice lacking CD28 signalling on 
T cells (Fig 2.1F & G). The production of N. brasiliensis specific type 1 antibodies (IgG2a and 
IgG2b) was also reduced in CD28
-/-
 mice compared with C57BL/6 mice (Figure 2.2), suggesting 
that CD28 deficiency results in a general attenuation of the humoral immune response during 
nematode infection. Together, these data reveal that CD28 is required for protective immunity 
against N. brasiliensis primary infection.  
 
CD28 costimulation is crucial for development of TFH cells and effector CD4
+
 T cells during 
primary infection with N. brasiliensis.  
To investigate the impact of CD28 deletion on the differentiation of CD4
+
 T cells, we analysed 
different CD4
+
 T cells subsets by flow cytometry after primary N. brasiliensis infection. Surface 
expression of CD28 by CD3
+
CD4
+
 T cells from CD28
-/-
 mice was impaired compared to C57BL/6 
mice (Fig 2.3A). There was no significant difference in the total number of CD3
+
CD4
+
 T cells 
between C57BL/6 and CD28
-/-
 mice (Fig 2.3B). However, the absolute numbers of follicular 
helper T cells (TFH) defined by the expression of CXCR5 (Fig 2.3C) and ICOS (Fig 2.3D) were 
significantly reduced in CD28
-/-
 mice compared to wild-type mice. There was similar numbers of 
naive CD4
+
 T cells (CD4
+
CD44
-
CD62L
+
) and central memory CD4
+
 T cells 
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(CD4
+
CD44
+
CD62L
+
) between the mutant and control mice (Fig 2.3E & F). Interestingly, the 
absolute numbers of effector CD4
+
 T cells was significantly reduced in CD28
-/-
 mice compared to 
C57BL/6 mice (Fig 2.3G). Together, these data suggest a critical requirement for CD28 
costimulation for the expansion of TFH cells and effector CD4
+
 T cells.  
 
Figure 2.1: CD28 is required for the development of protective immunity against N. brasiliensis primary 
infection. 
Wild-type (C57BL/6) and CD28
-/-
 mice were infected with 500 L3 N. brasiliensis larvae and killed 9 days post-
infection. (A), Schematic showing experimental set-up. (B), Intestinal worm burdens were quantified. (C), PAS 
staining of mucus producing goblet cells in the intestinal tissue. (D-E), Cytokine production by total mesenteric 
lymph node cells re-stimulated with 20 µg/ml NAg plus sub-optimal concentration of α-CD3 (2 µg/ml) or 20 µg/ml 
α-CD3 only was determined by ELISA. (F-G), Serum antibody titres of N. brasiliensis specific IgG1 and total IgE 
were determined by ELISA. Data are representative of two independent experiments. n= 4-6 mice per group. 
*P<0.05, **P<0.001, and ***P<0.0001 vs C75BL/6
 
mice. 
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Figure 2.2: Diminished serum titres of type1 antibodies in the absence of CD28 during infection with N. 
brasiliensis. 
Wild-type (C57BL/6) and CD28
-/-
 mice were infected with 500 L3 N. brasiliensis larvae and killed 9 days post-
infection. Blood was collected, spun at 8 000×g for 10 min to separate the serum. (A-B), Serum antibody titre of N. 
brasiliensis specific IgG2a and IgG2b was determined by ELISA. Data are representative of two independent 
experiments. n= 4-6 mice per group.  
 
CD28 is required for protective memory responses to N. brasiliensis infection. 
CD28 is indispensable for optimal development of Th2 immune responses, however, it 
significance in disease protection is unclear. Therefore, to investigate the contribution of CD28 in 
host protective memory responses, we took advantage of a novel inducible CD28 deleting mouse 
strain (CD28
-/lox
Cre
+/-
), a suitable experimental model system, recently developed by us [249,250]. 
CD28
-/lox
 mice (exon 2 and 3 are flanked by loxP) were intercrossed with rosaCreER
T2
 mice to 
generate CD28
-/lox
rosaCreER
T2
 mice. Oral administration of estrogen analogue tamoxifen allowed 
for translocation of estrogen-receptor-Cre fusion protein into the nucleus, where Cre carried out 
efficient deletion of cd28 gene [249,250,251].  
 
CD28
-/lox
Cre
+/-
 and CD28
-/-
 mice were infected with 500 L3 N. brasiliensis larvae, treated with 
Ivermectin and rested for 21 days (Fig 2.4A). At day 29, CD28
-/lox
Cre
+/-
 mice were either treated 
with tamoxifen in vegetable oil (CD28
-/lox
Cre
+/-
+TM) or oil only (CD28
-/lox
Cre
+/-
, control) for four 
consecutive days (Fig 2.4A). At day 35, mice were re-infected with 500 L3 N. brasiliensis larvae 
and killed 5 days post-infection (Fig 2.4A). Efficient deletion of CD28 was confirmed by flow 
cytometric analysis of CD3
+
CD4
+
 T cells. Here, oral administration of tamoxifen in CD28
-
/lox
Cre
+/-
 mice, resulted in similar levels of CD28 expression as was found in infected global 
CD28
-/-
 mice (Fig 2.5A). CD28
-/lox
Cre
+/-
 mice treated with tamoxifen before challenge with N. 
brasiliensis adult worms exhibited high intestinal worm burdens equivalent to CD28
-/-
 mice (Fig 
2.4B). Both tamoxifen treated CD28
-/lox
Cre
+/-
 and CD28
-/-
 mouse groups had significantly higher 
worm burdens than sham-treated CD28
-/lox
Cre
+/-
 control mice (Fig. 2.4B). Goblet cell hyperplasia 
was similar in all strains (Fig 2.4B). In vitro restimulation of total MLN cells with NAg in the 
presence of sub-optimal concentration of α-CD3 or optimal concentration of α-CD3 showed 
markedly reduced production of Th2 cytokines IL-13 and IL-4 in infected CD28
-/-
 and tamoxifen-
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treated CD28
-/lox
Cre
+/-
 mice (Fig 2.4D and E). Serum antibody levels for type 2 antibodies were 
also significantly reduced in mutant mouse strains compared with sham-treated CD28
-/lox
Cre
+/-
 
control mice (Fig 2.4F and G). Together, these results suggest that memory and subsequent 
production of protective Th2 cytokines and humoral immune responses are dependent on CD28 
during the secondary infection with N. brasiliensis.  
 
 
Figure 2.3: Differentiation of TFH cells and effector CD4
+
 T cells is dependent on CD28 costimulation. 
Single cell suspension was prepared from mesenteric lymph node and cells were stained for FACS. (A), Histogram 
showing efficiency of CD28 deletion on CD3
+
CD4
+
 T cells. (B), Absolute numbers of CD3
+
CD4
+
 T cells in the 
lymph node. Absolute numbers of CD3
+
CD4
+
CXCR5
+
 (C) and CD3
+
CD4
+
ICOS
+
 (D) T cells recruited to the MLN. 
(E-G) Absolute numbers of T cell subsets infiltrating the draining lymph node. T cell subsets were differentiated 
based on the following markers: naive (CD3
+
CD4
+
CD44
-
CD62L
+
), effector (CD3
+
CD4
+
CD44
hi
CD62L
lo
) and central 
memory (CD3
+
CD4
+
CD44
+
CD62L
+
) T cells. Data represents three independent experiments. n= 4-6 mice per 
experiment. **P<0.001 vs C57BL/6 mice. 
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Figure 2.4: CD28 is required for development of protective recall responses to re-infection with N. brasiliensis. 
Wild-type (CD28
-/lox
Cre
+/-
), tamoxifen treated CD28
-/lox
Cre
+/-
 and CD28
-/-
 mice were secondary infected with 500 L3 
N. brasiliensis and killed 5 days post-infection. (A), Schematic showing experimental set-up. (B), Intestinal worm 
burdens were quantified. (C), PAS staining of pulmonary mucus producing goblet cells (D-E), Cytokine production 
by total mediastinal lymph node cell re-stimulated with either 20 µg/ml NAg plus sub-optimal concentration of α-
CD3 (2 µg/ml) or optimal concentration of α-CD3 (20 µg/ml) was determined by ELISA. (F-G) Serum antibody titres 
of N. brasiliensis specific IgG1 and total IgE were determined by ELISA. Data is representative of three independent 
experiments. n= 4-6 mice per group. .*P<0.05, **P<0.001, and ***P<0.0001 vs CD28
-/lox
Cre
+/- 
mice given oil. 
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Development of TFH cells, memory and effector CD4
+
 T cells requires CD28 during 
secondary infection with N. brasiliensis. 
To further investigate possible cellular mechanisms, CD4
+
 T cell subsets were compared at 5 days 
post secondary infection. The absolute numbers of CD4
+
 T cells was significantly reduced in 
tamoxifen-treated CD28
-/lox
Cre
+/-
 mice compared to control mice, while there was no difference in 
the number of CD4
+
 T cells between global CD28
-/-
 mice and control mice (Fig 2.5B). Similar as 
in global CD28
-/-
 mice, absolute numbers of CXCR5
+
 and ICOS
+
 TFH cells were significantly 
reduced in CD28
-/lox
Cre
+/-
 mice given tamoxifen compared to sham-treated CD28
-/lox
Cre
+/-
 mice 
(Fig 2.5C and D). These data demonstrate that the development of TFH cells during recall 
responses to N. brasiliensis infection is critically reliant to CD28 costimulation during secondary 
infection only.  
 
There is evidence suggesting that memory T cells develop directly from effector CD4
+
 T cells 
[252]. Flow cytometric analysis of memory T cells was conducted to investigate the development 
of memory T cells during recall responses to nematode infections. The total numbers of naive 
CD4
+
 T cells (CD4
+
CD44
-
CD62L
+
) were similar in both CD28
-/-
 mice and CD28
-/lox
Cre
+/-
 mice 
given tamoxifen during recall responses to N. brasiliensis infection (Fig 2.5E). However, the 
absolute numbers of effector T cells (CD4
+
CD44
hi
CD62L
lo
) were significantly reduced in both 
CD28
-/lox
Cre
+/-
 mice given tamoxifen and CD28
-/-
 mice compared with CD28
-/lox
Cre
+/-
 mice given 
oil (Fig 2.5F). Moreover, the absolute numbers of central memory T cells (CD4
+
CD44
+
CD62L
+
) 
were also significantly reduced in both mutant mouse strains, when compared with control mice 
(Fig 2.5G). Together, these data suggest that CD28 is essential for the development of both 
effector CD4
+
 T cells and a new pool of central memory CD4
+
 T cells during re-infection with N. 
brasiliensis.  
 
CD28 influences B cell development in the draining lymph node during secondary infection 
with N. brasiliensis.  
Impairment of CD28 T cell costimulation also influenced humoral immunity, hence different 
subsets of B cells were analysed by flow cytometry in the mediastinal lymph node after secondary 
infection with N. brasiliensis. Global CD28
-/-
 mice showed normal total CD19
+
B220
+
 B cells (Fig 
2.6A), strikingly reduced follicular B cells (Fig. 2.6B), more than 6-fold increased marginal zone 
B cells (Fig 2.6C) and normal numbers of non-follicular B cells (Fig 2.6D) compared to sham-
control CD28
-/lox
Cre
+/-
 mice. This suggests that development of follicular and marginal zone B 
cells may be dependent on CD28 costimulation. CD28
-/lox
Cre
+/-
 mice given tamoxifen during 
secondary infection, presented reduced number of CD19
+
B220
+
 B cells (Fig. 2.6A) due to 
strikingly reduced follicular and non-follicular B cells (Fig. 2.6B, D), compared to sham-control 
CD28
-/lox
Cre
+/-
 mice. The absolute numbers of marginal zone B cells was slightly but significantly 
increased in CD28
-/lox
Cre
+/-
 mice treated with tamoxifen compared to sham-treated control mice 
(Fig 2.6C). The similarly reduced numbers of follicular B cells in CD28
-/-
 mice and CD28
-/lox
Cre
+/-
 
mice given tamoxifen during secondary infection, suggests that development of follicular B cells 
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is particularly dependent on CD28 costimulation during secondary infection. Moreover, the 
results further suggest that impairment of CD28 costimulation during primary and/or secondary 
infection influences follicular and non-follicular B cells. Together, we concluded that CD28 
costimulation is important for B cell development in the draining lymph node during re-infection 
with N. brasiliensis. 
 
Figure 2.5: CD28 is necessary for the development of TFH cells and optimal activation of CD4
+
 T cells. 
Single cell suspension was prepared from mediastinal lymph node and cells were stained for FACS. (A), Histogram 
showing efficiency of CD28 deletion on CD3
+
CD4
+
 T cells. (B), Absolute numbers of CD3
+
CD4
+
 T cells in the 
lymph node. Numbers of CD3
+
CD4
+
CXCR5
+
 (C) and CD3
+
CD4
+
ICOS
+
 (D) T cells recruited to the mediastinal 
lymph node. (E-G) Total number of T cell subsets infiltrating the draining lymph node. T cells subsets were 
differentiated based on the following markers: naive (CD3
+
CD4
+
CD44
-
CD62L
hi
), effector memory 
(CD3
+
CD4
+
CD44
hi
CD62L
lo
) and central memory (CD3
+
CD4
+
CD44
+
CD62L
+
) T cells. Data represents three 
independent experiments. n= 4-6 mice per experiment. *P<0.05, **P<0.001, and ***P<0.0001 vs CD28
-/lox
Cre
+/- 
mice given oil. 
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Figure 2.6: B cell development in the mediastinal lymph node is affected by CD28 deletion on CD4
+
 T cells. 
Single cells suspension was prepared from mediastinal lymph nodes and cells stained for FACS. (A), Total numbers 
of CD19
+
B220
+
 B cells population recruited into the mediastinal lymph node. (B-D), Numbers of different B cell 
subsets recruited into the draining mediastinal lymph node. B cell subsets were differentiated based on the following 
markers: follicular B cells (FO, CD19
+
B220
+
CD21
hi
CD23
hi
), marginal zone B cells (MZ, 
CD19
+
B220
+
CD21
hi
CD23
lo
) and non-follicular B cell (NF, CD19
+
B220
+
CD21
-
CD23
-
).Data represents three 
independent experiments. n= 4-6 mice. *P<0.05 and **P<0.001 vs CD28
-/lox
Cre
+/- 
mice given oil. 
 
2.4 DISCUSSION 
The contribution of CD28 costimulation during recall of memory responses to infections has 
remained controversial despite numerous attempts to study it. Some studies have suggested that 
CD28 costimulation is not required for recall of protective memory responses to nematode 
infections [66,69]. Furthermore, infection of CD28
-/-
 mice with the fungi B. dermatitidis showed 
that development of memory responses is CD28 independent [68]. In contrast, the absence of 
CD28 costimulation during recall of memory responses to T. gondii infection [70] and viral 
infections [71,72] inhibited the development of protective memory responses. The controversy 
surrounding the requirement of CD28 for recall of protective memory responses may depend on 
the pathogen itself. To address these questions for nematode infections, we utilised global CD28
-/-
 
mice, and more importantly a recently established conditional CD28 deleting mouse strain (CD28
-
/lox
Cre
+/-
), where CD28 deletion is induced by oral administration of estrogen analogue tamoxifen 
[250]. The latter mouse model allowed for abrogation of CD28 costimulation after primary 
infection with N. brasiliensis, ensuring that priming of the immune response occurred in the 
presence of CD28 costimulation.  
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Primary infection in global CD28
-/-
 mice with N. brasiliensis revealed that CD28 costimulation is 
essential for development of protective T cell immunity, as CD28
-/-
 mice failed to expel adult 
worms in the small intestines efficiently, mainly caused by an impaired IL-13-driven Th2 
cytokine response, known to play a crucial role in driving worm expulsion during primary 
infection with N. brasiliensis [145,195]. This outcome was also reproduced in anti-CD28 (E18) in 
vivo blocking experiments (our unpublished data) and is in agreement with previous studies by 
others, showing that interfering with CD28 costimulation during primary infection with 
nematodes impairs optimal development of Th2 cytokine responses [66,69]. Interestingly, 
analysis of the antibody responses showed reduced titres of both type 1 and type 2 antibody 
isotypes, indicating a general abrogation of humoral immunity in the absence of CD28 
costimulation. This was further investigated during secondary infection. Contrastingly, CD28
-/-
 
mice inoculated with H. polygyrus primary infection mounted a sufficient humoral immune 
response [243]. Hence, the requirement of CD28 costimulation in driving development of humoral 
immunity seems to depend on parasites causing the infection. In fact, infection with H. polygyrus 
seems to be sufficient to induce polyclonal antibody responses even in the absence of CD28 
costimulation, supporting the suggestion that parasites can trigger polyclonal B cells responses 
[253]. 
 
Abrogating CD28 costimulation during secondary infection in inducible CD28 deficient mice led 
to failure in mounting a protective memory response, strongly suggesting that CD28 costimulation 
is needed for efficient recall of protective immunity to N. brasiliensis. This conclusion is in 
contrast with previous findings using CTLA4-Ig to block the CD28 ligands CD80 and CD86 [66]. 
A possible explanation is that CTLA4-Ig exerts additional effects which may confound the 
situation. Thus, this fusion protein also prevents ligation of endogenous CTLA-4 expressed by 
regulatory and activated T-cells, which may partially counterbalance the desired effect. Failure of 
protective memory responses in inducible CD28 deficient mice was accompanied with striking 
reduced Th2 responses, including IL-4 and IL-13 in the lung draining lymph node. These results 
coincide with our current knowledge that CD28 costimulation enhances IL-4 receptor sensitivity 
and subsequently Th2 CD4
+
 T cell differentiation [254,255], the latter being involved in 
mediating protective immunity against reinfection with N. brasiliensis by lung-residentCD4
+
 T 
cells [256].  
Mice deficient in CD28 signalling throughout the infection or prior secondary infection had 
reduced cellular numbers in the draining lymph nodes compared to littermate control mice. This 
may be due impaired recruitment of cells to the lymph nodes or the fact that CD28 is known to 
prevent apoptosis [53,242]. Previous studies have suggested a number of pathways governing the 
development of memory CD4
+
 T cells. In a study by Hu and colleagues, memory CD4
+
 T cells 
were shown to develop directly from effector CD4
+
 T cells that reverted to a resting state 
suggesting a linear pathway for memory T cells generation [252]. However, other studies have 
suggested a more complex pathway for central memory T cell generation comprised of 
heterogeneous memory T cell populations [257]. Interestingly, the absolute numbers of CD4
+
 T 
cells was reduced in mice which lost CD28 after primary N. brasiliensis infection, while there was 
no difference in absolute CD4
+
 T cells numbers between CD28
-/-
 mice and CD28
-/lox
Cre
+/-
 mice 
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given oil. This is probably due to a contribution of CD28 to the homeostasis of the CD4 T-cell 
compartment, which is less pronounced if CD28 is absent already during thymic differentiation. 
However, total numbers of effector CD4
+
 T cells were markedly reduced in the absence of CD28 
costimulation during secondary infection, regardless of whether CD28 was constitutively missing 
or deleted after priming. This resulted in reduced total numbers of central memory CD4
+
 T cells in 
both CD28
-/lox
Cre
+/-
 mice given tamoxifen and CD28
-/-
 mice.  
 
Deficiency of CD28 costimulation also affected antibody responses as shown by reduced type 1 
and type 2 antibody titres in mice deficient of CD28 costimulation. This data concurs with 
reduced total IgE titres observed in mice treated with CTLA4-Ig during reinfection with N. 
brasiliensis [66]. Hence, CD28 costimulation seems to be crucial for sustaining CD4
+
 T cells 
dependent memory antibody responses. Cognate interaction between the antigen-specific T 
follicular helper cells (TFH) and B cells in the lymphoid tissue is crucial for germinal center 
formation and optimal antibody responses including isotype switching [60]. In a study by 
Zaretsky and colleagues, IL-4 producing Th2 cells were shown to possess the capacity to 
differentiate into TFH cells during immunisation with S. mansoni antigens [258]. This was further 
confirmed by a study by King and Mohrs that demonstrated that in a Th2 setting induced by 
infection with H. polygyrus, the majority of IL-4 producing CD4
+
 T cells in the reactive lymph 
nodes co-express canonical TFH cells markers and localised within the B cell follicles [259]. Our 
data showed that in the absence of CD28 costimulation, the expansion of TFH cells expressing the 
canonical markers CXCR5 and ICOS was reduced during reinfection with N. brasiliensis. ICOS 
plays an essential role in maintaining the expression of CXCR5 on CD4
+
 T cells during SRBC 
immunisation and enhances GC formation and antibody production [260]. Hence, we concluded 
that CD28 costimulation is important for development of TFH cells in the reactive lymph nodes 
during secondary infection with the nematode N. brasiliensis. Furthermore, the deficiency of 
CD28 impacted on the development of B cells in the reactive lymph nodes, shown by diminished 
population of follicular B cells in infected global CD28
-/-
 mice and as well as CD28
-/lox
Cre
+/-
 mice 
given tamoxifen after primary infection with N. brasiliensis. This can explain the diminished 
production of IL-4 in the reactive lymph nodes of CD28 mutant mouse strains and the observed 
abrogated humoral immunity. Together, these findings strongly demonstrate an important role 
played by CD28 costimulation during recall of protective memory responses to N. brasiliensis 
infection. CD28 costimulation seems to be required throughout the infection period to sustain the 
development of protective memory responses. These findings are in stark contrast to the normal 
development of protective memory responses exhibited by CD28
-/-
 mice infected with H. 
polygyrus [69]. A recent study by Harvie and colleagues showed that the lungs are a crucial site 
harbouring protective immunity against N. brasiliensis reinfection [256]. The differences 
observed in the requirement of CD28 costimulation during recall of memory responses to N. 
brasiliensis and H. polygyrus may be due to different migration patterns of the parasites within the 
host. H. polygyrus is a completely enteric parasite while N. brasiliensis migrates via the lungs to 
the intestines.  
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In conclusion, our study clearly demonstrates the essential role played by CD28 costimulation 
during recall of protective memory responses to N. brasiliensis infection. CD28 costimulation was 
shown to confer protection against primary infection with N. brasiliensis using conventional 
CD28
-/-
 mice. Failure to expel adult N. brasiliensis worms during secondary infection was 
associated with diminished Th2 cytokine responses and abrogated humoral immunity particularly 
the production of IgG1 and total IgE. Importantly, the deficiency of CD28 costimulation impaired 
recruitment of memory CD4
+
 T cell sub-populations and expansion of T follicular helper cells 
crucial for providing help to follicular B cells.  
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CHAPTER 3 
 
IL-4/IL-13 responsive B cells are required for protection against acute schistosomiasis and 
down-modulating liver and gut inflammation. 
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ABSTRACT 
IL-4Rα dependent Th2 immune responses are indispensable for mounting host protective 
immunity against S. mansoni infection. B cells are known to play an important role in controlling 
S. mansoni infection but whether an ability to respond to IL-4/IL-13 impacts on this is unknown. 
To address this we used a novel mouse strain lacking IL-4Rα expression on B cells (mb1creIL-
4Rα-/lox). We found that B cell-specific IL-4Rα-deficient mice had heightened susceptibility to S. 
mansoni infection compared to IL-4Rα-/lox littermate control mice. Increased susceptibility was 
related to increased granuloma size; hepatocellular damage indicated by heightened serum AST 
levels and augmented gut inflammation. This was associated with reduced production of Th2 
cytokines by total MLN cells from B cell-specific IL-4Rα-deficient mice after restimulation with 
SEA or α-CD3 ex vivo. Interestingly, abrogation of IL-4Rα signalling on B cells decreased 
secretion of both Th1 and Th2 cytokines by CD19
+
 B cells. Likewise, production of IL-4 and IL-
13 by CD4
+
 T cells and recruitment of CXCR5
+
 TFH cells and effector CD4
+
 T cells was impaired 
in mice lacking IL-4Rα expression on B cells. B cell-specific IL-4Rα-/lox mice failed to down-
modulate granuloma formation and cytokine production during the chronic stages of infection. 
Generation of bone marrow chimera mice lacking IL-4 production specifically on B cells 
demonstrated that IL-4 produced by B cells is not involved in orchestrating host protective 
immunity, as indicated by normal antibody production, diminished granuloma formation, lack of 
iNOS producing cells in the liver granuloma and intact cytokine production by MLN cells after 
restimulation. These data demonstrate that B cell driven Th2 immunity plays a critical role in co-
ordinating the induction of the immunological responses against acute schistosomiasis that are 
essential for host survival. 
 
Keywords: IL-4Rα, B cells, S. mansoni, mb1creIL-4Rα-/lox, mice. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
H. H. Ndlovu March 2013 Chapter 3 
38 
 
3.1 Introduction 
B cells are largely known for their capacity to produce antibodies in response to foreign antigens 
or pathogens. However, recent studies have expanded the functions of B cells during immune 
responses to pathogens. Activated B cells are competent antigen presenting cells (APCs) capable 
of internalising antigen through the B cell receptor (BCR), processing and presenting peptides to 
CD4
+
 T cells [90,92,261]. Mice lacking the ability to present antigen due to the deletion of the 
MHC II molecule specifically on B cells failed to clear Heligomosomoides polygyrus (Hp) 
infection and exhibited impaired humoral and cellular immunity, demonstrating the importance of 
cognate interactions between B cells and CD4
+
 T cells [90]. In fact, many studies have 
demonstrated the ability of antigen presenting B cells to assist in the expansion and differentiation 
of primary and memory CD4
+
 T cells [89,261] and induce Th1 and Th2 cytokine production in 
vivo [87,94,96,97,262].  
 
B cells have been shown to influence immunity to pathogens by producing a wide array of 
polarising cytokines such as IL-2, IL-4, IL-13, IFN-γ and IL-12 [93,104,105]. This has led to 
subdivision of B cells into three different effector B cell subsets that produce distinct cytokines, 
namely B effector 1 (Be1), B effector 2 (Be2) and regulatory B cells (Bregs) [106,107,263]. Be1 
cells under the control of transcription factor T-bet produce IFN-γ, IL-12p40, TNF-α and IL-10 in 
response to cognate interaction with Th1 cells and antigen in vitro [104]. Such Be1 cells were 
detected in vivo during infection with a Th1 polarising parasite Toxoplasma gondii [104,106]. In 
contrast, development of Be2 cells that secrete IL-4, IL-2, IL-13, IL-6, IL-10 and TNF-α is 
dependent on IL-4, IL-4Rα and Th2 cells in vitro and infection with Hp in vivo has been shown to 
induce differentiation of Be2 cells [105,106]. Bregs are defined by their ability to produce IL-10 
and TGF-β and are critical in immuno-suppression [263]. IL-10 producing B cells mediate 
protection against allergic airway inflammation [117], prevent colitis [118,119,120] and collagen-
induced arthritis [121,122].  
 
Cytokine producing effector B cells are crucial for the differentiation and expansion of effector 
Th2 cells during primary infection with Hp [90]. Although IL-4 producing Th2 cells are 
indispensable for host protection to Hp [264], chimeras lacking IL-4 production specifically in B 
cells cleared Hp infection, demonstrating that IL-4 producing B cells are not required for host 
protection and generation of protective memory Th2 cells [90]. In contrast, B cells producing IL-2 
and TNF-α provided partial protection against Hp infection by regulating humoral and cellular 
immune responses in chimeric mice [90]. Moreover, the capacity of B cells to respond to IL-4 or 
IL-13 signalling via IL-4Rα expression is required for protective immunity to Hp challenge in 
chimeric mice [90]. The importance of IL-4/IL-13 responsive B cells in infection with 
Schistosoma mansoni (S. mansoni), a parasite that induces a highly polarised Th2 immune 
response, is yet to be determined.  
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Schistosomiasis is a parasitic disease caused by trematode parasites belonging to Schistosoma 
genus, affects more than 200 million people worldwide and is estimated to cause approximately 
280 000 deaths per year in sub-Saharan Africa alone [203,265,266,267,268]. The disease is 
caused by parasite eggs that are lodged in the host’s tissue where they elicit a highly polarised 
Th2 immune response which induces granulomatous inflammation [131,217]. Mice deficient in 
IL-4, IL-4/IL-13, IL-4Rα and STAT-6 quickly succumb to S. mansoni infection due to impaired 
granuloma formation, hepatocellular damage and augmented gut inflammation which leads to 
endotoxemia and septic shock [147,148,218,219]. Furthermore, studies from our laboratory have 
demonstrated that IL-4/IL-13 responsive macrophages [147], smooth muscle cells [188] and pan-
T cells [190] are crucial for rendering host protection against S. mansoni infection and down-
modulating tissue pathology.  
 
During the chronic stage of S. mansoni infection, the marked Th2 immune response existing 
during the acute phase of infection is down-regulated alongside granuloma formation and tissue 
fibrosis [233,269]. Immuno-suppressive CD8
+
 T cells [229], cross-regulation by cytokines 
produced by Th1 or Th2 cells [230,270,271] and FcR signalling on B cells [233] are all involved 
in modulating pathology during chronic Schistosomiasis. Recently, it has been demonstrated that 
interfering with IL-10R signalling results in augmented tissue damage during chronic S. mansoni 
infection due to loss of B cells in the liver [221], confirming the suppressive effect of IL-10 on 
Th2 cell differentiation during chronic schistosomiasis [220,222,231,235].  
 
In this study, we investigated the role of IL-4/IL-13 responsive B cells in host protective 
immunity during acute schistosomiasis and the ability of these cells to down-modulate tissue 
pathology and T cell responsiveness during chronic S. mansoni infection, using transgenic mice 
(mb1
cre
IL-4Rα-/lox) lacking IL-4Rα expression on B cells. Mb1creIL-4Rα-/lox quickly succumbed to 
S. mansoni infection with similar kinetics to the highly susceptible IL-4Rα-/- mice. Increased 
susceptibility was associated with impaired production of Th2 cytokines, augmented granuloma 
formation; exacerbated liver damage indicated by high levels of serum AST, and severe gut 
inflammation. Mice deficient in IL-4Rα expression on B cells failed to down-modulate granuloma 
formation and exhibited mixed Th1, Th2 and Th17 cytokine responses at the later stages of 
chronic infection. Lastly, mice lacking IL-4 producing B cells developed normal Th2 immunity 
and had unaltered numbers of effector CD4
+
 T cells and follicular B cells. Taken together, these 
findings demonstrate an important role for IL-4/IL-13 responsive B cells in conferring protection 
to S. mansoni infection and down-regulating tissue pathology. 
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3.2 Materials and Methods 
Generation and genotyping of mb1
cre
IL-4Rα-/lox Balb/c mice. Mb1cre mice were intercrossed 
with IL-4Rαlox/lox Balb/c mice [147,191,272,273]. These mice were further mated with 
homozygous IL-4Rα-/- Balb/c mice [248] to generate hemizygous mb1creIL-4Rα-/lox mice. 
Hemizygous littermates (IL-4Rα-/lox) expressing functional IL-4Rα were used as wild-type 
controls in all experiments. Mice were genotyped as described previously [147,248]. All mice 
were housed in specific pathogen-free barrier conditions in individually ventilated cages at the 
University of Cape Town biosafety level 2 animal facility. Experimental mice were age and sex 
matched and used between 8-12 weeks of age.  
 
Ethics statement. This study was performed in strict accordance with the recommendations of the 
South African national guidelines and University of Cape Town practice of laboratory animal 
procedure. All mouse experiments were performed according to the protocols approved by the 
Animal Research Ethics Committee of the Faculty of Health Sciences, University of Cape Town 
(protocol number: 010/041). Efforts were made to minimise and reduce suffering of animals.  
 
Live S. mansoni infection of mice. Mice were percutaneously infected with 100 live cercariae 
(acute infection) or with 30 live cercariae (chronic infection) of a Puerto Rican strain of S. 
mansoni obtained from infected Biomphalaria glabrata (a generous gift from Adrian Mountford, 
York, UK). The mice were monitored weekly until 7 weeks post-infection.  
 
Pulmonary S. mansoni eggs model. Synchronous S. mansoni egg-challenge was conducted as 
previously described [274]. Briefly, mice were sensitised to schistosome eggs by intraperitoneal 
injection of 2 500 eggs. Mic  were subsequently challenged 14 days later by intravenous injection 
of 2 500 eggs and killed at day 7 and 14 post-challenge. 
 
Antibodies and flow cytometry. The following antibodies comprising the B cell antibody panel 
were used: B220-V500, CD19-PerCP Cy5.5, CD23-PE, CD21-APC, CD24-PE Cy7, CD80-V450, 
MHCII-FITC and IgM-Biotin (BD Bioscience, Erembodegem, Belgium). T cells panel consisted 
of the following antibodies: CD4-PerCP, CD3-AlexaFluor 700, CD62L-V500, CD44-FITC, 
CD28-PE, CXCR5-V450 and CD278-Biotin (BD Bioscience, Erembodegem, Belgium). Cells 
were acquired on a FACS Fortessa machine (BD Immunocytometry system, San Jose, CA, USA) 
and data was analyzed using Flowjo software (Treestar, Ashland, OR, USA). Macrophage 
activation profile was analysed in CD11b
+
MHCII
+
 macrophages by flow cytometry. Classically 
activated macrophages were detected by staining for intracellular expression of iNOS using rabbit 
anti-mouse iNOS antibody (Abcam) with goat anti-rabbit PE (Abcam). Alternatively activated 
macrophages were detected by detecting Arginase 1 and Ym-1-Biotin using goat anti-mouse 
arginase (Santa Cruz Biotechnology) with donkey anti-goat PE (Abcam) and Strep-APC 
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respectively. Staining specificity was verified by appropriate isotype-matched antibody controls 
and compensation performed with single-stain samples before acquiring the multi-coloured 
samples. Acquisition was performed using a FACSCalibur (BD Immunocytometry Systems). 
 
Intracellular cytokine staining. For detection of intracellular cytokines, MLN cells from S. 
mansoni infected mice or MST from S. mansoni eggs injected mice were plated at 1 × 10
6
 
cells/well and stimulated at 37ºC for 4 hours with 50 ng/ml phorbol (myristate acetate), 250 ng/ml 
ionomycin and 200 µM monensin in IMDM/10% FCS (all purchased from Sigma-Aldrich). Cells 
were stained with extracellular markers (CD4 Biotin-APC, B220 FITC or CD19 PercP), fixed for 
30 min on ice in 2% (w/v) paraformaldehyde and permeabilised with 0.5% saponin buffer and 
stained with PE-labelled anti-mouse IL-4, IL-5, IL-10 and IFN-γ for 15 min. Acquisition was 
performed using a FACSCalibur (BD Immunocytometry Systems, San Jose, CA, USA) and data 
were analysed using FlowJo software (Treestar, Ashland, OR, USA).  
 
Cell preparation and ex vivo restimulation. Single cell suspensions were prepared by pressing 
the draining lymph nodes through 70 µM cell-strainers. Cells were resuspended in complete 
IMDM (Gibco) supplemented with 10% FCS (Gibco) and penicillin and streptomycin (100 U/ml 
and 100 µg/ml, Gibco). The cells were cultured at 2 × 10
6
 cells/ml in 48-well plates coated with α-
CD3 (100 µg/ml) or soluble egg antigen (SEA, 20 µg/ml) and incubated at 37ºC in a humidified 
atmosphere containing 5% CO2. Supernatants were collected after 72 h and cytokines were 
measured by ELISA. Quantities of IL-4, IL-10 and IL-13 were measured by sandwich ELISA as 
previously described [248]. 
 
Preparation of cells from liver tissue. A method described by Metwali and colleagues was used 
to isolate granuloma associated cells [275]. Briefly, infected livers were finely chopped and then 
suspended in complete IMDM (Gibco) supplemented with 5% collagenase and the tissue 
suspension was incubated at 37ºC for one hour. The digested tissue was centrifuged at 5 000 ×g 
and the sediment was washed twice with ice-cold PBS. The dispersed granulomas were further 
disrupted by repeated suction and expulsion through a 20 ml syringe. The cells were washed and 
spun again and then viability was determined by staining cells with trypan blue. 
 
Enzyme Linked Immunosorbent Assays (ELISAs). Cytokines in supernatant were measured by 
sandwich ELISA as previously described [248]. For antibody ELISAs, blood was collected in 
serum separator tubes (BD Bioscience, San Diego, CA) and serum was separated by 
centrifugation at 8 000 ×g for 10 min at 4ºC. Titres of SEA-specific IgG1, IgG2a, IgG2b and total 
IgE were determined as previously described [248].  
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Hydroxyproline assay. Hydroxyproline content as a measure of collagen production was 
determined using a modified protocol [276]. Briefly, weighed liver samples were hydrolysed and 
added to a 40 mg Dowex/Norit mixture. The supernatants were neutralised with 1% 
phenolphthalein and titrated against 10 M NaOH. An aliquot was mixed with isopropanol and 
added to chloramine-T/citrate buffer solution (pH 6.5). Erlich’s reagent was added and absorbance 
was read at 570 nm. Hydroxyproline levels were calculated using 4-hydroxy-L-proline 
(Calbiochem) as a standard, and results were expressed as µmoles hydroxyproline per weight of 
tissue that contained 10
4
 eggs.  
 
Histology. Liver and gut samples were fixed in 4% (v/v) formaldehyde in phosphate buffered 
saline, embedded in wax and processed. Sections (5-7 µm) were stained with hematoxylin and 
eosin (H&E) and analine blue solution (CAB) and counterstained with Wegert’s hematoxylin for 
collagen staining. Micrographs of liver granuloma were captured using a Nikon 5.0 mega pixel 
colour digital camera (DCT DS-SMc).The diameter of each granuloma containing a single egg 
was measured with the ImageJ 1.34 software. An average of 25 granulomas per mouse was 
included in the analyses.  
 
Statistics. Statistical analysis was conducted using GraphPad Prism 4 software. Data was 
calculated as mean ± SD. Statistical significant was determined using the unpaired Student’s t test 
or 2-way ANOVA with Bonferroni’s post test, defining differences to IL-4Rα-/lox mice as 
significant (*,p≤0.05; **,p≤0.01; ***,p≤0.001). (Prism software; http://www.prism-software.com).  
 
3.3 Results 
B cell-specific IL-4Rα deficient mice are highly susceptible to acute Schistosomiasis 
Studies conducted in mice deficient in B cells (µMT) have demonstrated a critical role for B cells 
in down-regulating tissue pathology and conferring host protection during the chronic stage of S. 
mansoni infection [232,233]. Furthermore, mice lacking expression of the Fc R chain displayed 
augmented granuloma formation during both the acute and chronic stages of infection [233]. 
Therefore, these studies were essential in elucidating the role of B cells during the development of 
host protective immune responses against S. mansoni infection. However, the contribution of B 
cells responding to IL-4/IL-13 signalling via IL-4Rα in host survival and immunity during 
schistosomiasis is unknown.  
In order to determine the role of IL-4/IL-13 responsive B cells during acute S. mansoni infection, 
mb1
cre
IL-4Rα-/lox Balb/c mice were infected with 100 live S. mansoni cercariae and mortality 
monitored over a 14 weeks period (Fig 3.1A). Mb1
cre
IL-4Rα-/lox mice quickly succumbed to S. 
mansoni infection by 10 weeks post-infection, similarly to the highly susceptible IL-4Rα-/- mice 
(Fig 3.1A). In contrast, IL-4Rα-/lox littermate control mice displayed greater resistance to S. 
mansoni infection, with 40% of the mice surviving until 10 weeks post-infection (Fig 3.1A). IL-
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4Rα-/- mice are known to succumb to infection due to severe cachexia that coincides with the 
onset of egg-laying by the parasites [147,190]. As expected, IL-4Rα-/- began to drastically lose 
weight after 6 weeks post-infection and some mice had lost 20% of their body weight by the time 
of death (Fig 3.1B). However, mb1
cre
IL-4R
-/lox
 and IL-4Rα-/lox mice displayed similar kinetics for 
weight loss up until 9 weeks post-infection, when littermate control mice recovered some of their 
body weight (Fig 3.1B). Together, these data demonstrate an important role for IL-4/IL-13 
responsive B cells in host survival during acute schistosomiasis.  
 
To investigate the impact of S. mansoni infection in organ pathology, we conducted post-mortems 
on infected mice. There was no significant difference in spleen (Fig 3.1C) and liver (Fig 3.1D) 
weight between B cell-specific IL-4Rα deficient mice and littermate control mice. Conversely, IL-
4Rα-/- mice had significantly reduced spleen (Fig 3.1C) and liver (Fig 3.1D) weight compared to 
the littermate control mice, indicating severe multiple organ defects. Furthermore, examination of 
autopsy images indicated extensive haemorrhaging in the small intestines of IL-4Rα-/- mice 
compared to littermate control mice that exhibited no gut inflammation (Fig 3.1E). Interestingly, 
mb1
cre
IL-4Rα-/lox mice developed slight haemorrhaging in the gut lumen that was accompanied by 
colitis-type pathology (Fig 3.1E). Thus, these data suggest that hepatosplenomegaly and gut 
inflammation contribute to the increased susceptibility observed in B cell-specific IL-4Rα 
deficient mice.  
 
Reduced Th2 responses in mb1
cre
IL-4Rα-/lox mice during S. mansoni infection 
To investigate the cellular mechanism of susceptibility in mb1
cre
IL-4Rα-/lox mice during acute 
Schistosomiasis, we analysed cytokine production by total mesenteric lymph node (MLN) cells 
restimulated with either SEA or α-CD3 ex vivo. The abrogation of IL-4Rα expression on B cells 
significantly impaired the production of the Th2 cytokines IL-4, IL-5 and IL-10 by MLN cells 
after stimulation with SEA compared to the littermate control mice (Fig 3.2A). However, 
production of Th1 a d Th17 cytokines by MLN cells from mb1
cre
IL-4Rα-/lox mice following 
antigen-specific restimulation was not altered compared to littermate control mice (Fig 3.2A). In 
contrast, IL-4Rα-/- mice displayed a shift towards Th1 immune responses, characterised by 
augmented IFN-γ production by MLN cells stimulated with SEA and concomitant reduction in 
Th2 cytokine production (Fig 3.2A). Mitogenic restimulation of MLN cells from mb1
cre
IL-4Rα-/lox 
mice revealed diminished Th2 cytokine production, with the exception of IL-4, compared to 
littermate control mice (Fig 3.2B). Finally, a predominant Th1 and Th17 cytokine profile was 
produced by mitogen restimulated MLN cells from IL-4R
-/-
 mice compared with littermate control 
mice (Fig 3.2B). Therefore, these data demonstrate that IL-4/IL-13 responsive B cells are crucial 
for development of Th2 immunity during S. mansoni infection in mice. 
 
To explore the impact of IL-4Rα deficiency on B cells on the differentiation and cytokine 
production by CD4
+
 T cells during infection, single cell suspensions were prepared from MLN 
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and cells were stained for flow cytometric analysis. Interference with IL-4Rα expression on B 
cells did not affect cellular infiltration into the draining lymph node (data not shown). However, 
global abrogation of IL-4Rα resulted in reduced infiltration of cells into the MLN compared to the 
littermate control mice (data not shown). There was no significant difference in the absolute 
number of CD3
+
CD4
+
 T cells present in the MLN of all mutant mouse strains (Fig 3.2C). 
However, the lack of IL-4Rα expression on B cells resulted in significantly lower numbers of 
CXCR5
+
 TFH cells and effector CD4
+
 T cells (CD4
+
CD44
hi
D62L
lo
) compared to control mice (Fig 
3.2D & E). Similarly, global IL-4Rα deficient mice exhibited reduced numbers of CXCR5+ TFH 
cells and effector CD4
+
 T cells compared to littermate control mice (Fig 3.2D & E). Examination 
of intracellular cytokine production by CD4
+
 T cells restimulated with PMA/Ionomycin ex vivo 
revealed that abrogation of IL-4Rα expression on B cells results in reduced production of Th2 
cytokines IL-4 and IL-13, while IFN-γ production was not altered compared to control mice (Fig 
3.2F, G & H). Likewise, CD4
+
 T cells from IL-4Rα-/- mice failed to produce Th2 cytokines IL-4 
(Fig 3.2F) and IL-13 (Fig 3.2G) after ex vivo restimulation with PMA/Ionomycin compared to 
littermate control mice. Production of the Th1 cytokine IFN-γ was also reduced in CD4+ T cells 
from IL-4Rα-/- mice compared to littermate control mice, suggesting overall inhibition of T cell 
responses. In summary, IL-4Rα expression on B cells is crucial for differentiation of CD4+ T cells 
and generation of CD4
+
 Th2 immunity. 
 
Reduced type 2 antibody responses and B cell-specific cytokine production in S. mansoni 
infected mb1
cre
IL-4Rα-/lox mice 
The ability of B cells to respond to IL-4 signalling is crucial for isotype switching towards type 2 
antibody isotypes IgG1 and IgE during S. mansoni infection [253]. To assess the impact of IL-
4Rα deficiency in B cells on antibody production, we analysed sera from infected mice by ELISA. 
As expected, sera from infected B cell-specific IL-4Rα deficient mice contained low levels of 
SEA-specific IgG1 and total IgE antibody titers, similar to global IL-4Rα-/- mice (Fig 3.3A). In 
contrast, littermate control mice had higher type 2 antibody titers (IgG1 and total IgE), 
accompanied by concomitant reduced levels of antigen-specific type 1 antibody (IgG2a) titers 
(Fig 3.3A). Therefore, these data confirm a pivotal role for IL-4/IL-13 responsive B cells in the 
generation of type 2 antibody responses during S. mansoni infection in mice.  
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Figure 3.1: IL-4/IL-13 responsive B cells are required for protection against acute schistosomiasis in mice. 
IL-4Rα-/lox, mb1creIL-4Rα-/lox and IL-4Rα-/- mice were infected with 100 live S. mansoni cercariae and survival was 
monitored over a 14 weeks period. (A) Survival kinetics of mice infected percutaneously with 100 cercariae. (B) 
Percent body weight loss monitored on a weekly basis. (C) Spleen weight measured during autopsy. (D) Liver weight 
measured during autopsy. (E) Post-mortem images depicting pathology in infected mice. Data represents two 
independent experiments (n = 8-10). Survival curves were compared using Logrank test. *p< 0.05 and **p< 0.01 vs 
IL-4Rα-/lox mice. 
 
 
 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
H. H. Ndlovu March 2013 Chapter 3 
46 
 
 
Figure 3.2: Reduced Th2 immunity in B cell-specific IL-4Rα deficient mice. 
IL-4Rα-/lox, mb1creIL-4Rα-/lox and IL-4Rα-/- mice were infected with 100 live S. mansoni cercariae and analysed 7 
weeks post-infection. (A-B) Cytokine production by mesenteric lymph node cells restimulated with either SEA or α-
CD3 (mean ± SEM). Single cell suspension was prepared from mesenteric lymph node (MLN) and cells were stained 
for flow cytometric analysis. (C) Recruitment of CD3
+
CD4
+
 T cells into the secondary lymphoid tissue. (D-E) 
Expansion of CXCR5
+
 TFH cells and effector CD4
+
 T cells in the MLN. (F-H) Intracellular cytokine detection after 
restimulation of MLN cells with 25 ng/ml PMA and 1 µg/ml ionomycin in vitro. Data represents 3 independent 
experiments. n = 4-6 mice. *p<0.05, **p<, 0.01 and ***p< 0.001 vs IL-4Rα-/lox mice. 
 
To investigate the importance of IL-4Rα signalling in the differentiation of B cell subsets during 
S. mansoni infection, expression of CD21 and CD23 was analysed by flow cytometry. There was 
no difference in the absolute number of CD19
+
B220
+
 B cells draining into the MLN (Fig 3B). 
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However, the absolute number of follicular B cells (FO, B220
+
CD21
+
CD23
+
) was significantly 
reduced in both mb1
cre
IL-4Rα-/lox mice and IL-4Rα-/- mice compared to littermate control mice 
(Fig 3.3C). Simultaneously, the absolute number of marginal zone (MZ, B220
+
CD21
+
CD23
-
) B 
cells was increased in B cell-specific IL-4Rα deficient mice while it remained similar between IL-
4Rα-/- and littermate control mice (Fig 3.3D). Interestingly, expression of activation markers MHC 
II and CD86 was reduced in both mb1
cre
IL-4Rα-/lox mice and IL-4Rα-/- mice compared to 
littermate control mice (data not shown). These data suggests that B cell-specific IL-4Rα 
expression is essential for B cell differentiation and expression of activation markers during S. 
mansoni infection. 
 
B cells have been shown to produce cytokines in response to antigen-specific stimulation or in 
vivo during infection [106]. To explore the ability of IL-4Rα deficient B cells to produce 
cytokines during S. mansoni infection, single cell suspensions were prepared from MLN and cells 
were restimulated with PMA/Ionomycin before intracellular cytokine detection by flow 
cytometry. The percentage of CD19
+
 B cells producing Th2 cytokines IL-4 and IL-13 was 
significantly reduced in mb1
cre
IL-4Rα-/lox mice compared to littermate control mice (Fig 3.3E). 
Intriguingly, the percentage of IFN-γ producing B cells were also significantly reduced in B cell-
specific IL-4Rα deficient mice compared to littermate control mice. Likewise, the percentage of 
CD19
+
 B cells producing IL-4 and IL-13 was significantly reduced in IL-4Rα-/- mice, 
accompanied by a simultaneous reduction in the percentage of CD19
+
 B cells producing IFN-γ 
and TNF-α compared to control mice (Fig 3.3E). Therefore, these data suggests that there is a 
general reduction in cytokine production by CD19
+
 B cells in the absence of IL-4Rα expression 
during S. mansoni infection. 
 
Augmented liver pathology in S. mansoni infected mb1
cre
IL-4Rα-/lox mice 
Prior studies from our laboratory have demonstrated that liver pathology caused by uncontrolled 
granuloma formation, increased hepatocellular damage and tissue fibrosis is a major factor 
contributing to susceptibility to acute schistosomiasis [147,190]. In order to investigate the role 
played by IL-4/IL-13 responsive B cells during liver pathology caused by trapped S. mansoni 
eggs, liver tissue was examined by histology and serum AST levels were assayed. Liver 
inflammatory pathology was increased in B cell-specific IL-4Rα deficient mice, which had 
increased granuloma size (Fig 3.4A), unaltered liver fibrosis, measured as hydroxyproline 
concentration (Fig 3.4B) and significantly elevated levels of serum AST (Fig 3.4C), indicating 
increased hepatocellular damage compared with littermate control mice. In contrast, IL-4Rα-/- 
mice had significantly impaired granuloma formation (Fig 3.4A), slightly reduced fibrosis (Fig 
3.4B) and augmented hepatocellular damage (Fig 3.4C). In mb1
cre
IL-4Rα-/lox mice, liver pathology 
was associated with diminished Th1 and Th2 cytokine production by liver granuloma-associated 
cells stimulated with either SEA or α-CD3 compared with littermate control mice (Fig 3.4D). 
Liver granuloma-associated cells from IL-4Rα-/- mice restimulated with α-CD3 produced high 
levels of IL-6 and IFN-γ while the levels of IL-4 and IL-5 were down-regulated compared with 
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IL-4Rα-/lox mice (Fig 3.4D). Histological examination of H&E stained liver sections confirmed 
prior data, where granuloma formation was augmented in mb1
cre
IL-4Rα-/lox mice (Fig 3.4E) and 
reduced in IL-4Rα-/- mice compared to littermate control mice. Interestingly, liver granuloma-
associated cells from IL-4Rα-/- mice stained positive for iNOS (Fig 3.4E), a marker for classically 
activated macrophages [147]. In contrast, there were a few iNOS positive cells in granulomas 
from mb1
cre
IL-4Rα-/lox mice while iNOS positive cells were not detected in granulomas from 
infected littermate control mice (Fig 3.4E). Therefore, these data suggest that IL-4Rα expression 
by B cells is crucial for down-modulating liver pathology during S. mansoni infection in mice.  
 
 
Figure 3.3: Impaired type 2 antibody responses in B cell-specific IL-4R deficient mice. 
IL-4Rα-/lox, mb1creIL-4Rα-/lox and IL-4Rα-/- mice were infected with 100 live S. mansoni cercariae and analysed 7 
weeks post-infection. (A) Antigen-specific immunoglobulin (IgG) and total IgE titers were detected by ELISA. Single 
cell suspensions were prepared from mesenteric lymph nodes (MLN) and cells were stained for flow cytometry. (B-
D) Recruitment of CD19
+
B220
+
 B cells, follicular B cells (FO, B220
+
CD21
+
CD23
+
) and marginal zone B cells (MZ, 
B220
+
CD21
+
CD23
-
) into the secondary lymphoid tissue. (E) Analysis of intracellular cytokine production by CD19
+
 
B cells after restimulation of total MLN cells with 25 ng/ml PMA and 1 µg/ml ionomycin in vitro. Data represents 3 
independent experiments. n = 4-6 mice. *p<0.05, **p<, 0.01 and ***p< 0.001 vs IL-4Rα-/lox mice. 
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Figure 3.4: IL-4Rα responsive B cells are required to down-regulate liver granuloma formation and 
hepatocellular damage. 
IL-4Rα-/lox, mb1creIL-4Rα-/lox and IL-4Rα-/- mice were infected with 100 S. mansoni cercariae and analysed 7 weeks 
post-infection. (A) Granuloma area surrounding eggs quantified by microscopic analysis on H&E stained sections. 
Twenty to 30 granulomas per mouse were included in the measurement of granuloma area. (B) Liver fibrosis 
measured as hydroxyproline normalised to egg numbers. (C) Hepatocellular damage quantified as serum aspartate 
transaminase (AST) levels. (D) Cytokine production by total liver cells restimulated with either SEA or α-CD3. (E) 
Formalin-fixed liver sections (100×) stained with H&E for morphological analysis or iNOS for classical macrophages 
surrounding the eggs. Data is representative of 3 independent experiments. n= 4-6 mice. *p< 0.05, **p< 0.01 and 
***p< 0.001 vs IL-4Rα-/lox. 
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Increased gut inflammation in S. mansoni infected mb1
cre
IL-4Rα-/lox mice  
Mice that are highly susceptible to S. mansoni infection suffer from severe gut inflammation 
characterised by haemorrhaging in the gut, which ultimately results in endotoxemia 
[147,148,218,222]. To investigate whether mice lacking IL-4Rα expression on B cells can control 
gut integrity during infection, we examined gut pathology by histology and quantified 
hydroxyproline content. There was no significant difference in the quantity of gut hydroxyproline 
and tissue egg numbers between the different mutant mouse strains (Fig 3.5A & B). However, 
examination of H&E stained gut section from mb1
cre
IL-4Rα-/lox mice revealed intensive gut 
inflammation, similar to that observed in the highly susceptible IL-4Rα-/- mice (Fig 3.5C). 
Furthermore, there were an increased number of inflammatory cells surrounding S. mansoni eggs 
compared to littermate control mice that exhibited small gut granulomas (Fig 3.5C). Together, 
these data suggest that B cell-specific IL-4Rα expression is necessary to down-modulate gut 
inflammation during acute schistosomiasis in mice.  
 
 
Figure 3.5: IL-4Rα dependent B cell responses contribute to controlling gut pathology during acute 
schistosomiasis. 
IL-4Rα-/lox, mb1creIL-4Rα-/lox and IL-4Rα-/- mice were infected with 100 S. mansoni cercariae and analysed 7 weeks 
post-infection. (A) Intestinal fibrosis measured as hydroxyproline concentration normalised to tissue egg numbers 
(mean ± SEM, n= 4-6). (B) Intestinal eggs numbers normalised to tissue weight (mean ± SEM, n= 4-6). (C) Increased 
inflammation shown in H&E stained sections of the small intestine. L, lacteal spaces; m, muscularis layer and Lp, 
lamina propria. Original magnification, ×100. Data represents three independent experiments.  
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Macrophages display a classical activation profile in S. mansoni infected B cell-specific IL-
4Rα deficient mice  
Alternatively activated macrophages are crucial for mediating protection against acute 
schistosomiasis and limit tissue destruction caused by eggs trapped in the host tissue [147]. To 
investigate the activation profile of macrophages in the liver from infected mb1
cre
IL-4Rα-/lox, we 
prepared single cell suspensions from liver tissue and stained the cells for flow cytometric 
analysis. There was an increased proportion of iNOS positive CD11b
+
MHCII
+
 macrophages in 
both B cell-specific IL-4Rα deficient mice and global IL-4Rα knock-out mice compared to 
littermate control mice, suggesting a shift towards classical activation (Fig 3.6A). Furthermore, 
iNOS expression was significantly increased in macrophages from mb1
cre
IL-4Rα-/lox and IL-4Rα-/- 
mice compared to control mice (Fig 3.6B). Conversely, the proportions of Ym-1 positive 
CD11b
+
MHCII
+
 macrophages were reduced in both mb1
cre
IL-4Rα-/lox and IL-4Rα-/- mice 
compared to littermate control mice (Fig 3.6C). Analysis of Ym-1 expression levels confirmed 
down-regulation of Ym-1 production in macrophages from B cell-specific IL-4Rα deficient mice 
and IL-4Rα-/- mice compared to littermate control mice (Fig 3.6D). Therefore, these data suggest 
that either B cells expressing IL-4Rα interact directly with macrophages, influencing their 
activation profile, or that the prevailing cytokine microenvironment influences macrophage 
activation status during S. mansoni infection.  
 
 
Figure 3.6: Reduced expression of alternative activated macrophage markers in B cell-specific IL-4Rα 
deficient mice. 
Single cell suspensions were prepared from liver tissue and cells were stained for flow cytometry. (A) Proportions of 
CD11b
+
MHCII
+
 macrophages expressing iNOS in the liver granulomas. (B) Histogram showing the expression of 
iNOS by macrophages. (C) Proportions of CD11b
+
MHCII
+
 macrophages expressing alternative activation marker 
Ym-1. (D) Histogram showing the expression of Ym-1 by macrophages. Data represents two independent 
experiments. **p< 0.01, ***p<0.001 vs IL-4Rα-/lox mice. 
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IL-4 responsiveness by B cells is crucial for host survival during schistosomiasis 
Mice deficient in B cells display heightened susceptibility at the chronic stage of S. mansoni 
infection [233]. To investigate whether mb1
cre
IL-4Rα-/lox mice are more susceptible to S. mansoni 
infection than B cell knock-out mice (µMT), we conducted a mortality study where mb1
cre
IL-4Rα-
/lox
, µMT and IL-4Rα-/lox mice were infected with 100 live S. mansoni cercariae and mortality was 
monitored over a 13 week period. Mb1
cre
IL-4Rα-/lox mice began to die at 7 weeks post-infection 
and they had all succumbed to infection by 10 weeks post-infection compared to littermate control 
mice that had 50% survival at the same time point (Fig 3.7A). In contrast, B cell deficient mice 
displayed delayed susceptibility, with mice surviving the acute phase of infection (Fig 3.7A). 
However, during the chronic phase of infection, B cell knock-out mice had a drastic increase in 
mortality rate, with 50% of the mice succumbing to infection within the same week (Fig 3.7A). 
Together, these data suggest that the ability of B cells to respond to IL-4/IL-13 signalling and not 
the general lack of B cells is essential for host survival during S. mansoni infection.  
 
Liver granuloma formation was compared between mb1
cre
IL-4Rα-/lox mice and µMT mice at 7 
weeks post S. mansoni infection. As expected, B cell-specific IL-4Rα deficient mice had 
augmented granuloma size compared to littermate control mice (Fig 3.7B). However, the 
granulomas from B cell knock-out mice were larger than the ones from B cell-specific IL-4Rα 
deficient mice (Fig 3.7B). In fact, B cell knock-out mice developed granulomas that were almost 
twice the size of those from littermate IL-4Rα-/lox mice (Fig 3.7B). Livers from µMT mice 
contained almost double the concentration of hydroxyproline than both the mb1
cre
IL-4Rα-/lox and 
littermate control mice during the acute phase of infection, indicating increased hepatic fibrosis 
(Fig 3.7C). These data suggest that the lack of B cells results in uncontrolled liver pathology in 
mice. 
 
To investigate whether the lack of IL-4/IL-13 responsive B cells influences cellular immunity, we 
restimulated MLN cells from infected mice with either SEA or α-CD3 ex vivo and measured 
cytokine production by ELISA. In accordance with prior data, cells from mb1
cre
IL-4Rα-/lox mice 
failed to produce Th2 cytokines IL-4, IL-5 and IL-10 in response to antigen-specific stimuli 
compared to littermate control mice (Fig 3.7D). Similarly, cells from µMT mice stimulated with 
SEA failed to produce IL-4 and IL-10 although the levels of IL-5 were the same as that in 
littermate control mice (Fig 3.7D). Conversely, mitogenic stimulation of cells from µMT mice 
triggered a substantial release of IL-10 and IFN-γ while the production of IL-4 was diminished 
compared to littermate control mice (Fig 3.7D). Finally, in comparison to littermate control mice, 
cells from B cell-specific IL-4Rα deficient mice showed defects in the production of IL-4 and IL-
5 while the production of IL-10 and IFN-γ was unaltered after restimulation with α-CD3 (Fig 
3.7D). These data suggest that abrogating IL-4Rα expression on B cells impairs the development 
of Th2 immunity during S. mansoni infection in mice.  
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Figure 3.7: IL-4/IL-13 responsive B cells confer protection to the host against S. mansoni infection. 
IL-4Rα-/lox, mb1creIL-4Rα-/lox and µMT mice were infected with 100 S. mansoni cercariae and analysed 7 weeks post-
infection. (A) Survival kinetics of mice infected with S. mansoni (n= 8-10 mice). Survival curves were compared 
using Logrank test. *p< 0.05 and **p< 0.01 vs IL-4Rα-/lox mice.(B) Granuloma area measured by microscopic 
analysis of formalin-fixed liver sections after H&E staining. (C) Liver fibrosis measured as hydroxyproline content 
normalised to tissue egg numbers (mean ± SEM, n= 4-6). (D) Cytokine production by total mesenteric lymph node 
cells re-stimulated with either SEA or α-CD3 (mean ± SEM, n= 4-6). Data are representative of two independent 
experiments. *p< 0.05, **p< 0.01 and ***p< 0.001 vs IL-4Rα-/lox mice.  
 
B cell-specific IL-4Rα deficient mice fail to down-modulate liver and gut granuloma 
formation during chronic schistosomiasis 
B cells are known to play a crucial role in modulating S. mansoni egg-induced granuloma 
formation during chronic stages of infection [233]. To determine whether IL-4Rα expression on B 
cells is required to regulate liver pathology during chronic stages of infection, we infected 
mb1
cre
IL-4Rα-/lox, IL-4Rα-/- and IL-4Rα-/lox mice with 30 live S. mansoni cercariae and killed mice 
at 16 and 24 weeks post-infection. Mb1
cre
IL-4Rα-/lox mice failed to down-regulate granuloma 
formation during the chronic stages of infection, displaying granulomas that were 3-fold bigger 
than those from the littermate control mice (Fig 3.8A). In contrast, IL-4R
-/-
 mice consistently 
displayed smaller granulomas at both time points compared to littermate control mice (Fig 3.8A). 
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Analysis of systemic responses revealed that there was no significant difference in the serum 
levels of IL-4 between the mutant mouse strains at 16 weeks post-infection (Fig 3.8B). However, 
sera from mb1
cre
IL-4Rα-/lox mice contained elevated levels of IL-4 at 24 weeks post-infection 
compared to littermate control mice (Fig 3.8B). These data suggest that IL-4/IL-13 responsive B 
cells are required to down-regulate granuloma formation during the chronic stages of infection.  
 
To investigate the importance of B cell-specific IL-4Rα expression in regulating cellular 
immunity during chronic stages of infection, MLN cells from chronically infected mice were 
stimulated with the mitogen α-CD3 and cytokines were detected by ELISA. While IL-10 was 
significantly reduced in mb1
cre
IL-4Rα-/lox and IL-4Rα-/- mice compared to littermate control mice, 
the levels of IL-4, IL-5 and IFN-γ were similar between the mutant mouse strains at 16 weeks 
post-infection (Fig 3.8C). In contrast, at 24 weeks post-infection, cells from B cell-specific IL-
4Rα deficient mice produced augmented levels of Th1, Th2 and Th17 cytokines compared to 
littermate control mice, while cells from IL-4R
-/-
 mice produced increased levels of Th1 and 
Th17 cytokines only (Fig 3.8D). Histological examination of H&E stained liver section from mice 
killed at 16 and 24 weeks post-infection confirmed prior findings, where mb1
cre
IL-4Rα-/lox mice 
were found to have exacerbated liver granuloma formation compared to littermate control mice 
(Fig 3.8E). Interestingly, B cell-specific IL-4Rα deficient mice and global IL-4Rα knock-out mice 
both had increased mortality during the chronic stages of infection compared to littermate control 
mice (data not shown). Furthermore, there was shunting of S. mansoni eggs into the lungs and 
spleen of mb1
cre
IL-4Rα-/lox mice and IL-4Rα-/lox mice at both 16 and 24 weeks post-infection, 
whereas no eggs were detected in the lungs and spleen of IL-4Rα-/- mice (data not shown). In 
addition, Mb1
cre
IL-4Rα-/lox and IL-4Rα-/- mice exhibited enhanced gut inflammation, indicated by 
increased inflammatory cells surrounding the eggs at both time points, while the IL-4Rα-/lox mice 
controlled gut inflammation (Fig 3.9A). This suggests that B cell-specific IL-4Rα expression in 
crucial for down-regulating gut pathology during the chronic stages of S. mansoni infection. 
Together, these data sugg st that the absence of IL-4Rα expression on B cells leads to 
dysregulated immune responses and granuloma formation during the chronic stages of S. mansoni 
infection.  
 
Enhanced lung granuloma formation and fibrosis in mb1
cre
IL-4Rα-/lox mice challenged with 
synchronous S. mansoni eggs 
To confirm the importance of IL-4/IL-13 responsive B cells in down-modulating tissue pathology 
during infection, we utilised a synchronous S. mansoni pulmonary model where mice were 
sensitised for two weeks by intraperitoneal injection of 2 500 S. mansoni eggs, subsequently 
challenged intravenously with 2 500 eggs and then killed at day 7 and 14 post-challenge. 
Mb1
cre
IL-4Rα-/lox mice had augmented granuloma formation at both time points compared to the 
littermate control mice (Fig 3.10A). There was no significant difference in lung fibrosis in B cell-
specific IL-4Rα deficient mice at day 7 post-challenge but by day 14 fibrosis was significantly 
increased compared to littermate control mice (Fig 3.10B). Histological examination of H&E 
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stained lung sections showed that B cell-specific IL-4Rα deficient mice had bigger granulomas 
than littermate control mice at both time points (Fig 3.10C). Therefore, these data strongly support 
our initial conclusion that B cell-specific IL-4Rα expression is crucial for down-modulating 
granuloma formation and fibrosis in mice.  
 
 
Figure 3.8: IL-4/IL-13 responsive B cells are required for down-regulating hepatic pathology during chronic 
schistosomiasis. 
IL-4Rα-/lox, mb1creIL-4Rα-/lox and IL-4Rα-/- mice were infected with 30 S. mansoni cercariae and killed at 16 and 24 
weeks post-infection. (A) Liver granuloma area was measured using a computerised morpho-metric analysis program 
(NIS elements by NIKON) by measuring 20-25 granulomas per mouse. (B) Serum IL-4 levels were detected by 
ELISA at both time points. (C-D) Detection of cytokine production by MLN cells after in vitro restimulation with α-
CD3 for 72 h. (E) Histology images showing liver granuloma formation at 16 and 24 weeks post-infection. Data 
represents two independent experiments. **p<0.01, ***p< 0.001 vs IL-4Rα-/lox mice. n = 4-6 mice per group. 
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Figure 3.9: Augmented gut inflammation in B cell-specific IL-4Rα deficient mice during chronic 
schistosomiasis. 
IL-4Rα-/lox, mb1creIL-4Rα-/lox and IL-4Rα-/- mice were infected with 30 S. mansoni cercariae and analysed at 16 and 24 
weeks post-infection. (A) Histological examination of gut tissue after staining sections with H&E (×100). Data 
represents two independent experiments. n= 4-6 mice per group. 
 
We next examined the cellular immune responses to S.mansoni eggs in B cell-specific IL-4Rα 
deficient mice. Here, mediastinal lymph node (MST) cells from challenged mice were 
restimulated with α-CD3 ex vivo and cytokines were detected by ELISA. There was no significant 
difference in the production of Th1 and Th2 cytokines by cells from both mutant mouse strains 
that received mitogenic stimulation after 7 days post-challenge (Fig 3.11A). However at day 14 
post-challenge, cells from mb1
cre
IL-4Rα-/lox mice responded to mitogenic stimulation by up-
regulating the production of IL-4, IL-10 and IFN-γ compared to littermate control mice (Fig 
3.11B). Furthermore, mice deficient in IL-4Rα expression on B cells had significantly reduced 
absolute numbers of CD3
+
CD4
+
 T cells and CXCR5
+
 TFH cells (Fig 3.11C & D). Although the 
number of effector CD4
+
 T cells was not altered at day 7 post-challenge between the mutant 
mouse strains, mice lacking IL-4Rα expression on B cells had diminished numbers of effector 
CD4
+
 T cells at day 14 post-challenge compared to littermate control mice (Fig 3.11E). Finally, 
abrogation of IL-4Rα expression on B cells significantly impaired intracellular cytokine 
production by CD3
+
CD4
+
 T cells at both time points, indicated by reduced number of IL-4, IL-10 
and IFN-γ secreting cells after stimulation with PMA/Ionomycin compared to littermate control 
mice. Therefore, these data suggest that IL-4Rα expressing B cells influence CD4+ T cell cellular 
responses during S. mansoni eggs challenge.  
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Figure 3.10: Exacerbated lung granuloma formation and fibrosis in mb1
cre
IL-4Rα-/lox mice challenged 
intravenously with S. mansoni eggs. 
IL-4Rα-/lox, mb1creIL-4Rα-/lox and IL-4Rα-/- mice were sensitised with 2 500 S. mansoni eggs intraperitoneally, 
challenged with 2 500 eggs intravenously 14 days later and killed over two time points (7 and 14 days post-
challenge). (A) Granuloma formation measured using a computerised morpho-metric analysis program (NIS elements 
by NIKON) by measuring 20-25 granulomas per mouse. (B) Lung fibrosis measured by determining hydroxyproline 
concentration. (C) Histological examination of H&E stained lungs sections. Data represents two independent 
experiments. *p< 0.05, **p< 0.01 and ***p< 0.001 vs IL-4Rα-/lox mice. n= 6 mice per group. 
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Figure 3.11: Impaired recruitment of CD4
+
 T cells, TFH cells and effector CD4
+
 T cells in mb1
cre
IL-4Rα-/lox mice 
challenged with S. mansoni eggs. 
Single cell suspensions were prepared from mediastinal lymph nodes (MST) and cells were stained for flow 
cytometry. (A-B) Cytokine production by total MST cells restimulated with α-CD3 in vitro, detected by ELISA. (C-
E) Recruitment of CD3
+
CD4
+
 T cells, CXCR5
+
 TFH cells and effector CD4
+
 T cells into the lung draining lymph 
nodes. (F-H) Intracellular cytokine secretion by CD4
+
 T cells after restimulation of total MST cells with 50 ng/ml 
PMA and 250 ng/ml ionomycin. Data are representative of two independent experiments. *p< 0.05, **p<0.01 vs IL-
4Rα-/lox mice. n= 6 mice per group. 
 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
H. H. Ndlovu March 2013 Chapter 3 
59 
 
Impaired B cells responses in mice deficient in IL-4Rα expression on B cells during S. 
mansoni egg-challenge 
To investigate the requirement for IL-4Rα expression on B cells during differentiation and 
cytokine production by B cells, we prepared single cell suspensions from MST and stained the 
cells for flow cytometric analysis. The numbers of CD19
+
B220
+
 B cells (Fig 3.12A) and follicular 
B cells (Fig 3.12B) were not altered between the mutant mouse strains at day 7 post-challenge, 
however, at day 14 post challenge mb1
cre
IL-4Rα-/lox mice had reduced total numbers of 
CD19
+
B220
+
 B cells (Fig 3.12A) and follicular B cells (Fig 3.12B) compared to IL-4Rα-/lox mice. 
The total number of marginal zone B cells was enhanced in mb1
cre
IL-4Rα-/lox mice at day 7 post-
challenge but remained the same at day 14 post-challenge in comparison to littermate control mice 
(Fig 3.12C). There was a general impairment of intracellular cytokine secretion by CD19
+
 B cells 
from B cell-specific IL-4Rα deficient mice at both time points compared to littermate control 
mice (Fig 3.12D, E & F). These data suggest that IL-4Rα expression on B cells is required for 
differentiation of B cell subsets and optimal secretion of cytokines.  
 
 
Figure 3.12: Impaired recruitment of CD19
+
B220
+
 B cells in B cell-specific IL-4Rα deficient mice challenged 
with S. mansoni eggs. 
Single cell suspensions were prepared from MST and cells were stained for flow cytometry. (A-C) Recruitment of 
CD19
+
B220
+
 B cells, FO B cells and MZ B cells into the MST. (D) Intracellular cytokine detection after stimulating 
total MST cells with 50 ng/ml PMA and 250 ng/ml ionomycin in vitro. Data represents two independent experiments. 
*p< 0.05, **p<0.01, ***p<0.001 vs IL-4Rα-/lox mice. 
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Macrophages displayed a classically activated profile in the absence of IL-4Rα expression on 
B cells 
To determine the activation status of macrophages during S. mansoni egg-challenge in mb1
cre
IL-
4Rα-/lox mice, we prepared single cell suspensions from MST cells and stained for flow cytometric 
analysis. At day 7 post-challenge, there was no significant difference in the expression of the 
alternative activation markers arginase 1 (Fig 3.13A) and Ym-1 (Fig 3.13B), as well as the 
classical activation marker iNOS (Fig 13C) in CD11b
+
MHCII
+
 cells from mb1
cre
IL-4Rα-/lox mice 
compared to littermate control mice. However, CD11b
+
MHCII
+
 macrophages from mb1
cre
IL-4Rα-
/lox
 mice exhibited a shift towards classical activation at day 14 post-challenge by up-regulating 
the expression of iNOS with a concomitant down-regulation of Arginase and Ym-1 compared to 
littermate control mice (Fig 3.13A, B & C). Recruitment of Siglec-F
+
 eosinophils into the draining 
lymph node was unaltered at day 7 post-challenge but their number was significantly reduced at 
day 14 post-challenge in B cell-specific IL-4Rα deficient mice compared to the littermate control 
mice (Fig 3.13 D). These data may either suggest that a cytokine microenvironment in the 
draining lymph nodes of mb1
cre
IL-4Rα-/lox mice influences the macrophage activation profile or 
that B cells expressing IL-4Rα act directly on macrophages, thus, influencing their activation 
status.  
 
 
Figure 3.13: Increased expression of iNOS by alveolar macrophages from B cell-specific IL-4Rα deficient mice 
challenged with S. mansoni eggs. 
Single cell suspension was prepared from lungs and cells were stained for flow cytometric analysis. (A-B) Expression 
of Arg-1 and Ym-1 by alveolar macrophages. (C) Expression of iNOS by alveolar macrophages. (D) Absolute 
number of Siglec-F
+
 eosinophils draining into the lymph node. Data represents two independent experiments. **p< 
0.05 vs IL-4Rα-/lox mice. n= 6 mice per group. 
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Generation of chimeric mice lacking IL-4 production by B cells  
We have successfully established that IL-4Rα expression on B cells is essential in the 
development of host protective immunity against S. mansoni infection. However, we have not 
determined the cellular source of the IL-4 that mediates IL-4Rα signalling on B cells leading to 
protective immunity against infection. Previous studies have demonstrated the capacity of B cells 
to produce IL-4 during Hp infection [106]. Since there is no transgenic mouse strain that has 
impaired production of IL-4 specifically on B cells, we decided to exploit the mixed bone marrow 
chimera method because it allowed us to selectively express or delete a particular gene in a 
specific hematopoietic lineage cell [90,277]. Here, lethally irradiated B cell-deficient mice (µMT) 
were reconstituted with 80% µMT and 20% IL-4
-/-
 bone marrow (BM) to generate chimera that 
lacked IL-4 expression specifically on B cells (B-IL-4
-/-
). As controls, we reconstituted recipient 
mice with a mixture of 80% µMT and 20% Balb/c BM to generate wild-type chimera (WT), 
sufficient in IL-4 expression in all hematopoietic cells. Finally, to generate chimera that have 
impaired IL-4 expression in all hematopoietic cells we reconstituted recipient mice with 100% IL-
4
-/-
 BM (IL-4
-/-
). All the chimeric mice contained equivalent proportions of CD3
+
CD4
+
 T cells and 
CD19
+
B220
+
 B cells in peripheral blood 8 weeks after reconstitution, indicating successful 
reconstitution (Fig 3.14).  
 
 
Figure 3.14: Efficient bone marrow reconstitution of irradiated recipient µMT mice. 
Irradiated µMT mice were reconstituted with 80% µMT and 20% Balb/c BM (WT), 80% µMT and 20% IL-4
-/-
 BM 
(B IL-4
-/-
) or 100% IL-4
-/-
 BM (IL-4
-/-
) and allowed to reconstitute for 8 weeks. Mice were bled at 8 weeks and cells 
were stained for flow cytometric analysis. (A) Proportions of CD3
+
CD4
+
 T cells found in blood after reconstitution. 
(B) Proportions of CD19
+
B220
+
 B cells found in blood after reconstitution. Data represent two independent 
experiments. n= 6 mice per group. 
 
To further confirm successful generation of the mixed bone marrow chimeric mice, we infected 
chimeras with 100 live S. mansoni cercariae and collected sera at 7 week post-infection by cardiac 
puncture. As expected, WT and B-IL-4
-/-
 chimeras made SEA-specific IgG1 and total IgE 
antibodies in response to S. mansoni infection (Fig 3.15A & B). Concomitantly, WT and B-IL-4
-/-
 
chimeras failed to produce antigen specific type 1 (IgG2a and IgG2b) antibody isotypes (Fig 
3.15C & D). In contrast, infected IL-4
-/-
 chimeras failed to class switch antibody isotypes as 
demonstrated by a robust SEA-specific IgG2a and IgG2b type 1 response (Fig 3.15C & D) and a 
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diminished type 2 antibody response (Fig 3.15A & B). These data demonstrate that sufficient 
antibody responses develop in the absence of B cell-specific IL-4 production.  
 
 
Figure 3.15: Sufficient humoral immunity develops in mice lacking IL-4 producing B cells during S. mansoni 
infection. 
Irradiated µMT mice were reconstituted with 80% µMT and 20% Balb/c BM (WT), 80% µMT and 20% IL-4
-/-
 BM 
(B IL-4
-/-
) or 100% IL-4
-/-
 BM (IL-4
-/-
) and infected with 100 S. mansoni cercariae. Mice were killed 7 weeks post-
infection and blood was collected for serum preparation. (A-D) Serum antibody titers detected by ELISA. Data 
represent two independent experiments. *p<0.05 vs WT mice. n= 6 mice per group. 
 
Reduced granuloma formation in B cell-specific IL-4 deficient mice infected with S. mansoni 
To investigate whether IL-4 expressing B cells contribute towards limiting tissue pathology 
during S. mansoni infection, we measured liver granuloma size from H&E stained liver sections 
from infected chimeric mice. B-IL-4
-/-
 chimeras had significantly reduced granuloma size (Fig 
3.16A) but similar tissue fibrosis (Fig 3.16B) and levels of serum AST, an indicator of 
hepatocellular damage (Fig 3.16C) compared to WT control mice. As expected, IL-4
-/-
 chimeras 
had significantly augmented granuloma size while hydroxyproline concentration remained similar 
to WT control chimeras (Fig 3.16A & B). However, IL-4
-/-
 chimeras had increased serum AST 
levels than WT chimeras, indicating increased hepatocellular damage (Fig 3.16 C). Examination 
of H&E stained liver sections confirmed that B-IL-4
-/-
 chimeras develop smaller granulomas than 
WT chimera while IL-4
-/-
 chimera have bigger granulomas (Fig 3.16 D). Interestingly, iNOS 
positive cells surrounded the granuloma egg in IL-4
-/-
 chimeras while iNOS positive cells were 
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not detected in granulomas from infected B-IL-4
-/-
 and WT chimeras (Fig 3.16D). Together, these 
data demonstrate that IL-4 producing B cells are not involved in limiting tissue destruction during 
S. mansoni infection.  
 
 
Figure 3.16: Reduced granuloma formation and unaltered liver fibrosis in B IL-4
-/-
 mice. 
Irradiated µMT mice were reconstituted with 80% µMT and 20% Balb/c BM (WT), 80% µMT and 20% IL-4
-/-
 BM 
(B IL-4
-/-
) or 100% IL-4
-/-
 BM (IL-4
-/-
) and infected with 100 S. mansoni cercariae. (A) Granuloma area was measured 
using computerised morph-metric analysis (NIS Elements, Nikon) by measuring 20-25 granulomas per mouse. (B) 
Liver fibrosis determined by assaying hydroxyproline concentration normalised to tissue eggs. (C) Hepatocellular 
damage indicated by serum AST concentration. (D) Histological examination of H&E and iNOS stained liver 
sections. Data are representative of two independent experiments. *p<0.05, ***<0.001 vs WT mice. n= 6 mice per 
group. 
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Unaltered development of Th2 immunity and differentiation of CD4
+
 T cells in B-IL-4
-/-
 
chimera mice 
IL-4 producing B cells play a crucial role during the differentiation of Th2 cells in vitro [106]. To 
test whether IL-4 produced by B cells is required for the generation of Th2 immune responses 
during S.mansoni infection, we cultured MLN cells from infected chimeric mice with either SEA 
or α-CD3 for 72 hours and detected cytokine production by ELISA. There was no significant 
difference in the production of both Th1 and Th2 cytokines by infected B-IL-4
-/-
 and WT 
chimeras after restimulation with SEA ex vivo (Fig 3.17A). However, cells from infected IL-4
-/-
 
chimeras failed to produce IL-4, IL-6, IL-10 and IL-13 in response to antigen-specific stimulation 
ex vivo compared to WT control mice (Fig 3.17A). Mitogenic restimulation of cells from infected 
B-IL-4
-/-
 chimeras resulted in similar production of IL-4, IL-5, IL-10 and IFN-γ but significantly 
reduced IL-6 and IL-13 compared to WT chimeras (Fig 3.17B). As expected, IL-4 was not 
detected in supernatant from infected IL-4
-/-
 chimera cells stimulated with the mitogen and other 
Th2 cytokines were similarly reduced (Fig 3.17B). Therefore, these data suggest that B cell-
specific IL-4 production is not required for generation of Th2 cytokine responses during S. 
mansoni infection.  
 
To investigate whether IL-4 produced by B cells contributes to the differentiation and activation 
of CD4
+
 T cells in the draining lymph nodes, we prepared single cell suspensions from MLN of 
infected chimeras and stained the cells for flow cytometric analysis. We found no significant 
difference in the absolute number of CD3
+
CD4
+
 T cells (Fig 3.17C), CD4
+
 T cells expressing 
ICOS (Fig 17D) and effector CD4
+
 T cells expressing CD44
hi
CD62L
lo
 (Fig 3.17E) between B-IL-
4
-/-
 and WT chimeras. In contrast, although there was no significant difference in the number of 
CD3
+
CD4
+
 T cells between IL-4
-/-
 and WT chimeras, differentiation of ICOS expressing CD4
+
 T 
cells (Fig 3.17D) and expansion of effector CD4
+
 T cells were impaired in IL-4
-/-
 chimeras (Fig 
3.17E). These data demonstrate that the absence of IL-4 production by all hematopoietic cells 
results in impaired differentiation of CD4
+
 T cells during infection.  
 
Differentiation of B cells is not altered in chimeric mice deficient in B cell IL-4 production 
To explore the impact of abrogation of IL-4 production by B cells on their activation profile and 
cytokine production, we prepared cells from infected chimeric mice and stained for flow 
cytometric analysis. The absence of IL-4 produced by B cells did not prevent the differentiation of 
CD19
+
B220
+
 B cells in B-IL-4
-/-
 chimeras compared to WT chimeras (Fig 3.18A). In contrast, 
differentiation of CD19
+
B220
+
 B cells was impaired in IL-4
-/-
 chimeras compared to WT 
chimeras, indicating the importance of IL-4 in the differentiation of B cells during infection (Fig 
3.18A). Likewise, the expansion of follicular B cells was impaired in IL-4
-/-
 chimeras while there 
was no significant difference in the absolute number of follicular B cells between B-IL-4
-/-
 and 
WT chimeras (Fig 3.18B). Numbers of marginal zone B cells were significantly increased in both 
B-IL-4
-/-
 and IL-4
-/-
 chimeras, with IL-4
-/-
 chimera displaying almost five times more marginal 
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zone B cells than WT chimeras (Fig 3.18C). Taken together, these data show that differentiation 
of B cells occurs in the absence of IL-4 production by B cells.  
 
 
Figure 3.17: Normal Th2 immunity and CD4
+
 T cell activation in mice deficient of B cell-derived IL-4. 
Bone marrow chimera mice were infected with 100 live S. mansoni cercariae and killed 7 weeks post-infection. 
Single cell suspensions were prepared from MLN and cells were restimulated with 20 µg/ml SEA or α-CD3 ex vivo. 
(A-B) Cytokine production by restimulated total MLN cells was detected by ELISA. (C-E) Recruitment of 
CD3
+
CD4
+
 T cells, ICOS
+
 T cells and effector CD4
+
 T cells into draining lymph node. (F-H) Intracellular secretion 
by CD4
+
 T cells after restimulation of total MLN cells with 50 ng/ml PMA and 250 ng/ml ionomycin. Data are 
representative of two independent experiments. n= 6 mice per group. 
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Figure 3.18: Normal recruitment of B cells in mice deficient in IL-4 producing B cells 
Single cell suspensions were prepared from MLN of infected bone marrow chimera mice and cells were stained for 
flow cytometry. (A-C) Recruitment of CD19
+
B220
+ 
B cells, FO B cells and MZ cells into the draining lymph node. 
(D-F) Intracellular cytokine production by B220
+
 B cells after stimulation of total MLN cells with 50 ng/ml PMA and 
250 ng/ml ionomycin. (G-H) Histogram showing the expression of activation markers MHC II and CD80 by 
CD19
+
B220
+
 B cells. Data represents two independent experiments. *p<0.05, **p<0.01 vs WT mice. n= 6 mice per 
group.  
 
Next, to investigate whether the lack of IL-4 production by B cells altered their capacity to 
produce other cytokines, we analysed intracellular cytokine production by B220
+
 B cells after 
stimulation of MLN cells with PMA and Ionomycin ex vivo and staining for flow cytometric 
analysis. As expected, intracellular secretion of IL-4 by B220
+
 B cells from B-IL-4
-/-
 and IL-4
-/-
 
chimeras was reduced, relative to WT chimeras (Fig 3.18D). However, intracellular production of 
IL-5 and IFN-γ was not significantly reduced in both B-IL-4-/- and IL-4-/- compared to WT 
chimeras (Fig 3.18E & F). Finally, we analysed expression of activation markers MHC II and 
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CD80 on B cells from cells of infected chimeras by flow cytometry. Expression of MHC II and 
CD80 was impaired on B cells from infected B IL-4
-/-
 and IL-4
-/-
 compared to WT chimeras (Fig 
3.18G & H). Therefore, these data suggest that B cells maintain production of both IL-5 and IFN-
γ even after the interference with the production of IL-4.  
 
3.4 Discussion 
In this study, we examined the role of IL-4/IL-13 responsive B cells during host immune 
responses to acute and chronic schistosomiasis. We found that B cell-specific IL-4Rα deficient 
mice are highly susceptible to acute schistosomiasis and this is related to augmented liver 
pathology, severe gut inflammation, impaired Th2 immunity and abrogated humoral responses. 
Furthermore, mice deficient in IL-4Rα expression on B cells presented with significantly bigger 
hepatic and intestinal granulomas than littermate control mice during the chronic stages of 
infection, indicating the importance of IL-4/IL-13 responsive B cells in down-regulating tissue 
pathology. Lastly, mice lacking IL-4 expression specifically in B cells developed normal antibody 
responses, sufficient Th2 immunity and smaller liver granulomas, demonstrating that IL-4 
producing B cells are not required to mediate protective immunity to S. mansoni infection. Thus, 
it appears that the ability of B cells to respond to IL-4/IL-13 stimuli is critical for protective 
immunity against S. mansoni infection. 
 
Mb1
cre
IL-4Rα-/lox mice rapidly succumbed to acute Schistosomiasis and exhibited 100% mortality 
by 10 weeks post-infection, whereas 40% of littermate control mice were still alive at this time 
point. Consistent with previous studies, IL-4Rα-/- were found to be highly susceptible to S. 
mansoni infection and had all died by 8 weeks post-infection. IL-4Rα-/- mice displayed severe 
weight loss that began at the onset of egg-laying and mice had lost almost 20% of their body 
weight at the time of death. However, there was no difference in the kinetics of weight loss 
between mb1
cre
IL-4Rα-/lox mice and IL-4Rα-/lox mice until 8 weeks post-infection, when littermate 
control mice began to recover and gain some weight. Previous studies have found that IL-4Rα-/- 
mice suffer from multiple organ defects, indicated by severe atrophy of the spleen and liver during 
the acute stages of infection [147]. Our findings were consistent with previous data since the 
weight of liver and spleen from IL-4Rα-/- mice was significantly reduced compared to littermate 
control mice. In contrast, there was no difference in spleen and liver weight between B cell-
specific IL-4Rα deficient mice and littermate control mice, where both mouse strains had severe 
splenomegaly. Mice that quickly succumb to S. mansoni infection display two key morbidity 
factors: hepatocellular damage caused by dysregulated nitric oxide production and endotoxemia 
caused by destruction of gut integrity [219]. Global IL-4Rα knock-out mice displayed severe 
haemorrhaging of the gut indicated by severe bleeding and bloody stool. Similarly, mb1
cre
IL-4Rα-
/lox
 mice had slight haemorrhaging in the gut accompanied by colitis-type pathology whereas 
littermate control mice maintained gut integrity. Therefore, the inability of B cells to respond to 
IL-4 signalling is detrimental to host survival during acute schistosomiasis than their ability to 
produce this cytokine.  
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Development of a polarised Th2 immune response is indispensable for host survival during S. 
mansoni infection [218,222]. Interestingly, mice deficient in IL-4Rα expression on B cells 
displayed abrogated antigen-specific Th2 immunity, indicated by impaired production of IL-4 and 
IL-5 compared to littermate control mice. As expected, IL-4Rα-/- mice displayed a shift towards 
Th1 immune responses that was accompanied by significant production of IFN-γ after antigen 
specific restimulation of MLN cells and concomitant reduced production of Th2 cytokines. 
Therefore, it is plausible that the impaired Th2 immune response contributes to the mechanism 
underlying susceptibility to acute schistosomiasis in B cell-specific IL-4Rα deficient mice. In a 
study by Hoffman and colleagues, IL-10
-/-
 mice were found to be even more highly susceptible to 
S. mansoni infection than IL-4
-/-
 mice, despite the presence of Th2 cytokines, suggesting that IL-
10 plays an important immunoregulatory role during infection [222]. Hence, the impaired 
production of IL-10 by MLN cells stimulated with SEA presents another factor that could explain 
the exacerbated mortality in B cell-specific IL-4Rα deficient mice.  
 
The expansion and differentiation of cytokine producing T cells has been shown to be largely 
dependent on B cells [90,96,106]. In our study, we found no significant difference in the absolute 
number of CD3
+
CD4
+
 T cells between all the mutant mouse strains. However, the expansion of 
follicular helper T cells (TFH) in the secondary lymphoid tissue was significantly impaired in 
mb1
cre
IL-4Rα-/lox mice and IL-4Rα-/- mice compared to littermate control mice. TFH cells are 
crucial for lymphoid tissue organisation as they assist in germinal center formation and promote 
antibody responses, including isotype switching [59,60,62]. In a study by Lin and colleagues, 
deficiency in B cells was shown not to alter the differentiation of antigen-specific T cells and 
expression of activation markers CD69 and CD44 [96]. Likewise, the expansion of effector CD4
+
 
T cells was not hindered in B cell-specific IL-4Rα deficient mice whereas IL-4Rα-/- mice 
displayed significantly reduced absolute numbers of effector CD4
+
 T cells compared to littermate 
control mice. Importantly, the lack of IL-4Rα expression on B cells resulted in abrogated 
intracellular production of Th2 cytokines IL-4 and IL-13 by CD4
+
 T cells after restimulation with 
PMA/Ionomycin ex vivo, suggesting that IL-4/IL-13 responsive B cells are crucial for promoting 
the expansion of Th2 cells. Indeed, previous studies have shown that the lack of B cells alters the 
expansion and differentiation of IL-4 producing effector Th2 cells in response to Hp infection in 
vivo [90]. Furthermore, B cells mediate the expansion of primary Th2 cells in response to protein 
antigens delivered with Nippostrongylus brasiliensis (Nb) [96] and protein antigens delivered with 
alum [89]. B cells have also been shown to contribute to susceptibility during Leishmania major 
LV 39 infection in Balb/c mice and promote Th2 immunity [97]. 
 
IL-4 is a key cytokine mediating isotype switching towards the production of IgG1 and IgE by B 
cells [253]. As expected, mb1
cre
IL-4Rα-/lox and IL-4Rα-/- mice developed a predominant type 1 
antibody response characterised by the production of IgG2a and IgG2b whereas the production of 
type 2 antibody isotypes was abrogated compared to littermate control mice. Although there was 
no significant difference in the absolute number of CD19
+
B220
+
 B cells recruited into the MLN of 
infected mice, the number of follicular (FO) B cells was significantly reduced in both mb1
cre
IL-
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4Rα-/lox and IL-4Rα-/-mice compared to littermate control mice. Conversely, the number of 
marginal zone (MZ) B cells was significantly increased in B cell-specific IL-4Rα deficient mice 
and remained similar between global IL-4Rα knock-out mice and littermate control mice. FO B 
cells are found within germinal centres where they form tight physical contact with T cells, thus 
ensuring optimal T cell proliferation [278]. B cells have been shown to produce Th2 cytokines in 
response to Hp infection in vivo [90,106]. The number of IL-4 and IL-13 producing B cells was 
reduced in both mb1
cre
IL-4Rα-/lox and IL-4Rα-/- mice after restimulation of MLN cells with 
PMA/Ionomycin compared to the littermate control mice. Interestingly though, the absolute 
number of IFN-γ and TNF-α producing B cells was not concomitantly increased in both B cell-
specific IL-4Rα mice and IL-4Rα-/- compared to control mice, suggesting that abrogating IL-4Rα 
expression on B cells alters both the secretion of Th1 and Th2 cytokines in vitro. This contradicts 
previously published data where B cells generated in the presence of Th2 cells and antigen up-
regulated the expression of Th2 cytokines while restricting the production of Th1 cytokines [106]. 
Expression of activation markers MHC II and CD80 was attenuated in B220
+
 B cells from both B 
cell-specific IL-4Rα deficient mice and IL-4Rα-/- mice compared to littermate control mice (data 
not shown). MHC II dependent cognate interactions between B and T cells have been shown to be 
crucial for the development of optimal Th2 immunity to Hp infection [90]. Therefore, IL-4/IL-13 
responsive B cells are important for maintaining optimal cellular immunity during infection with 
S. mansoni.  
 
S. mansoni eggs trapped in the host liver and intestine drive CD4
+
 T cell-dependent 
granulomatous pathology [217,219]. Infected mb1
cre
IL-4Rα-/lox mice developed augmented 
granuloma formation, increased hepatocellular damage, and similar liver fibrosis to littermate 
controls. Consistent with previousl  published data, infected IL-4Rα-/- mice had impaired 
granuloma formation and enhanced hepatocellular damage compared to littermate control mice 
[147,148,190]. Exacerbated liver pathology is a key morbidity factor contributing to mortality in 
IL-4
-/-
 and IL-13
-/-
 mice alongside endotoxemia [219,279]. Restimulation of hepatocytes with 
either SEA or mitogen resulted in impaired production of both Th1 and Th2 cytokines in B cell-
specific IL-4Rα mice. IL-4 is crucial for limiting tissue pathology induced by unregulated nitric 
oxide production [279]. Alternatively activated macrophages have also been shown to minimise 
tissue damage after infection with S. mansoni in mice [147]. Inflammatory macrophages 
characterised by the expression of iNOS were detected in close proximity to S. mansoni eggs in 
both mb1
cre
IL-4Rα-/lox and IL-4Rα-/- mice while they were not detected at all in littermate control 
mice. This was further corroborated by flow cytometric analysis of iNOS and Ym-1 expression by 
liver cells, where CD11b
+
MHCII
+
 macrophages from mb1
cre
IL-4Rα-/lox and IL-4Rα-/- mice 
displayed a shift towards classical activation compared to littermate control mice.  
 
Maintaining the integrity of the gut is important for surviving S. mansoni infection. Mice deficient 
in IL-4/IL-13 responsive macrophages and IL-4Rα-/- mice fail to regulate intestinal pathology and 
had massive inflammation in the gut lumen with leaking of LPS into the bloodstream, resulting in 
endotoxemia and septic shock [147,190,218]. In our study, mice deficient in IL-4Rα expression 
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specifically on B cells presented with severe gut inflammation indicated by bigger granulomas 
around the parasite eggs and increased infiltration of inflammatory cells similar to that observed 
in the highly susceptible IL-4Rα-/- mice. Therefore, these data suggest that severe gut 
inflammation may have contributed to heightened susceptibility of B cell-specific IL-4Rα 
deficient mice.  
 
Previous studies have demonstrated that B cell-deficient mice are susceptible to acute 
schistosomiasis due to accentuated granuloma formation and intensive fibrosis [232,233]. It was 
further shown that abrogating the expression of FcRγ resulted in exacerbated tissue pathology 
during both the acute and chronic phases of infection [233]. In this study, we compared mortality 
between B cell-deficient mice and mice lacking expression of IL-4Rα specifically on B cells to 
determine the factors contributing to extensive susceptibility to S. mansoni infection. We found 
that mb1
cre
IL-4Rα-/lox mice rapidly succumbed to S. mansoni infection compared to µMT mice and 
displayed 100% mortality by 10 weeks post-infection. In contrast, µMT mice survived the acute 
phase of infection without mortality and began to dramatically die during the chronic stage of 
infection, with 50% of mice succumbing to infection in one week. B cell deficient mice had 
extensive liver damage compared to mb1
cre
IL-4Rα-/lox mice as indicated by augmented granuloma 
formation and hepatic fibrosis. Consistent with previously published data, MLN cells from µMT 
mice stimulated with SEA failed to produce IL-4 and IL-10 while the production of IL-5 and IFN-
γ was comparable to littermate control mice [233]. Likewise, cells from mb1creIL-4Rα-/lox mice 
had decreased production of IL-4, IL-5 and IL-10 after antigen specific restimulation, while IFN-γ 
production was similar to that of littermate control mice. It is interesting to note that B cell 
deficient mice amplified the production of IL-10 in response to mitogenic stimulation compared 
to both mb1
cre
IL-4Rα-/lox mice and littermate control mice, suggesting that IL-10 may be playing 
an immunomodulatory role that results in the delayed susceptibility in these mice. Thus, these 
data suggest that the ability of B cells to respond to IL-4/IL-13 stimuli and not the absence of B 
cells is crucial for conferring protection against acute schistosomiasis. 
 
Studies have demonstrated that the host immune response is gradually attenuated as the infection 
progresses towards chronicity and this is indicated by the decreased size of newly formed 
granulomas and T cell hypo-responsiveness to egg antigen. Initially, CD8
+
 suppressor cells 
[229,271] and cross-regulatory cytokines produced by CD4
+
 T cells [230,231,270] were thought 
to be involved in the mechanism down-regulating the host immune response during the chronic 
stages. However, a study by Yap and colleagues demonstrated that mice deficient in functional 
CD8
+
 T cells or IFN-γ are still capable of down-modulating egg-induced pathology during chronic 
stages of infection [280]. However, mice deficient in B cells failed to down-regulate granuloma 
formation although T cell responsiveness was unaltered during the chronic stages of infection 
[232,233]. A recent study by Fairfax and colleagues showed that interference with IL-10R 
responsiveness results in severe chronic disease characterised by portosystemic shunting of the 
eggs to the heart and lungs due to increased hepatic-portal blood pressure [221]. In our study we 
found that B cell-specific IL-4Rα deficient mice failed to down-regulate liver and intestinal 
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granuloma size during the chronic stages of infection compared to littermate control mice. At 16 
weeks post-infection, production of the immunoregulatory cytokine IL-10 was significantly 
reduced in both mb1
cre
IL-4Rα-/lox and IL-4Rα-/- mice compared to littermate control mice, while at 
24 weeks post infection B cell-specific IL-4Rα deficient mice displayed dramatic up-regulation of 
IL-4, IL-6, IL-17 and IFN-γ. Importantly, S. mansoni eggs were found in the lungs and spleen of 
both mb1
cre
IL-4Rα-/lox mice and IL-4Rα-/lox mice, indicating the development of severe disease. In 
humans, hepatosplenic disease reflects a failure to modulate the immune response and causes 
mortality if left untreated [220]. 
 
B cells make large quantities of Th2 cytokines after being cultured in the presence of Th2 cells 
and antigen in vitro [105,106]. The lack of IL-4 producing B cells during Hp infection did not 
hamper parasite clearance, indicating that development of protective immunity occurs 
independently of B cell-derived IL-4 [90]. Consistent with this data, we found in our study that 
mice lacking IL-4 production specifically by B cells (B IL-4
-/-
) developed slightly reduced 
granuloma formation, normal fibrosis and hepatocellular damage, unaltered antigen-specific 
cytokine production and a CD4
+
 T cell activation profile similar to wild-type (WT) mice. 
Production of Th2 cytokines by CD4
+
 T cells stimulated with PMA/Ionomycin ex vivo was not 
affected in mice lacking IL-4 expression by B cells, although IFN-γ production was significantly 
reduced compared to WT mice. Liu and colleagues showed that B cell-derived IL-4 does not play 
an essential role in Th2 cell development [96]. B cell responses were sufficient in B IL-4
-/-
 mice 
as indicated by isotype switching towards the production of IgG1 and total IgE, recruitment of 
B220
+
 B cells into the lymphoid tissue, expansion of FO B cells and similar levels of cytokine 
production compared to WT mice. However, the expression of the activation markers MHC II and 
CD80 was abrogated in both B-IL-4
-/-
 and IL-4
-/-
 mice compared to WT mice. In a study by 
Wojciechowski and colleagues, IL-2 and TNF-α derived from B cells were found to mediate 
protection to Hp infection and contribute to the development of Th2 cells. Thus, B cell-derived 
IL-2 and TNF-α may be involved in the mechanism conferring protection during S. mansoni 
infection in mice.  
 
In conclusion, we have demonstrated that IL-4/IL-13 responsive B cells are required for surviving 
acute schistosomiasis and contribute towards limiting organ injury. Moreover, expression of IL-
4Rα on B cells is crucial for the development of optimal cellular and humoral immunity during 
infection. Mice lacking IL-4Rα expression specifically on B cells failed to down-modulate 
granuloma formation during the chronic stages of infection, exhibited T cell hyper-responsiveness 
at the later stages of infection and developed severe disease characterised by shunting of the eggs 
to the lungs and spleen. Lastly, B cell-derived IL-4 was shown not to be contributing towards the 
generation of host protective immune responses to S. mansoni infection.  
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CHAPTER 4 
 
IL-4/IL-13 responsive CD11c
+
 dendritic cells are required for protection against acute 
schistosomiasis and modulate T helper cell immunity. 
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International Center for Genetic Engineering and Biotechnology (ICGEB), Cape Town  Component and Institute of 
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Abstract 
Development of IL-4Rα-dependent Th2 immunity and granuloma formation is crucial for host 
survival during acute Schistosomiasis. Mice deficient in IL-4Rα expression on macrophages 
quickly succumb to S. mansoni infection due to increased liver and gut pathology. Furthermore, 
pan-T cell-specific IL-4Rα deficient mice (iLckcreIL-4Rα-/lox) were highly susceptible to acute 
schistosomiasis despite controlling gut inflammation, indicating a requirement for IL-4/IL-13 
responsive non-CD4
+
 T cells during protective responses. Other possible IL-4/IL-13 responsive 
cellular populations involved in conferring protection against acute schistosomiasis are yet to be 
identified. Hence, in this study, we investigated the role of IL-4Rα signalling on CD11c+ dendritic 
cells (DCs) during S. mansoni infection using a novel mouse (CD11c
cre
IL-4Rα-/lox) which lacks 
IL-4Rα expression on CD11c+ dendritic cells and alveolar macrophages. CD11ccreIL-4Rα-/lox 
Balb/c mice developed a severe wasting disease that resulted in 100% mortality by 13 weeks post-
infection. Mortality occurred despite controlled liver and intestinal pathology and was associated 
with increased serum TNF-α levels. Abrogation of IL-4Rα expression on DCs impacted on the 
activation of CD4
+
 T cells, resulting in reduced numbers of effector CD4
+
 T cells and impaired 
production of IL-5, IL-13 and IFN-γ by CD4+ T cells ex vivo. In addition, DCs and macrophages 
had significantly increased iNOS expression, a marker for classical activation. Therefore, IL-4/IL-
13 responsive CD11c
+
 DCs are required for surviving acute schistosomiasis and play an important 
role in orchestrating cellular immunity.  
 
Keywords: Dendritic cells, acute, schistosomiasis, T helper; mice. 
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4.1 Introduction 
Schistosomiasis is an important parasitic disease infecting more than 200 million people, mostly 
in the developing countries, and causing an estimated 280 000 deaths per annum in sub-Saharan 
Africa alone [265,266]. During infection in both humans and mice, S. mansoni eggs trapped in the 
host tissue (particularly in the liver) induce a strong granulomatous inflammatory response that is 
accompanied by augmented production of Th2 cytokines, eosinophilia, goblet cell hyperplasia and 
increased IgG1 and IgE production [131,217,281]. Infection of IL-4
-/-
 and IL-4/IL-13
-/-
 mice with 
S. mansoni revealed a crucial protective role for Th2 cytokine mediated responses and granuloma 
formation [148,219,222]. IL-4 and IL-13 are key Th2 cytokines that signal though the common 
receptor chain, the IL-4 receptor alpha (IL-4Rα) [167,168]. IL-4 exclusively signals through the 
type 1 receptor composed of IL-4Rα and the common gamma chain (γc) while both IL-4 and IL-
13 signal through the type II receptor comprising of IL-4Rα and IL-13Rα1 chains [167,168]. Mice 
deficient in IL-4Rα signalling quickly succumb to S. mansoni infection due to impaired 
granuloma formation, impaired Th2 polarization, increased liver inflammation and destruction of 
the gut integrity that results in endotoxemia and septic shock [147,148,190]. Therefore, IL-4 and 
IL-13 responsiveness plays a key role in down-regulating organ injury induced by S. mansoni 
eggs.  
 
Development of cell-specific IL-4Rα mutant mouse strains has proven to be an invaluable tool for 
dissecting the mechanisms conferring protection or susceptibility to the host during S. mansoni 
infection. Previous studies from our laboratory have demonstrated a pivotal role for IL-4/IL-13 
responsive macrophage in host protective responses during acute Schistosomiasis [147]. Mice 
deficient in IL-4Rα expression on macrophages (LysMcreIL-4Rα-/lox) were extremely susceptible 
to S. mansoni infection due to increased hepatocellular damage and intestinal inflammation that 
led to endotoxemia and septic shock [147]. Furthermore, using mice that lacked IL-4Rα 
expression on pan-T cells (iLck
cre
IL-4Rα-/lox), it was shown that IL-4Rα responsive non –CD4+ T 
cells contribute to resistance against acute schistosomiasis by controlling excessive liver 
inflammation [190]. Interestingly, the candidate IL-4Rα responsive cellular populations 
responsible for conferring protection against S. mansoni infection are yet to be identified. Here, 
we postulate that IL-4Rα responsive dendritic cells contribute to host protection to S. mansoni 
infection via amplification of the Th2 immune response.  
 
Dendritic cells (DCs) are the most specialised antigen presenting cells (APCs), capable of 
recognising and processing foreign antigen, migrating to the lymph nodes and efficiently initiating 
T cell activation [282,283,284]. The ability of DCs to orchestrate Th1/Th17 immunity in response 
to bacterial and viral pathogens is well established, whereas there is a paucity of understanding 
about their activation and functional capability in a Th2 setting induced by helminth infection 
[217,285]. However, recent studies conducted using CD11c-diphtheria toxin receptor mice to 
deplete CD11c
+
 DCs, have demonstrated a critical role played by CD11c
+
 DCs in inducing Th2 
immunity during S. mansoni infection [286]. Furthermore, bone marrow derived dendritic cells 
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(BMDCs) have been shown to respond to IL-4 by up-regulating alternative activation markers 
such as Ym1/2 and RELMα, and abrogation of IL-4Rα expression on DCs resulted in impaired 
IFN-γ production in both Th1 and Th2 settings [287]. Interestingly, IL-4 has been shown to 
induce the production of IL-12p70 by bone marrow derived dendritic cells (BMDCs) stimulated 
with bacterial LPS or CpG in vitro [288,289,290,291].  
 
Here, we investigated whether IL-4Rα signalling on DCs plays a role in rendering the host 
protected or susceptible during S. mansoni infection, utilising a transgenic mouse strain 
(CD11c
cre
IL-4Rα-/lox) where IL-4Rα expression was interrupted specifically on CD11c+ DCs. 
CD11c
cre
IL-4Rα-/lox mice were highly susceptible to S. mansoni infection regardless of their 
ability to down-regulate liver and gut inflammation. Furthermore, the lack of IL-4Rα expression 
on DCs did not inhibit production of key Th2 cytokines IL-4 and IL-5 after restimulation of total 
lymph nodes cells with either SEA or α-CD3 ex vivo. Interestingly though, production of both Th1 
and Th2 cytokines by CD4
+
 T cells was impaired in CD11c
cre
IL-4Rα-/lox mice. Finally, 
macrophage and DCs activation appeared to be skewed towards classical activation as indicated 
by elevated levels of iNOS. Together, these data reveal that IL-4Rα signalling on DCs is 
important for resistance to acute schistosomiasis and plays a major role in driving T cell 
responses. 
 
4.2 Materials and Methods 
Generation and genotyping of CD11c
cre
IL-4Rα-/lox Balb/c mice. CD11ccre mice were 
intercrossed with IL-4Rαlox/lox Balb/c mice [147]. These mice were further mated with 
homozygous IL-4Rα-/- Balb/c mice [248] to generate hemizygous CD11ccreIL-4Rα-/lox mice. 
Hemizygous littermates (IL-4Rα-/lox) were used as wild-type controls in all experiments. Mice 
were genotyped as described previously [147,248]. All mice were housed in specific pathogen-
free barrier conditions in individually ventilated cages at the University of Cape Town biosafety 
level 2 animal facility. Experimental mice were age and sex matched and used between 8-12 
weeks of age.  
 
Ethics statement. This study was performed in strict accordance with the recommendations of the 
South African national guidelines and University of Cape Town practice of laboratory animal 
procedure. All mouse experiments were performed according to the protocols approved by the 
Animal Research Ethics Committee of the Faculty of Health Sciences, University of Cape Town 
(protocol number: 010/041). Efforts were made to minimise and reduce suffering of animals.  
Live S. mansoni infection of mice. Mice were percutaneously infected with 100 live cercariae 
(acute infection) of a Puerto Rican strain of S. mansoni obtained from infected Biomphalaria 
glabrata (a generous gift from Adrian Mountford, York, UK). The mice will be monitored weekly 
until 7 weeks post-infection.  
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Footpad model. Mice were challenged by injection of 2 500 S. mansoni eggs into the right hind 
footpad and killed 7 days post-challenge. 
 
Antibodies and flow cytometry. The following antibodies comprising the B cell antibody panel 
were used: B220-V500, CD19-PerCP Cy5.5, CD23-PE, CD21-APC, CD24-PE Cy7, CD80-V450, 
MHCII-FITC and IgM-Biotin (BD Bioscience, Erembodegem, Belgium). T cells panel consisted 
of the following antibodies: CD4-PerCP, CD3-AlexaFluor 700, CD62L-V500, CD44-FITC, 
CD28-PE, CXCR5-V450 and CD278-Biotin (BD Bioscience, Erembodegem, Belgium). Cells 
were acquired on a FACS Fortessa machine (BD Immunocytometry system, San Jose, CA, USA) 
and data was analyzed using Flowjo software (Treestar, Ashland, OR, USA). 
 
Macrophage and dendritic cell staining. Activation profile of macrophage (CD11b
+
MHCII
+
) 
and DCs (CD11c
+
MHCII
+
) was analysed by flow cytometry. Classically activated macrophages 
and DCs were detected by staining for intracellular expression of iNOS using rabbit anti-mouse 
iNOS antibody (Abcam) with goat anti-rabbit PE (Abcam). Alternatively activated macrophages 
and DCs were detected by detecting Arginase 1 and Ym-1-Biotin using goat anti-mouse arginase 
(Santa Cruz Biotechnology) with donkey anti-goat PE (Abcam) and Strep-APC respectively. 
Staining specificity was verified by appropriate isotype-matched antibody controls and 
compensation performed with single-stain samples before acquiring the multi-coloured samples. 
Acquisition was performed using a FACSCalibur (BD Immunocytometry Systems). 
 
Intracellular cytokine staining. For detection of intracellular cytokines, MLN cells from S. 
mansoni infected mice or MST from S. mansoni eggs injected mice were plated at 1 × 10
6
 
cells/well and stimulated at 37ºC for 4 hours with 50 ng/ml phorbal (myristate acetate), 250 ng/ml 
ionomycin and 200 µM monensin in IMDM/10% FCS (all purchased from Sigma-Aldrich). Cells 
were stained with extracellular markers (CD4 Biotin-APC, B220 FITC or CD19 PercP), fixed for 
30 min on ice in 2% (w/v) paraformaldehyde and permeabilised with 0.5% saponin buffer and 
stained with PE-labelled anti-mouse IL-4, IL-5, IL-10 and IFN-γ for 15 min. Acquisition was 
performed using a FACSCalibur (BD Immunocytometry Systems, San Jose, CA, USA) and data 
were analysed using FlowJo software (Treestar, Ashland, OR, USA).  
 
Cell preparation and ex vivo restimulation. Single cell suspensions were prepared by pressing 
the draining lymph nodes through 70 µM cell-strainers. Cells were resuspended in complete 
DMEM (Gibco) supplemented with 10% FCS (Gibco) and penicillin and streptomycin (100 U/ml 
and 100 µg/ml, Gibco). The cells were cultured at 2 × 10
6
 cells/ml in 48-well plates coated with α-
CD3 (20 µg/ml) or soluble egg antigen (SEA, 20 µg/ml) and incubated at 37ºC in a humidified 
atmosphere containing 5% CO2. Supernatants were collected after 72 h and cytokines were 
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measured by ELISA. Quantities of IL-4, IL-10 and IL-13 were measured by sandwich ELISA as 
previously described [248]. 
 
Enzyme Linked Immunosorbent Assays (ELISAs). Cytokines in supernatant were measured by 
sandwich ELISA as previously described [248]. For antibody ELISAs, blood was collected in 
serum separator tubes (BD Bioscience, San Diego, CA) and serum was separated by 
centrifugation at 8 000 ×g for 10 min at 4ºC. Titres of SEA-specific IgG1, IgG2a, IgG2b and total 
IgE were determined as previously described [248] 
 
Hydroxyproline assay. Hydroxyproline content as a measure of collagen production was 
determined using a modified protocol [276]. Briefly, weighed liver samples were hydrolysed and 
added to a 40 mg Dowex/Norit mixture. The supernatants was neutralised with 1% 
phenolphthalein and titrated against 10 M NaOH. An aliquot was mixed with isopropanol and 
added to chloramine-T/citrate buffer solution (pH 6.5). Erlich’s reagent was added and absorbance 
was read at 570 nm. Hydroxyproline levels were calculated using 4-hydroxy-L-proline 
(Calbiochem) as a standard, and results were expressed as µmoles hydroxyproline per weight of 
tissue that contained 10
4
 eggs.  
 
Histology. Liver and gut samples were fixed in 4% (v/v) formaldehyde in phosphate buffered 
saline, embedded in wax and processed. Sections (5-7 µm) were stained with hematoxylin and 
eosin (H&E) and analine blue solution (CAB) and counterstained with Wegert’s hematoxylin for 
collagen staining. Micrographs of liver granuloma were captured using a Nikon 5.0 mega pixel 
colour digital camera (DCT DS-SMc).The diameter of each granuloma containing a single egg 
was measured with the ImageJ 1.34 software. An average of 25 granulomas per mouse was 
included in the analyses.  
 
Statistics. Statistical analysis was conducted using GraphPad Prism 4 software. Data was 
calculated as mean ± SD. Statistical significant was determined using the unpaired Student’s t test 
or 2-way ANOVA with Bonferroni’s post test, defining differences to IL-4Rα-/lox mice as 
significant (*,p≤0.05; **,p≤0.01; ***,p≤0.001). (Prism software; http://www.prism-software.com). 
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4.3 Results 
IL-4/IL-13 responsive CD11c
+
 dendritic cells are essential for survival in acute 
schistosomiasis 
In order to investigate the role of IL-4Rα responsive DCs during S. mansoni infection, 
CD11c
cre
IL-4Rα-/lox Balb/c, IL-4Rα-/- and IL-4Rα-/lox mice were infected with 80 live S. mansoni 
cercariae and mortality was monitored over a 16 weeks period (Fig 4.1A). Although IL-4Rα-/lox 
littermate control mice survived infection with little mortality and morbidity, all IL-4Rα-/- mice 
rapidly succumbed to infection by 10 weeks post-infection, and CD11c
cre
IL-4Rα-/lox mice 
succumbed to infection by 13 weeks post-infection ((Fig 4.1A). The high mortality rate observed 
in IL-4Rα-/- mice correlated with increased morbidity, indicated by severe body weight loss that 
began shortly after 6 weeks post-infection, coinciding with egg laying by the parasites (Fig 4.1B). 
Initially, infected CD11c
cre
IL-4Rα-/lox mice began to lose weight at 6 weeks post-infection, but 
appeared to recover around 9 weeks post-infection (Fig 4.1B). Nevertheless, they began to 
drastically lose weight again as they entered the more chronic stages of infection compared to IL-
4Rα-/lox littermate control mice (Fig 4.1B). These data suggests that IL-4/IL-13 responsive DCs 
are required for protection against acute schistosomiasis in mice. 
 
To investigate the mechanism responsible for increased susceptibility in CD11c
cre
IL-4Rα-/lox and 
IL-4Rα-/- mice, sera from infected mice were analysed for levels of aspartate transaminase (AST) 
and key cytokines IL-4 and TNF-α. Surprisingly, the levels of AST were similar between DC-
specific IL-4Rα-deficient mice and IL-4Rα-/lox littermate control mice (Fig 4.1C), indicating 
normal liver function. In contrast, levels of AST were significantly increased in sera from IL-4Rα-
/-
 mice compared with IL-4Rα-/lox littermate control mice, indicating increased hepatocellular 
damage (Fig 4.1C). The levels of serum TNF-α were significantly elevated in both CD11ccreIL-
4Rα-/lox mice and IL-4Rα-/- mice, while the levels of key protective cytokine IL-4 were reduced in 
both mutant strains compared with IL-4Rα-/lox littermate control mice (Fig 4.1D and E). These 
data show that elevated serum TNF-α level was associated with high mortality rates in mutant 
mouse strains.  
 
Another cause of death during S. mansoni infection in mice is septic shock caused by leaking of 
LPS into the bloodstream due to destruction of gut integrity [147,219]. Although both IL-4Rα 
mutant mice succumbed to S. mansoni infection, examination of organ pathology clearly showed 
that distinct mechanisms were responsible for mortality. Small intestines from IL-4Rα-/- mice 
were highly inflamed (Figure 4.1F). Furthermore, mice suffered from multiple organ defects, 
indicated by severe atrophy of the spleen and liver (Figure 4.1F). In contrast, small intestines from 
CD11c
cre
IL-4Rα-/lox mice showed little or no inflammation. However, mice presented with severe 
colon problem resulting in failure to excrete the faeces (Figure 4.1F).  
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Figure 4.1: IL-4Rα responsive CD11c+ dendritic cells are required for protection against acute schistosomiasis 
in mice. 
IL-4Rα-/lox, CD11ccreIL-4Rα-/lox and IL-4Rα-/- mice were infected with 80 live S. mansoni cercariae and survival 
monitored over a 16 week period. (A) Survival kinetics of mice infected percutaneously with 100 cercariae. (B) 
Percent body weight loss monitored on a weekly basis. (C) Serum levels of aspartate transaminase. (D-E), Serum 
levels of TNF-α and IL-4 was determined by ELISA. Data represents two independent experiments (n = 8-10). 
Survival curves were compared using Logrank test. *p< 0.05 and **p< 0.01 vs IL-4Rα-/lox mice. 
 
Unaltered cytokine production by total LN cells from CD11c
cre
IL-4Rα-/lox mice. 
Cellular responses were examined to determine whether abrogation of IL-4Rα responsiveness on 
CD11c
+
 DCs affects the development of Th2 immune responses during S. mansoni infection. 
Total draining lymph node cells were restimulated with SEA and α-CD3 and cytokines were 
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measured in the supernatants. The production of antigen specific Th2 cytokines (IL-4, IL-5 and 
IL-10) by total MLN cells was similar in CD11
cre
IL-4R
-/lox
 mice and littermate controls, 
although IL-13 production was reduced in CD11c
cre
IL-4R
-/lox 
mice (Fig 4.2A). Restimulation of 
total MLN cells with α-CD3 resulted in similar levels of IL-4, IL-5, IL-13 and IL-10 in 
CD11c
cre
IL-4Rα-/lox mice and littermate control mice, but increased level of Th1 cytokine IFN-γ in 
CD11c
cre
IL-4Rα-/lox mice (Fig 4.2B). These data suggests that Th1 and Th2 cytokines detected 
during antigen-specific and mitogen restimulation of total MLN cells may have come from non-
CD4
+
 T cell source. 
 
Single cell suspensions were prepared from mesenteric lymph node and cells were stained for 
flow cytometry. The total number of MLN cells was significantly reduced in CD11c
cre
IL-4Rα-/lox 
mice compared to littermate control mice (Fig 4.2C). This corresponded with a dramatic decrease 
in the total number of CD4
+
 T cells in CD11c
cre
IL-4Rα-/lox mice (Fig 4.2D), although the 
percentages of CD4
+
 T cells were similar between the CD11c
cre
IL-4Rα-/lox  mice and littermate 
control mice (data not shown). Likewise, the total number of effector CD4
+
 T cells was 
significantly reduced in CD11c
cre
IL-4Rα-/lox mice compared to littermate control mice (Fig 4.2E). 
This suggests that IL-4/IL-13 responsive DCs are required for promoting CD4
+
 T cell responses 
during S. mansoni infection. Cytokine secretion by LN CD4
+
 T cells was also determined by 
intracellular flow cytometry. Although the percentage of CD4
+
 T cells secreting IL-4 and IL-10 
was similar between CD11c
cre
IL-4Rα-/lox mice and littermate controls, the percentage of CD4+ T 
cells producing IL-5 and IL-13 was significantly reduced in CD11c
cre
IL-4R
-/lox 
mice (Fig 4.2F). 
In addition, production of Th1 cytokine IFN-γ by CD4+ T cells was also reduced in CD11ccreIL-
4Rα-/lox mice compared to littermate control mice, suggesting that IL-4/IL-13 responsive DCs are 
required to initiate and maintain cytokine production by CD4
+
 T cells.  
 
Reduced recruitment and activation of B cells in CD11c
cre
IL-4Rα-/lox mice. 
Depletion of CD11c
+
 DCs has been shown to affect B cells development during S. mansoni 
infection [286]. The levels of type 2 antibodies (SEA-specific IgG1 and total IgE) and type 1 
antibodies (SEA-specific IgG2a and IgG2b) were similar between infected CD11c
cre
IL-4Rα-/lox 
mice and littermate control mice (Fig 4.3A). In contrast, IL-4Rα-/- mice displayed elevated serum 
titres of SEA-specific type 1 antibodies and reduced type 2 antibodies (Fig 4.3A). Therefore, these 
data suggest that IL-4/IL-13 responsive DCs are not important for the development of humoral 
immune responses. Flow cytometry was performed to explore the role of IL-4Rα deficient DCs in 
B cell activation. The total number of CD19
+
 B cells was reduced in CD11c
cre
IL-4Rα-/lox mice 
compared to littermate control mice (Fig 4.3B). Expression of activation markers MHCII and 
CD86 by CD19
+
 B cells was also reduced in CD11c
cre
IL-4Rα-/lox mice compared with littermate 
control mice (Fig 4.3C). Furthermore, there was no difference in the secretion of IL-4 and IL-5 by 
CD19
+
 B cells from CD11c
cre
IL-4Rα-/lox mice compared to littermate control mice, except for the 
reduced secretion of IL-13 and IFN-γ (Fig 4.3D). Together, these data suggest that IL-4/IL-13 
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responsive DCs may affect activation of B cells, possibly via activation of CD4
+
 T cells and are 
crucial for the production of IL-13 and IFN-γ by CD4+ T cells.  
 
Figure 4.2: Decreased numbers of CD4
+
 T cells recruited to the draining lymph node of CD11c
cre
IL-4Rα-/lox 
mice. 
Single cell suspension was prepared from mesenteric lymph nodes and cells were stained for flow cytometry. (A-B) 
Cytokine production by mesenteric lymph node cells re-stimulated with either SEA or α-CD3 (mean ± SEM). (C) 
Total cell numbers in the draining lymph node. Total numbers of CD4
+
 T cells (D) and effector CD4
+
 T cells 
(CD4
+
CD44
hi
CD62L
lo
, E) in the lymph node. (F) Intracellular cytokine production by MLN CD4
+
 T cells re-
stimulated with 25 ng/ml PMA and 1 µg/ml ionomycin ex vivo in the presence of monensin. Data are representative 
of two independent experiments. **p< 0.01 vs IL-4Rα-/lox mice.  
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Figure 4.3: Antibody production and lymph node cell cytokine production in CD11c
+
 dendritic cell-specific IL-
4Rα deficient mice. 
IL-4Rα-/lox, CD11ccreIL-4Rα-/lox and IL-4Rα-/- mice were infected with 100 live S. mansoni cercariae and analysed 7 
weeks post-infection. (A) Serum antibody titres of SEA specific immunoglobulin (IgG) and total IgE were quantified 
by ELISA. (B) Total number of CD19
+
 B cells in the MLN. (C), Histograms showing the expression of MHC II and 
CD86 by CD19
+
 B cells. (D) Intracellular cytokine production by MLN CD19
+
 B cells re-stimulated with 25 ng/ml 
PMA and 1 µg/ml ionomycin ex vivo in the presence of monensin.  Data represents 2 independent experiments. n = 4-
6 mice. *p<0.05, **p<, 0.01 and ***p< 0.001 vs IL-4Rα-/lox mice. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
H. H. Ndlovu March 2013     Chapter 4 
  82 
 
 
IL-4/IL-13 responsive CD11c
+
 DCs are required for optimal Th2 responses to S. mansoni 
eggs injected into the footpad 
To confirm the importance of IL-4/IL-13 responsive DCs in Th2 priming, we utilised a controlled 
system where S. mansoni eggs were injected in the right hind footpad of CD11c
cre
IL-4Rα-/lox mice, 
IL-4Rα-/- mice and IL-4Rα-/lox littermate control mice. Antigen-specific (SEA) restimulation of 
total popliteal lymph node cells (pLN) revealed significantly reduced production of IL-13 in 
CD11c
cre
IL-4Rα-/lox mice, but no difference in the production of IL-4 and IL-10, compared to 
littermate control mice (Fig 4.4A). In global IL-4R  knock-out mice the levels of Th2 cytokines 
(IL-4, IL-13 and IL-10) were significantly reduced compared to littermate control mice (Fig 
4.4A), while IFN-γ production was significantly increased indicating a shift towards a Th1 
immune response (Fig 4.4A). Restimulation of total pLN cells with α-CD3 showed significantly 
reduced production of IL-4 in CD11c
cre
IL-4Rα-/lox mice, but production of IL-13 and IL-10 was 
similar to the littermate control mice (Fig 4.4B). Surprisingly, production of the Th1 cytokine 
IFN-γ was significantly reduced in CD11ccreIL-4Rα-/lox mice compared with littermate control 
mice (Fig 4.4B). Likewise, IFN-γ production was down-regulated in IL-4Rα-/- mice, 
concomitantly with the reduced levels of Th2 cytokines IL-4, IL-13 and IL-10. Interestingly, 
production of IL-4 and IFN-γ by CD19+ B cells was abrogated in CD11ccreIL-4Rα-/lox mice 
compared to littermate control mice while CD19
+
 B cells from IL-4Rα-/- mice failed to secrete 
both Th1 and Th2 cytokines following restimulation with PMA/Ionomycin ex vivo (Fig 4.4C). 
Therefore, these data suggests that antigen-specific IL-13 production is dependent on IL-4/IL-13 
responsive DCs.  
 
Increased production of INOS by IL-4Rα deficient DCs.  
Previously it was shown that bone marrow derived DCs (BMDCs) restimulated with recombinant 
IL-4 in vitro up-regulated the production of Relm-α and Ym-1/2 and had increased mRNA 
transcripts for Retnla, Clec7a, Mrc1 and Ccl24 [287], markers previously associated with 
alternatively activated macrophages [292,293]. We assessed the impact of IL-4Rα deficiency on 
DCs during live S. mansoni infection. The proportion and median of Ym-1 expression by 
CD11c
+
MHCII
+
 DCs was similar between CD11c
cre
IL-4Rα-/lox mice and littermate control mice 
(Fig 4.5A). In contrast, expression of iNOS by DCs was significantly up-regulated in IL-4Rα 
deficient DCs, indicating a shift towards classical activation of DCs (Fig 4.5B). Macrophages 
from CD11c
cre
IL-4Rα-/lox mice also displayed a classically activation profile indicated by 
increased expression of iNOS by CD11b
+
MHCII
+
 macrophages and decreased Ym-1 expression 
(Fig 4.5C and D). Finally, the proportion of CD11c
+
MHCII
+
 DCs producing IL-12 and IL-10 was 
significantly reduced in CD11c
cre
IL-4Rα-/lox mice compared to littermate control mice (Fig 4.5E)..  
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Figure 4.4: Reduced production of Th2 cytokines by total pLN cells. 
IL-4Rα-/lox, CD11ccreIL-4Rα-/lox and IL-4Rα-/- mice were injected with 2 500 S. mansoni egg in the right hind footpad 
and mice were killed 7 post-infection. Single cells suspension of popliteal lymph node (pLN) cells was prepared and 
cells were in vitro restimulated with 20 µg/ml SEA or 20 µg/ml α-CD3 for 72 hrs. Data shown are gated on CD19+ B 
cells. (A) Cytokine production by total pLN restimulated with 20 µg/ml SEA. (B) Cytokine production by total pLN 
cells restimulated with 20 µg/ml α-CD3. (C) Intracellular cytokine production by CD19+ B cells after restimulation 
with 25 ng/ml PMA and 1 µg/ml ionomycin in vitro Data are representative of two independent experiments. n= 6 
mice.  *p< 0.05, **p< 0.01 and ***< 0.001 vs IL-4Rα-/lox mice. 
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Figure 4.5: Elevated expression of iNOS in CD11c
+
 dendritic cells deficient in IL-4Rα expression. 
Single cell suspensions were prepared from liver tissue and cells were stained for FACS. (A-B) Analysis of Ym-1 and 
iNOS intracellular expression by CD11c
+
MHCII
+
 dendritic cells in the liver. (C-D) Intracellular expression of Ym-1 
and iNos by CD11b
+
MHCII
+
 liver macrophages. (E) Intracellular cytokine production by CD11c
+
MHCII
+
 dendritic 
cells in the draining mesenteric lymph node after re-stimulation with 25 ng/ml PMA and 1 µg/ml Ionomycin. . Data 
represents two independent experiments. *p< 0.05 and **p< 0.01 vs IL-4Rα-/lox mice. 
 
CD11c
cre
IL-4Rα-/lox mice have reduced liver and gut pathology after S. mansoni infection 
IL-4Rα signalling is critical for controlling granulomatous pathology during S. mansoni infection 
[147,186,190]. Previously, abrogation of IL-4Rα signalling on macrophages resulted in 
augmented granuloma formation, increased hepatocellular damage indicated by elevated serum 
AST, and unaltered hydroxyproline production, thus suggesting that IL-4/IL-13 responsive 
macrophages are essential for down-modulating liver pathology [147]. Therefore, we investigated 
the contribution of IL-4/IL-13 responsive dendritic cells in granulomatous liver pathology induced 
by S. mansoni eggs. Histological examination of H&E stained liver sections from IL-4Rα mutant 
strains revealed impaired granuloma formation (Fig 4.6A) and reduced collagen production, 
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quantified as hydroxyproline compared to littermate control mice (Fig 4.6B). Serum AST levels 
were increased in IL-4Rα-/- mice while it was similar between CD11ccreIL-4Rα-/lox mice and 
littermate control mice (Fig 4.6C). Both the CD11c
cre
IL-4Rα-/lox and IL-4Rα-/- mice had 
significantly reduced levels of tissue IL-10 and IFN-γ compared to control mice (Fig 4.6D & E). 
Histological examination of liver sections showed that both CD11c
cre
IL-4Rα-/lox and IL-4Rα-/- 
developed smaller granulomas around parasite eggs than the littermate control mice (Fig 4.6F). 
Therefore, these data suggest that the lack of IL-4/IL-13 responsive DCs ameliorates liver 
pathology by limiting granuloma formation and fibrosis induced by S. mansoni eggs. 
 
Figure 4.6: CD11c
cre
IL-4Rα-/lox mice develop reduced liver pathology during acute schistosomiasis. 
IL-4Rα-/lox, CD11ccreIL-4Rα-/lox and IL-4Rα-/- mice were infected with 100 S. mansoni cercariae and analysed 7 weeks 
post-infection. (A) Granuloma area surrounding eggs quantified by microscopic analysis on H&E stained sections. 
Twenty to 30 granulomas per mouse were included in the analysis. (B) Liver fibrosis measured as hydroxyproline 
normalised to egg numbers. (C) Hepatocellular damage measured as serum levels of aspartate transaminase enzyme. 
(D) Formalin-fixed liver sections (100×) stained with H&E for morphological analysis or CAB for collagen content. 
Data is representative of 2 independent experiments. n= 4-6 mice. *p< 0.05, **p< 0.01 and ***p< 0.001 vs IL-4Rα-
/lox
. 
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To determine the contribution of IL-4/IL-13 responsive DCs to gut inflammation induced by S. 
mansoni eggs, gut hydroxyproline content and the number of S. mansoni eggs trapped in the tissue 
were quantified. This suggests that deletion of IL-4Rα signalling specifically on CD11c+ DCs and 
all haematopoietic cells has no impact on worm maturity. There was no significant difference in 
the quantity of gut hydroxyproline or the number of eggs trapped in the tissue between mutant 
strains and littermate control mouse (Fig 4.7A & B). Furthermore, CD11c
cre
IL-4Rα-/lox mice 
showed reduced gut inflammation, indicated by reduced inflammatory cells surrounding the eggs, 
while IL-4Rα-/- mice had increased gut inflammation compared to littermate control mice (Fig 
4.7C). These data suggests that IL-4/IL-13 responsive DCs may be driving immune responses 
mediating severe gut inflammation during S. mansoni infection.  
 
 
Figure 4.7: Reduced gut pathology in CD11c
cre
IL-4R
-/lox
 mice during acute schistosomiasis. 
IL-4Rα-/lox, CD11ccreIL-4Rα-/lox and IL-4Rα-/- mice were infected with 100 S. mansoni cercariae and analysed 7 weeks 
post-infection. (A) Intestinal fibrosis measured as hydroxyproline normalised to tissue egg numbers (mean ± SEM, n= 
4-6). (B) Intestinal eggs numbers normalised to tissue weight (mean ± SEM, n= 4-6). (C) Reduced inflammation 
shown in H&E stained sections of the small intestine (×100). Data represents two independent experiments. 
 
4.4 Discussion 
Studies have demonstrated that IL-4 driven Th2 immune responses and granuloma formation are 
vital for host protection during S. mansoni infection [148,217,219,222]. Recent studies have 
delineated specific IL-4 responsive cellular populations that are crucial for prolonging survival to 
acute schistosomiasis. Mice deficient in IL-4/IL-13 responsive macrophages were found to be 
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extremely susceptible to S. mansoni infection due to increased hepatocellular damage, impaired 
egg expulsion, increased NOS-2 activity and gut inflammation that ultimately led to endotoxemia 
and septic shock [147]. Moreover, mice deficient in IL-4Rα expression on pan-T cells quickly 
succumbed to S. mansoni infection, despite controlling gut inflammation, in contrast to mice 
lacking IL-4R  only on CD4
+
 T cells, which resisted S. mansoni infection similarly to control 
mice [186,190]. This suggests that IL-4/IL-13 responsive non-CD4
+
 T cells contribute to host 
resistance during infection [190]. However, the contribution of IL-4/IL-13 responsive CD11c
+
 
dendritic cells (DCs) in the host protection or susceptibility to S. mansoni infection and their 
impact on the development of polarised Th2 immune response and tissue pathology have not yet 
been fully explored. To address these critical questions, novel mice lacking IL-4Rα expression 
specifically on CD11c
+
 DCs (CD11c
cre
IL-4Rα-/lox) were generated using the cre/loxP recombinase 
system under the control of the CD11c gene locus [192].  
 
CD11c
cre
IL-4Rα-/lox mice infected with S. mansoni developed a slow and prolonged wasting 
disease that ultimately resulted in 100% mortality during the chronic stages (13 weeks) of 
infection as compared to IL-4Rα-/lox littermate control mice that had 25% mortality throughout the 
infection period. In contrast, IL-4Rα-/- mice quickly succumbed to infection and developed severe 
cachexia immediately after the onset of egg-laying. Previous studies have demonstrated that the 
mechanism responsible for mortality in IL-4Rα-/- mice is caused by increased hepatocellular 
damage, up-regulation of proinflammatory cytokines particularly TNF-α, impaired faecal egg 
output, impaired granuloma formation and augmented gut inflammation and damage with 
subsequent septicaemia [147,148,190]. A similar mechanism was the cause of death in mice 
deficient in alternatively activated macrophages [147] and IL-4, IL-4/IL-13 and IL-10/IL-4 
deficient mice [148,218,219,222]. Conversely, IL-10/IL-12 double deficient mice died of a 
distinct mechanism characterised by a wasting disease, relatively low AST levels indicating little 
hepatotoxicity, increased serum TNF-α levels and augmented hepatic fibrosis [222]. Infected 
CD11c
cre
IL-4Rα-/lox mice displayed low serum AST levels but increased serum TNF-α levels, 
suggesting that TNF-α may be contributing to mortality. High levels of IFN-γ, TNF-α and soluble 
TNF receptor  are associated with severe hepatosplenomegaly caused by S. mansoni infection in 
human patients [238,294]. Therefore, impairment of IL-4/IL-13 signalling on DCs is extremely 
detrimental to the host during the later stages of S. mansoni infection. Furthermore, CD11c
cre
IL-
4Rα-/lox mice appear to be dying from a mechanism that is distinct from that operating in the 
highly susceptible IL-4Rα-/- mice. 
 
S. mansoni eggs trapped in the host tissue induce a highly polarised Th2 immune response 
characterised by up-regulation of cytokines such as IL-4, IL-5 and IL-13 and type 2 anti-
Schistosoma antibodies [217,281]. Depletion of CD11c
+
 DCs inhibits the production of Th2 
cytokines by splenocytes and CD4
+
 T cells during synchronous challenge with S. mansoni eggs 
[286]. In addition, adoptive transfer of SEA sensitised IL-4R
-/-
 BMDCs resulted in impaired 
production of IL-10 and IFN-γ by restimulated pLN cells, suggesting that IL-4/IL-13 responsive 
DCs regulate Th1 polarisation in vivo [287]. In our study, restimulation of total MLN cells with 
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SEA revealed similar production of both Th1 and Th2 cytokines in CD11
cre
IL-4R
-/lox
 mice 
compared to littermate controls, except for diminished production of IL-13. CD11c
cre
IL-4Rα-/lox 
mice displayed dominant type 2 antibody responses characterised by secretion of antigen-specific 
IgG1 and total IgE, similar to the levels produced by the IL-4Rα-/lox littermate control mice. In 
contrast, a previous study showed that partial depletion of CD11c
+
 DC impaired secretion of IgE 
despite unaltered levels of serum IgM and IgG1 [287]. Deletion of IL-4Rα expression on CD11c+ 
DCs had a dramatic impact on the recruitment of effector CD4
+
 T cells during infection. This 
agrees with previously published data, where depletion of CD11c
+
 DCs hindered induction of 
effector and regulatory CD4
+
 T cells during the initiation of the response against S. mansoni 
infection [286]. Abrogation of IL-4Rα expression on DCs impaired secretion of Th2 cytokines IL-
5 and IL-13 and Th1 cytokine IFN-γ by CD4+ T cells restimulated with PMA/Ionomycin ex vivo, 
suggesting that IL-4/IL-13 responsive DCs are important for the production of cytokines by CD4
+
 
T cells during infection. Likewise, secretion of Th1 and Th2 cytokines by CD4
+
 T cells was 
impaired following the depletion of CD11c
+
 DCs during infection in the previous study [286]. 
Therefore, this strongly suggests that non-CD4
+
 T cells were the source of Th1 and Th2 cytokines 
detected after antigen specific restimulation of total MLN cells from infected CD11c
cre
IL-4Rα-/lox 
mice. Beyond affecting CD4
+
 T cell responses, depletion of CD11c
+
 DCs was previously shown 
to inhibit B cell development by altering the proportions of marginal zone, follicular and 
transitional B cells [286]. Recruitment of CD19
+
 B cells was impaired in mice deficient in IL-4Rα 
expression on DCs and expression of activation markers MHCII and CD86 was reduced. 
Therefore, the absence of IL-4Rα expression on DCs seems to have a dramatic effect on the 
activation of both CD4
+
 T cells and CD19
+
 B cells.  
 
In a study by Phythian-Adams and colleagues, depletion of CD11c
+
 DCs during challenge with S. 
mansoni eggs resulted in polarised production of Th1 cytokine IFN-γ and concomitantly reduced 
production of IL-4 and IL-10 by pLN cells stimulated with SEA [286]. In addition, production of 
IL-10 and IFN-γ by SEA stimulated pLN cells was found to be dependent on IL-4Rα expression 
on DCs [287]. However, our findings contradict this data, since the production of IL-4, IL-5, IL-
10 and IFN-  by total pLN cells stimulated with SEA was similar in CD11c
cre
IL-4Rα-/lox mice 
compared to littermate control mice after synchronous S. mansoni eggs injection into the right 
hind footpad. In stark contrast, SEA stimulation of pLN cells from global IL-4Rα-/- mice resulted 
in dramatically impaired production of IL-4, IL-13 and IL-10, and increased production of IFN-α, 
suggesting a shift towards Th1 immunity. Interestingly, the lack of IL-4/IL-13 responsive DCs 
had a dramatic impact on the proportions of cytokine producing B cells.  
 
Previously, in vitro stimulation of IL-4/IL-13 responsive BMDCs with recombinant IL-4 resulted 
in substantial up-regulation of mRNA transcripts and protein secretion of RELMα, Ym-1, MR and 
Dectin-1 [287], markers previously associated with alternatively activated macrophages 
[292,293]. In our study, IL-4/IL-13 unresponsive DCs were found to have unaltered expression of 
Ym-1 and increased iNOS expression, indicating a subtle shift towards classical activation. In 
addition, macrophages from CD11c
cre
IL-4Rα-/lox mice displayed a classical activation phenotype 
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characterised by up-regulation of iNOS and down-regulation of Ym-1 expression, which could be 
a result of the decreased production of Th2 cytokines by CD4
+
 T cells. Alternatively activated 
macrophages down-modulate organ injury caused by S. mansoni eggs trapped in the host tissue 
[147] and function as effector cells mediating host protection against H. polygyrus infection [295]. 
In contrast, alternatively activated macrophages increase susceptibility to L. major infection 
[296,297].  
 
Mature DCs are capable of polarising Th cell immunity by influencing the cytokine 
microenvironment where T cell activation occurs. In the presence of pathogen products such as 
CpG DNA or LPS, IL-4 instructs BMDCs to up-regulate IL-12 secretion by suppressing IL-10 
production [288,290,291]. Interestingly, murine DCs stimulated with SEA have a muted 
activation profile characterised by little or no up-regulation of maturation markers MHCII, CD80 
and CD86 [298], impaired production of proinflammatory cytokines IL-12p70, TNF, IL-6 and 
most notably, they are unable to induce the production of anti-inflammatory cytokines IL-10 and 
IL-4 [299,300]. Interestingly, the production of both IL-12 and IL-10 was impaired in DCs from 
infected CD11c
cre
IL-4Rα-/lox mice after restimulation with PMA/Ionomycin ex vivo, supporting 
the previously published data. This had a dramatic impact on the production of both Th1 and Th2 
cytokines by CD4
+
 T cells from infected CD11c
cre
IL-4Rα-/lox mice, suggesting that IL-4/IL-13 
responsive DCs may regulate Th1 and Th2 immune responses via IL-10 and IL-12 production. 
Accumulating reports suggest that DC-derived IL-10 is capable of promoting Th2 responses 
[301,302], T cell tolerance [303,304] and prevent expansion of Th1 immunity through its 
autocrine inhibition of IL-12 secretion [305]. 
 
Infected CD11c
cre
IL-4Rα-/lox mice developed smaller liver granulomas, reduced fibrosis and 
unaltered levels of AST, an enzyme indicating hepatocellular damage compared to littermate 
control mice. In accordance with previously published data, global IL-4Rα-/- mice presented 
impaired liver granuloma formation, reduced hepatic fibrosis and enhanced serum AST levels 
compared to littermate control mice [147,148,186,190]. IL-13 is known as a key cytokine 
mediating hepatic fibrosis by activating collagen production by fibroblasts [149,224,306] . 
Moreover, Th1 cytokines IL-12 and IFN-γ are capable of suppressing collagen deposition [307]. 
Hence, the reduced production of IL-13 by SEA restimulated MLN cells from infected 
CD11c
cre
IL-4Rα-/lox mice offers a plausible explanation for impaired hepatic fibrosis in these 
mice. Therefore, abrogation of IL-4/IL-13 responsiveness on DCs impairs S. mansoni eggs 
induced liver pathology that may contribute towards morbidity in the host.  
 
Studies have unequivocally demonstrated that mice that quickly succumb to S. mansoni infection 
developed an augmented gut inflammation, accompanied by destruction of gut lumen that 
ultimately results in endotoxemia and septic shock [147,148,218,222]. Paradoxically, iLck
cre
IL-
4Rα-/lox mice were able to control S. mansoni eggs induced gut inflammation and endotoxemia 
although they were highly susceptible to infection [190]. In agreement with these findings, 
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infected CD11c
cre
IL-4Rα-/lox mice managed to control gut inflammation as indicated by smaller 
granuloma size and less infiltrating cells around the eggs compared to global IL-4Rα-/- mice and 
littermate control mice. Therefore, these findings further support our contention that the 
mechanism responsible for mortality in CD11c
cre
IL-4Rα-/lox mice is distinct from that operating in 
IL-4Rα-/- mice.  
 
In conclusion, our study demonstrates that IL-4/IL-13 responsive DCs are crucial for conferring 
host protection to S. mansoni infection by limiting the deleterious effects of the proinflammatory 
cytokine TNF-α and regulating recruitment of effector CD4+ T cells and CD4+ T cell cytokine 
production. The lack of IL-4Rα expression on DCs skewed DCs and macrophage activation 
profiles toward classical activation as indicated by up-regulated expression of iNOS. Interestingly, 
the inability of DCs to respond to IL-4/IL-13 signalling resulted in impaired production of both 
IL-10 and IL-12, providing an explanation for diminished cytokine production by CD4
+
 T cells.  
  
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 5: GENERAL DISCUSSION 
 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
H. H. Ndlovu March 2013 General discussion 
91 
 
General discussion 
The aim of this thesis was to address the role of CD28 costimulation during recall of protective 
memory immune responses against secondary infection with N. brasiliensis and to investigate the 
contribution of IL-4/IL-13 responsive B cells and CD11c
+
 dendritic cells in host protective 
immune responses during S. mansoni infection. In the first study, the requirement of CD28 
costimulation during recall of memory responses against nematode infections was investigated 
using a novel mouse model (CD28
-/lox
Cre
+/-
) that allowed for inducible deletion of cd28 gene by 
oral administration of tamoxifen. As expected, CD28
-/-
 mice failed to expel N. brasiliensis adult 
worms during primary infection compared to C57BL/6 mice. This was further confirmed by 
blocking CD28 signalling with mouse anti-mouse CD28 monoclonal antibody. Previous studies 
have unequivocally demonstrated the importance of IL-13, IL-4Rα and STAT-6 in the expulsion 
of N. brasiliensis adult worms from infected mice [144,145,155]. The production of Th2 
cytokines IL-4 and IL-13 was impaired in CD28
-/-
 mice following restimulation of total lymph 
node cells with either NAg plus sub-optimal concentration of α-CD3 or α-CD3 alone ex vivo. 
Furthermore, humoral immunity was abrogated in CD28
-/-
 mice compared to control C57BL/6 
mice. Therefore, CD28 costimulation is indispensable for the development of host protective 
immune responses to primary infection with N. brasiliensis.  
 
Importantly, mice treated with tamoxifen prior to secondary infection failed to clear N. 
brasiliensis secondary infection, similarly to the conventional CD28
-/-
 mice. Both the tamoxifen 
treated (CD28
-/lox
Cre
+/-
+TM) and CD28
-/-
 mice failed to develop sufficient Th2 immune responses 
indicated by reduced production of key cytokines IL-13 and IL-4 after restimulation of total MST 
cells with either NAg plus sub-optimal α-CD3 or α-CD3 alone ex vivo. Moreover, CD28-/loxCre+/-
+TM mice exhibited impaired humoral immunity, reduced numbers of effector CD4
+
 T cells and 
CXCR5
+
 TFH cells. Cognate interaction between TFH cells and B cells is essential for germinal 
center formation and antibody production by B cells [60]. Previous studies have demonstrated that 
IL-4 producing Th2 cells can differentiate into TFH in the reactive lymph nodes during 
immunisation with S. mansoni antigens [258] and during infection with H. polygyrus [259]. 
Together, our findings suggest that CD28 costimulation is crucial for recall of efficient memory 
immune responses that provide protection against N. brasiliensis secondary infection.  
 
Earlier studies aimed at elucidate factors governing the mechanisms conferring host protection or 
susceptibility to S. mansoni infection utilised gene deficient mice. These studies demonstrated that 
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IL-4, IL-4/IL-13, IL-4Rα and STAT-6 are essential for the development of host protective Th2 
immune responses and granuloma formation during S. mansoni infection in mice 
[148,149,218,219]. In our laboratory, we have generated novel mouse models lacking IL-4Rα 
expression on specific cell-types and these have been tested with different infectious disease 
models. Mice lacking IL-4Rα expression on macrophages (LysMcreIL-4Rα-/lox) were found to be 
extremely susceptible to S. mansoni infection due to increased production of Th1 cytokines, 
uncontrolled liver inflammation, impaired egg expulsion, increased NOS-2 activity and 
exaggerated gut pathology [147]. Therefore, this study demonstrated that IL-4/IL-13 responsive 
alternatively activated macrophages play an essential role in host protection during acute 
schistosomiasis and limit tissue injury by down-regulating egg-induced inflammation. Subsequent 
studies from our laboratory demonstrated the importance of IL-4Rα expression on pan-T cells 
[190] and smooth muscle cells [188] in the development of host protective immune responses 
during S. mansoni infection in mice. Recently, novel mouse models deficient in IL-4Rα 
expression on B cells [191] and CD11c
+
 DCs [192] have been generated and characterised in our 
laboratory.  
 
In the second study, we used the previously characterised B cell-specific IL-4Rα deficient mice 
(mb1
cre
IL-4Rα-/lox) [191], to investigate the role of IL-4/IL-13 responsive B cells in host protective 
immune response during acute schistosomiasis. In this study we used three experimental models 
of S. mansoni, acute infection model where mice were infected with 100 live cercariae, a chronic 
infection model where mice were infected with 30 live cercariae and a more controlled pulmonary 
model where mice were synchronously challenged with S. mansoni eggs. We found that IL-4/IL-
13 responsive B cells are crucial for protection against acute schistosomiasis and down-regulate 
liver and gut inflammation. Macrophages from infected mb1
cre
IL-4Rα-/lox mice displayed a 
classically activated phenotype characterised by up-regulation of iNOS production and reduced 
expression of Ym-1 compared to littermate control mice. Alternatively activated macrophages 
have been shown to be essential for protection against S. mansoni infection by limiting organ 
injury [147]. Importantly, production of both Th1 and Th2 cytokines by CD19
+
 B cells was 
impaired in mb1
cre
IL-4Rα-/lox mice compared to littermate control mice. Furthermore, the 
recruitment of CXCR5
+
 TFH cells, effector CD4
+
 T cells and follicular B cells was impaired in 
mice deficient in IL-4Rα expression on B cells compared to littermate control mice. Together, 
these findings suggest that IL-4/IL-13 responsive B cells are important for development of CD4
+
 
T cell immunity and alternative activation of macrophages during S. mansoni infection.  
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The contribution of B cells in down-regulating granuloma formation during the chronic stages of 
S. mansoni infection is well established [148,232]. However, the requirement of IL-4/IL-13 
responsive B cells in regulating granuloma formation and T cell responsiveness during the chronic 
stages of infection has not yet been studied. Mb1
cre
IL-4Rα-/lox mice failed to down-regulate 
granuloma formation and T cell responsiveness during the chronic stages of infection. The 
importance of IL-4/IL-13 responsive B cells in limiting granuloma formation was further 
demonstrated in the pulmonary model where lungs from mb1
cre
IL-4Rα-/lox mice had bigger 
granulomas compared to littermate control mice. Therefore, we have unequivocally demonstrated 
the importance of B cells responsive to IL-4/IL-13 signalling during down-regulation of 
granuloma formation induced by S. mansoni eggs.   
 
It is well established that the development of a Th2 immune responses is indispensable for host 
protection against S. mansoni infection [147,148,218,219]. Hence, we hypothesised that IL-4 
derived from B cells initiates the development of the host protective Th2 immune responses 
during S. mansoni infection. Our data from BM chimera mice showed that B cell derived IL-4 is 
not crucial for the development of sufficient Th2 immune responses during S. mansoni infection. 
The findings are in agreement with the previous findings, where IL-4 producing B cells were 
shown to be unnecessary for protection against H. polygyrus infection [90]. However, B cell 
derived IL-2 and TNF-α were shown to regulate immunity to H. polygyrus infection [90]. We 
suspect that a similar mechanism might operate in mice infected with S. mansoni. Hence, future 
work will involve generating BM chimeras that lack IL-2 and TNF-α production specifically by B 
cells. Furthermore, we plan to generate BM chimeras lacking MHC II expression on B cells to 
study the importance of antigen presentation by B cells and how it influences the development of 
host protective immune responses during S. mansoni infection.  
 
In the third study, we determined the role of IL-4/IL-13 responsive CD11c
+
 DCs during S. 
mansoni infection using a novel mouse model lacking IL-4Rα expression specifically on CD11c+ 
DCs (CD11c
cre
IL-4Rα-/lox). In this study we used two experimental models of S. mansoni; acute 
infection model and the footpad model where S. mansoni eggs were injected into hind footpad of 
mice. Our study found that IL-4/IL-13 responsive DCs are essential for surviving S. mansoni 
infection despite controlled liver and gut inflammation. Deletion of IL-4Rα expression on DCs 
impaired activation of CD4
+
 T cells as indicated by abrogated intracellular production of IL-5, IL-
13 and IFN-γ by CD4+ T cells stimulated with PMA/Ionomycin ex vivo and reduced numbers of 
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effector CD4
+
 T cells. We further showed that the production of Th2 cytokine by total pLN cells 
from CD11c
cre
IL-4Rα-/lox mice was unaltered compared to littermate control mice following 
restimulation with SEA. This contradicts previously published data where depletion of CD11c
+
 
DCs was shown to result in reduced production of Th2 cytokines IL-4 and IL-10 by pLN cells 
stimulated with SEA ex vivo [286]. The activation profile of DCs and macrophages showed a shift 
towards classical activation indicated by increased iNOS expression and a concomitant reduced 
expression of Arg-1, a marker for alternatively activated macrophages. Alternatively activated 
macrophages are associated with limiting inflammation and wound healing [292]. 
 
In conclusion, cell-specific IL-4Rα deficient mice offer a unique tool for studying the mechanisms 
conferring protection or susceptibility to the host during S. mansoni infection. The results 
presented in this thesis demonstrate the importance of IL-4Rα signalling on B cells and CD11c+ 
DCs in the development of host protective immune responses to S. mansoni infection. The 
complexity of the mechanisms conferring host protective immunity to S. mansoni infection and 
the many different IL-4Rα expressing cell types involved in disease protection present significant 
challenges for developing an effective vaccine. Hence, more work is still needed to dissect the key 
factors contributing to the immunological mechanism of schistosomiasis. 
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APPENDIX A 
Reagents: 
Anaesthetic 
1.2 ml  Anaket-V (100mg/ml) (Centaur labs, Isando) 
0.8 ml  Rompun (2%) (Bayer, Germany) 
8.0 ml  PBS (1X) 
 
Blocking Buffer 
20g  Milk powder (spar instant) (2%) 
Make up to 1L with 1X PBS 
 
Coating Buffer 
10 ml  10X PBS 
8g  BSA (Merck) 
Make to 1L in ddH2O and pH 9.5 
 
Dilution Buffer 
10g  BSA (1%) (Roche) 
0.2g  NaN3 (0.02%) (Merck) 
Make up to 1L with 1X PBS 
 
FACS Buffer 
0.1%  BSA (Roche) 
0.05%  NaN3 (Merck) 
Make up in 1X PBS 
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Iscove’s Modified Dulbecco’s Medium (IMDM) 
500 ml  IMDM (Gibco) 
2.5 ml  Penicillin/streptomycin (200X) 
10%  FCS 
Adjust pH to 7.2 – 7.4 
 
Phosphate Buffered Saline (PBS 10X) 
80g  NaCl (1.37M) 
2g  KCl (0.03M) 
14.4g  H2PO4 (0.01M) 
2.4g  KH2PO4 
Dissolve in 1L ddH2O 
 
Red cell lysis buffer 
5 mM  EDTA    150mM  NaCl 
10%  glycerol   25 mM   Tris-Cl pH 7.5 
0.1%  SDS    1%   Triton-X 100 
0.5%  Non idet P-40   0.5%   Deoxycholate 
5 mM  PMSF 
Make to 1L with ddH2O 
 
Substrate Buffer 
0.2g  NaN3 (0.02%) 
97 ml  di-ethanolamine 
0.8g  MgCl2.6H2O 
700 ml  ddH2O 
Adjust the pH to 9.8 and make up to 1L with ddH2O 
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Washing Buffer (20X) 
20g  KCl 
144g  Na2HPO4.H2O 
50 ml  Tween 
20g  KH2PO4 
800g  NaCl  
100 ml  10% NaN3  
Make up to 5L with ddH2O 
 
 
